| NO | NAME OF PRODUCT | COMPOSITION | GRADE | STRENGTH | MARKET |
| 1 | ACECLOFENAC TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ACECLOFENAC | I.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 2 | ACECLOFENAC, DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ACECLOFENAC | I.P. | 100 MG | |||
| DROTAVERINE HYDROCHLORIDE | I.P. | 80 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 3 | ACECLOFENAC, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ACECLOFENAC | I.P. | 100 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 4 | ACECLOFENAC, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ACECLOFENAC | I.P. | 100 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 5 | ACECLOFENAC, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ACECLOFENAC | B.P. | 100 MG | |||
| PARACETAMOL | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 6 | ACECLOFENAC, THIOCOLCHICOSIDE TABLETS | EACH FILM COATED TABLETS CONTAINS: | DOMESTIC | ||
| ACECLOFENAC | I.P. | 100 MG | |||
| THIOCOLCHICOSIDE | I.P. | 4 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 7 | ACECLOFENAC, THIOCOLCHICOSIDE TABLETS | EACH FILMCOATED TABLET CONTAINS: | DOMESTIC | ||
| ACECLOFENAC | I.P. | 100 MG | |||
| THIOCOLCHICOSIDE | I.P. | 8 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOURED USED | |||||
| 8 | ACECLOFENAC, PARACETAMOL, CHLORZOXAZONE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ACECLOFENAC | I.P. | 100 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| CHLORZOXAZONE | U.S.P. | 250 MG | |||
| EXCIPIENTS | Q.S | ||||
| 9 | ACECLOFENAC, PARACETAMOL, SERRATIOPEPTIDASE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ACECLOFENAC | I.P. | 100 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| SERRATIOPEPTIDASE | I.P. | 10 MG | |||
| (EQ.TO 20000 ENZYME ACTIVITY UNITS OF SERRATIOPEPTIDASE) | |||||
| (AS ENTERIC COATED GRANULES) | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 10 | ACECLOFENAC, PARACETAMOL, SERRATIOPEPTIDASE TABLETS | EACH FILM COATED TABLET CONTAINS | DOMESTIC | ||
| ACECLOFENAC | I.P. | 100 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| SERRATIOPEPTIDASE | I.P. | 15 MG | |||
| (EQ.TO 30000 ENZYME ACTIVITY UNITS OF SERRATIOPEPTIDASE) | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 11 | ACETAZOLAMIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ACETAZOLAMIDE | B.P. | 250 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 12 | ACETYLSALICYLIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| ACETYLSALICYLIC ACID | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| 13 | ACICLOVIR TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| ACICLOVIR | B.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| 14 | ACICLOVIR TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ACICLOVIR | I.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| 15 | ACICLOVIR TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ACICLOVIR | I.P. | 800 MG | |||
| EXCIPIENTS | Q.S | ||||
| 16 | ACICLOVIR DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | EXPORT | ||
| ACICLOVIR | B.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| 17 | ACICLOVIR DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | EXPORT | ||
| ACICLOVIR | B.P. | 800 MG | |||
| EXCIPIENTS | Q.S | ||||
| 18 | ALBENDAZOLE CHEWABLE TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS: | EXPORT | ||
| ALBENDAZOLE | U.S.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 19 | ALBENDAZOLE CHEWABLE TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS: | EXPORT | ||
| ALBENDAZOLE | U.S.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 20 | ALBENDAZOLE CHEWABLE TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS: | DOMESTIC | ||
| ALBENDAZOLE | I.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 21 | ALBENDAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| ALBENDAZOLE | U.S.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| 22 | ALBENDAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ALBENDAZOLE | I.P. | 400 MG | |||
| EXCIPIENTS Q.S | Q.S | ||||
| 23 | ALBENDAZOLE, IVERMECTIN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ALBENDAZOLE | I.P. | 400 MG | |||
| IVERMECTIN | I.P. | 6 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 24 | ALBENDAZOLE, IVERMECTIN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ALBENDAZOLE | I.P. | 400 MG | |||
| IVERMECTIN | I.P. | 12 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 25 | ALPRAZOLAM DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLETCONTAINS: | DOMESTIC | ||
| ALPRAZOLAM | I.P. | 0.25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 26 | ALPRAZOLAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ALPRAZOLAM | I.P. | 0.25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 27 | ALPRAZOLAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ALPRAZOLAM | I.P. | 0.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 28 | ALPRAZOLAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ALPRAZOLAM | I.P. | 1 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 29 | ALPRAZOLAM, FLUOXETINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ALPRAZOLAM | I.P. | 0.25 MG | |||
| FLUOXETINE HYDROCHLORIDE | I.P. | ||||
| EQ TO FLUOXETINE | 20 MG | ||||
| EXCIPIENTS | Q.S | ||||
| 30 | AMBROXOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | |||
| EXCIPIENTS | Q.S | ||||
| 31 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | |||
| CETIRIZINE HYDROCHLORIDE | B.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 32 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| AMBROXOL HYDROCHLORIDE | B.P. | 60 MG | |||
| CETIRIZINE HYDROCHLORIDE | B.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 33 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| AMBROXOL HYDROCHLORIDE | I.P. | 60 MG | |||
| CETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 34 | AMISULPRIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| AMISULPRIDE | I.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| 35 | AMISULPRIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| AMISULPRIDE | I.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 36 | AMITRIPTYLINE HYDROCHLORIDE TABLETS | EACH FILM COTAED TABLET CONTAINS: | DOMESTIC | ||
| AMITRIPTYLINE HYDROCHLORIDE | I.P. | ||||
| EQ.TO AMITRIPTYLINE | 10 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 37 | AMITRIPTYLINE HYDROCHLORIDE TABLETS | EACH FILM COTAED TABLET CONTAINS: | DOMESTIC | ||
| AMITRIPTYLINE HYDROCHLORIDE | I.P. | ||||
| EQ.TO AMITRIPTYLINE | 25 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 38 | AMITRIPTYLINE HYDROCHLORIDE, CHLORDIAZEPOXIDE TABLETS | EACH FILM COTAED TABLET CONTAINS: | DOMESTIC | ||
| CHLORDIAZEPOXIDE | I.P. | 5 MG | |||
| AMITRIPTYLINE HYDROCHLORIDE | I.P. | ||||
| EQ.TO AMITRIPTYLINE | 12.5 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 39 | AMITRIPTYLINE HYDROCHLORIDE, CLONAZEPAM TABLETS | EACH FILM COTAED TABLET CONTAINS: | DOMESTIC | ||
| AMITRIPTYLINE HYDROCHLORIDE | I.P. | ||||
| EQ.TO AMITRIPTYLINE | 10 MG | ||||
| CLONAZEPAM | I.P. | 0.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 40 | AMLODIPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| AMLODIPINE BESYLATE | I.P. | ||||
| EQ. TO AMLODIPINE | 2.5 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 41 | AMLODIPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| AMLODIPINE BESYLATE | I.P. | ||||
| EQ. TO AMLODIPINE | 5 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 42 | AMLODIPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| AMLODIPINE BESYLATE | B.P. | ||||
| EQ.TO AMLODIPINE | 5 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 43 | AMLODIPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| AMLODIPINE BESYLATE | B.P. | ||||
| EQ.TO AMLODIPINE | 10 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 44 | AMLODIPINE, LISINOPRIL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| LISINOPRIL DIHYDRATE | B.P. | ||||
| EQ. TO ANHYDROUS LISINOPRIL | 5 MG | ||||
| AMLODIPINE BESYLATE | B.P. | ||||
| EQ. TO AMLODIPINE | 5MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 45 | AMLODIPINE, ATENOLOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| AMLODIPINE BESYLAT | I.P. | ||||
| EQ. TO AMLODIPINE | 5 MG | ||||
| ATENOLOL | I.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 46 | AMLODIPINE, ATENOLOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| S-AMLODIPINE BESYLATE | I.P. | ||||
| EQ TO S-AMLODIPINE | 2.5 MG | ||||
| ATENOLOL | I.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| 47 | AMLODIPINE, LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| AMLODIPINE BESYLATE | I.P. | ||||
| EQ TO AMLODIPINE | 5 MG | ||||
| LOSARTAN POTASSIUM | I.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 48 | AMLODIPINE, LOSARTAN POTASSIUM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| S-AMLODIPINE BESYLATE | I.P. | ||||
| EQ TO S-AMLODIPINE | 2.5 MG | ||||
| LOSARTAN POTASSIUM | I.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| 49 | AMLODIPINE, TELMISARTAN TABLETS | EACH UNCOATED TABLET CONTAINS : | DOMESTIC | ||
| TELMISARTAN | I.P. | 40 MG | |||
| AMLODIPINE BESYLATE | I.P. | ||||
| EQ TO AMLODIPINE | 5 MG | ||||
| EXCIPIENTS | Q.S | ||||
| 50 | ARIPIPRAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ARIPIPRAZOLE | I.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 51 | ARIPIPRAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ARIPIPRAZOLE | I.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 52 | ARIPIPRAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ARIPIPRAZOLE | I.P. | 15 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 53 | ARIPIPRAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ARIPIPRAZOLE | I.P. | 30 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 54 | ARTEMETHER, LUMEFENTRINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| ARTEMETHER | B.P. | 80 MG | |||
| LUMEFANTRINE | U.S.P. | 480 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 55 | ARTEMETHER, LUMEFENTRINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ARTEMETHER | I.P. | 80 MG | |||
| LUMEFANTRINE | I.P. | 480 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 56 | ARTEMETHER, LUMEFENTRINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ARTEMETHER | I.P. | 40 MG | |||
| LUMEFANTRINE | I.P. | 240 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 57 | ATENOLOL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ATENOLOL | B.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 58 | ATORVASTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ATORVASTATIN CALCIUM | U.S.P. | ||||
| EQ. TO ATORVASTATIN | 10 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 59 | ATORVASTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ATORVASTATIN CALCIUM | U.S.P. | ||||
| EQ. TO ATORVASTATIN | 20 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 60 | ATORVASTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ATORVASTATIN CALCIUM | U.S.P. | ||||
| EQ. TO ATORVASTATIN | 40 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 61 | ATORVASTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ATORVASTATIN CALCIUM | I.P. | ||||
| EQ TO ATORVASTATIN | 10 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 62 | ATORVASTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ATORVASTATIN CALCIUM | I.P. | ||||
| EQ TO ATORVASTATIN | 20 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 63 | AZITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| AZITHROMYCIN DIHYDRATE | U.S.P. | ||||
| EQ.TO AZITHROMYCIN | 250 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 64 | AZITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| AZITHROMYCIN DIHYDRATE | U.S.P. | ||||
| EQ.TO ANHYDROUS AZITHROMYCIN | 500 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 65 | AZITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| AZITHROMYCIN DIHYDRATE | I.P. | ||||
| EQ.TO AZITHROMYCIN | 250 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 66 | AZITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| AZITHROMYCIN DIHYDRATE | I.P. | ||||
| EQ.TO ANHYDROUS AZITHROMYCIN | 500 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 67 | BENDAZOLE TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| BENDAZOLE | B.P. | 20 MG | |||
| EXCIPIENTS | Q.S | ||||
| 68 | BETAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| BETAMETHASONE | I.P. | 0.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 69 | BETAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| BETAMETHASONE | I.P. | 1 MG | |||
| EXCIPIENTS | Q.S | ||||
| 70 | BISACODYL DELAY RELEASE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| BISACODYL | U.S.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 71 | BISACODYL TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| BISACODYL | I.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 72 | BISOPROLOL FUMARATE TABLETS | EACH UNCOATED TABLET CONATINS: | EXPORT | ||
| BISOPROLOL FUMARATE | B.P. | 2.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 73 | BISOPROLOL FUMARATE TABLETS | EACH UNCOATED TABLET CONATINS: | EXPORT | ||
| BISOPROLOL FUMARATE | U.S.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 74 | BISOPROLOL FUMARATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| BISOPROLOL FUMARATE | U.S.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| 75 | BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| BROMHEXINE HYDROCHLORIDE | I.P. | 4 MG | |||
| TERBUTALINE SULPHATE | I.P. | 2.5 MG | |||
| GUAIPHENESIN | I.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 76 | BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| BROMHEXINE HYDROCHLORIDE | I.P. | 8 MG | |||
| TERBUTALINE SULPHATE | I.P. | 2.5 MG | |||
| GUAIPHENESIN | I.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 77 | CALCIUM GLUCONATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CALCIUM GLUCONATE | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 78 | CALCIUM WITH CHOLECALCIFEROL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CALCIUM CARBONATE (FROM ORGANIC SOURCE OYSTER SHELL) | B.P. | 250 MG | |||
| CHOLECALCIFEROL | B.P. | 125 I.U | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 79 | CALCIUM WITH VITAMIN D3 TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CALCIUM CARBONATE | 1250 MG | ||||
| (FROM AN ORGANIC SOURCE OYSTER SHELL) | |||||
| EQ. TO 500 MG ELEMENTAL CALCIUM | |||||
| VITAMIN D3 | I.P. | 250 I.U | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 80 | CALCIUM WITH VITAMIN D3 TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CALCIUM CARBONATE (FROM ORGANIC SOURCE OYSTER SHELL) | B.P. | 1250 MG | |||
| EQ. TO ELEMENTAL CALCIUM | 500 MG | ||||
| VITAMIN D3 | B.P. | 250 I.U | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 81 | CALCIUM WITH MAGNESIUM, ZINC AND VITAMIN D3 TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CALCIUM CITRATE | U.S.P. | 1000 MG | |||
| MAGNESIUM HYDROXIDE | I.P. | ||||
| EQ. TO ELEMENTAL MAGNESIUM | 100 MG | ||||
| ZINC SULFATE MONOHYDRATE | I.P. | ||||
| EQ TO ELEMENTAL ZINC | 4 MG | ||||
| VITAMIN D3 | I.P. | 200 I.U | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 82 | CAPTOPRIL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| CAPTOPRIL | B.P. | 25 MG | |||
| EXCIPIENTS | Q.S | ||||
| 83 | CARBAMAZEPINE TABLETS | EACH UNCOATED TABLET. CONTAINS: | EXPORT | ||
| CARBAMAZEPINE | B.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| 84 | CARISOPRODOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CARISOPRODOL | I.P. | 350 MG | |||
| EXCIPIENTS | Q.S | ||||
| 85 | CETIRIZINE DI-HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CETIRIZINE DIHYDROCHLORIDE | U.S.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOURS USED | |||||
| 86 | CETIRIZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CETIRIZINE HYDROCHLORIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 87 | CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 88 | CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAIN | DOMESTIC | ||
| CETIRIZINE HYDROCHLORIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 89 | CETIRIZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CETIRIZINE HYDROCHLORIDE | B.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 90 | CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| EACH UNCOATED TABLET CONTAIN | U.S.P. | 10 MG | |||
| EXCIPIENTS | |||||
| APPROVED COLOUR USED | |||||
| 91 | CHLORAMPHENICOL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CHLORAMPHENICOL | U.S.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 92 | CHLORDIAZEPOXIDE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CHLORDIAZEPOXIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 93 | CHLORDIAZEPOXIDE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CHLORDIAZEPOXIDE | I.P. | 25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 94 | CHLORDIAZEPOXIDE, TRIFLUOPERAZINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CHLORDIAZEPOXIDE | I.P. | 10MG | |||
| TRIFLUOPERAZINE HYDROCHLORIDE | I.P. | ||||
| EQ TO TRIFLUOPERAZINE | 1 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 95 | CHLORPHENIRAMINE MALEATE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CHLORPHENIRAMINE MALEATE | I.P. | 4 MG | |||
| EXCIPIENTS | Q.S | ||||
| 96 | CHLORPHENIRAMINE MALEATE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CHLORPHENIRAMINE MALEATE | U.S.P. | 4 MG | |||
| EXCIPIENTS | Q.S | ||||
| 97 | CHLORPROMAZINE HDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONATINS: | EXPORT | ||
| CHLORPROMAZINE HYDROCHLORIDE | U.S.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 98 | CINNARIZINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| CINNARIZINE | B.P. | 25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 99 | CINNARIZINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CINNARIZINE | I.P. | 25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 100 | CINNARIZINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CINNARIZINE | I.P. | 75 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 101 | CINNARIZINE, PIRACETAM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CINNARIZINE | B.P. | 25 MG | |||
| PIRACETAM | B.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 102 | CINNARIZINE, DOMPERIDONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CINNARIZINE | I.P. | 20 MG | |||
| DOMPERIDONE | I.P. | 15 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 103 | CINNARIZINE, DOMPERIDONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CINNARIZINE | I.P. | 75 MG | |||
| DOMPERIDONE | I.P. | 15 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 104 | CIPROFLOXACIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CIPROFLOXACIN HYDROCHLORIDE | I.P. | ||||
| EQ TO CIPROFLOXACIN | 250 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 105 | CIPROFLOXACIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CIPROFLOXACIN HYDROCHLORIDE | I.P. | ||||
| EQ TO CIPROFLOXACIN | 500 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 106 | CIPROFLOXACIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CIPROFLOXACIN HYDROCHLORIDE | U.S.P. | ||||
| EQ TO CIPROFLOXACIN | 250 MG | ||||
| EXCIPIENTS | Q.S | ||||
| 107 | CIPROFLOXACIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CIPROFLOXACIN HYDROCHLORIDE | U.S.P. | ||||
| EQ TO CIPROFLOXACIN | 500 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 108 | CIPROFLOXACIN HYDROCHLORIDE, TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CIPROFLOXACIN HYDROCHLORIDE | B.P. | ||||
| EQ.TO CIPROFLOXACIN | 500 MG | ||||
| TINIDAZOLE | B.P. | 600 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 109 | CIPROFLOXACIN HYDROCHLORIDE, TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CIPROFLOXACIN HYDROCHLORIDE | I.P. | ||||
| EQ TO CIPROFLOXACIN | 500 MG | ||||
| TINIDAZOLE | I.P. | 600 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 110 | CIPROFLOXACIN HYDROCHLORIDE, ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CIPROFLOXACIN HYDROCHLORIDE | I.P. | ||||
| EQ TO CIPROFLOXACIN | 500 MG | ||||
| ORNIDAZOLE | I.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 111 | CLARITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CLARITHROMYCIN | U.S.P. | 250 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 112 | CLARITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| CLARITHROMYCIN | U.S.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 113 | CLOBAZAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CLOBAZAM | I.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 114 | CLOBAZAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CLOBAZAM | I.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| 115 | CLOMIPHENE CITRATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| CLOMIPHENE CITRATE | U.S.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| 116 | CLOMIPRAMINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CLOMIPRAMINE HYDROCHLORIDE I.P. | I.P. | 25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 117 | CLOMIPRAMINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| CLOMIPRAMINE HYDROCHLORIDE I.P. | I.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 118 | CLONAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CLONAZEPAM | I.P. | 0.25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 119 | CLONAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CLONAZEPAM | I.P. | 0.50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 120 | CLONAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| CLONAZEPAM | U.S.P. | 0.25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 121 | CLONAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| CLONAZEPAM | U.S.P. | 0.50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 122 | CLONAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| CLONAZEPAM | I.P. | 1 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 123 | CLONAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| CLONAZEPAM | I.P. | 2 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 124 | CLONAZEPAM, PAROXETINE (CONTROLLED RELEASED) TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PAROXETINE HYDROCHLORIDE | I.P. | ||||
| EQ TO PAROXETINE (AS CONTROLLED RELEASE) | 12.5 MG | ||||
| CLONAZEPAM (AS IMMEDIATE RELEASE) | I.P. | 0.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 125 | CLONAZEPAM, PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CLONAZEPAM | I.P. | 0.5 MG | |||
| PROPRANOLOL HYDROCHLORIDE | I.P. | 20 MG | |||
| EXCIPIENTS | Q.S | ||||
| 126 | CLONAZEPAM, PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CLONAZEPAM | I.P. | 0.5 MG | |||
| PROPRANOLOL HYDROCHLORIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| 127 | CLONIDINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| CLONIDINE HYDROCHLORIDE | U.S.P. | 0.15 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 128 | CLOTRIMAZOLE VAGINAL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CLOTRIMAZOLE | I.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| 129 | CLOZAPINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CLOZAPINE | I.P. | 25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 130 | CLOZAPINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CLOZAPINE | I.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 131 | CLOZAPINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CLOZAPINE | I.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 132 | CLOZAPINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| CLOZAPINE | U.S.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| 133 | CYPROHEPTADINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| CYPROHEPTADINE HYDROCHLORIDE | I.P. | ||||
| EQ. TO CYPROHEPTADINE (ANHYDROUS) | 4 MG | ||||
| EXCIPIENTS | Q.S | ||||
| 134 | DEFLAZACORT TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DEFLAZACORT | 1 MG | ||||
| EXCIPIENTS | Q.S | ||||
| 135 | DEFLAZACORT TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DEFLAZACORT | 6 MG | ||||
| EXCIPIENTS | Q.S | ||||
| 136 | DESLORATADINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DESLORATADINE | B.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 137 | DESLORATADINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DESLORATADINE | U.S.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 138 | DESVENLAFAXINE EXTENDED RELEASE TABLETS | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| DESVENLAFAXINE SUCCINATE | I.P. | ||||
| EQ. TO DESVENLAFAXINE | 50 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 139 | DESVENLAFAXINE EXTENDED RELEASE TABLETS | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| DESVENLAFAXINE SUCCINATE | I.P. | ||||
| EQ. TO DESVENLAFAXINE | 100 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 140 | DEXAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DEXAMETHASONE | I.P. | 0.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 141 | DEXAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DEXAMETHASONE | B.P. | 0.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 142 | DEXAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DEXAMETHASONE | U.S.P. | 0.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 143 | DEXAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DEXAMETHASONE | U.S.P. | 4 MG | |||
| EXCIPIENTS | Q.S | ||||
| 144 | DEXTROMETHORPHAN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DEXTROMETHORPHAN HYDROBROMIDE | I.P. | 20 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 145 | DEXTROMETHORPHAN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DEXTROMETHORPHAN HYDROBROMIDE | I.P. | 30 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 146 | DIAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DIAZEPAM | I.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 147 | DIAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DIAZEPAM | I.P. | 30 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 148 | DICLOFENAC SODIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| DICLOFENAC SODIUM | B.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 149 | DICLOFENAC SODIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| DICLOFENAC SODIUM | U.S.P. | 25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 150 | DICLOFENAC SODIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| DICLOFENAC SODIUM | U.S.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 151 | DICLOFENAC SODIUM SUSTAINED RELEASED TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DICLOFENAC SODIUM | I.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| 152 | DICLOFENAC SODIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DICLOFENAC SODIUM | B.P. | 50 MG | |||
| PARACEAMOL | B.P. | 325 MG | |||
| EXCIPIENTS | Q.S | ||||
| 153 | DICLOFENAC SODIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DICLOFENAC SODIUM | B.P. | 50 MG | |||
| PARACETAMOL | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| 154 | DICLOFENAC SODIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DICLOFENAC SODIUM | B.P. | 50 MG | |||
| PARACETAMOL | B.P. | 650 MG | |||
| EXCIPIENTS | Q.S | ||||
| 155 | DICLOFENAC SODIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DICLOFENAC SODIUM | I.P. | 50 MG | |||
| PARACEAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q. S | ||||
| 156 | DICLOFENAC SODIUM, PARACETAMOL, CHLORZOXAZONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DICLOFENAC SODIUM | B.P. | 50 MG | |||
| PARACETAMOL | B.P. | 325 MG | |||
| CHLORZOXAZONE | U.S.P. | 250 MG | |||
| EXCIPIENTS | Q.S | ||||
| 157 | DICLOFENAC SODIUM, PARACETAMOL, CHLORZOXAZONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DICLOFENAC SODIUM | I.P. | 50 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| CHLORZOXAZONE | U.S.P | 250 MG | |||
| EXCIPIENTS | Q.S | ||||
| 158 | DICLOFENAC SODIUM, PARACETAMOL, CHLORPHENAMINE MALEATE, MAGNESIUM TRISILICATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DICLOFENAC SODIUM | B.P. | 50 MG | |||
| PARACETAMOL | B.P. | 500 MG | |||
| CHLORPHENAMINE MALEATE | B.P. | 4 MG | |||
| MAGNESIUM TRISILICATE | B.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 159 | DICLOFENAC POTASSIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| DICLOFENAC POTASSIUM | U.S.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 160 | DICLOFENAC POTASSIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DICLOFENAC POTASSIUM | B.P. | 50 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q.S | ||||
| 161 | DICLOFENAC POTASSIUM, PARACETAMOL, SERRATIOPEPTIDASE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| DICLOFENAC POTASSIUM | B.P. | 50 MG | |||
| PARACETAMOL | B.P. | 325 MG | |||
| SERRATIOPEPTIDASE | B.P. | 15 MG | |||
| (EQ TO 30000 ENZYME ACTIVTY UNITS OF SERRATIOPEPTIDASE) | |||||
| (AS ENTERIC COATED) | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 162 | DICLOFENAC POTASSIUM, PARACETAMOL, SERRATIOPEPTIDASE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DICLOFENAC POTASSIUM | B.P. | 50 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| SERRATIOPEPTIDASE | I.P. | 10 MG | |||
| (EQ TO 20000 ENZYME ACTIVTY UNITS OF SERRATIOPEPTIDASE) | |||||
| (AS ENTERIC COATED) | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 163 | DICYCLOMINE HYDROCHLORIDE, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DICYCLOMINE HYDROCHLORIDE | U.S.P. | 20 MG | |||
| PARACETAMOL | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| 164 | DICYCLOMINE HYDROCHLORIDE, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DICYCLOMINE HYDROCHLORIDE | I.P. | 20 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q. S | ||||
| 165 | DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DIETHYLCARBAMAZINE CITRATE | I.P. | 150 MG | |||
| CHLORPHENIRAMINE MALEATE | I.P. | 2.5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 166 | DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DIETHYLCARBAMAZINE CITRATE | I.P. | 250 MG | |||
| CHLORPHENIRAMINE MALEATE | I.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 167 | DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DIETHYLCARBAMAZINE CITRATE | I.P. | 200 MG | |||
| CHLORPHENIRAMINE MALEATE | I.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 168 | DIGOXIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| DIGOXIN | B.P. | 0.25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 169 | DIGOXIN TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DIGOXIN | B.P. | 0.25 MG | |||
| EXCIPIENTS | Q.S | ||||
| 170 | DILUTED ISOSORBIDE MONONITRATE TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DILUTED ISOSORBIDE MONONITRATE | I.P. | ||||
| EQ TO ISOSORBIDE | 20 MG | ||||
| EXCIPIENTS | Q. S | ||||
| 171 | DIPHENOXYLATE HYDROCHLORIDE, ATROPINE SULPHATE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| DIPHENOXYLATE HYDROCHLORIDE | I.P. | 2.5 MG | |||
| ATROPINE SULPHATE | I.P. | 0.025 MG | |||
| EXCIPIENTS | Q. S | ||||
| 172 | DIPHENHYDRAMINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DIPHENHYDRAMINE HYDROCHLORIDE | B.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 173 | DIPYRIDAMOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| DIPYRIDAMOLE | U.S.P. | 25 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 174 | DIVALPROEX SODIUM EXTENDED RELEASE TABLETS | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| DIVALPROEX SODIUM | I.P. | ||||
| EQ TO VALPROIC ACID | 250 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 175 | DIVALPROEX SODIUM EXTENDED RELEASE TABLETS | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| DIVALPROEX SODIUM | I.P. | ||||
| EQ TO VALPROIC ACID | 500 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 176 | DOMPERIDONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| DOMPERIDONE MALEATE | B.P. | ||||
| EQ TO DOMPERIDONE | 10 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 177 | DOMPERIDONE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| DOMPERIDONE | B.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 178 | DOXEPIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DOXEPIN HYDROCHLORIDE | I.P. | ||||
| EQ TO DOXEPIN | 25 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 179 | DOXEPIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DOXEPIN HYDROCHLORIDE | I.P. | ||||
| EQ TO DOXEPIN | 75 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 180 | DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| DOXYLAMINE SUCCINATE | U.S.P. | 10 MG | |||
| PYRIDOXINE HYDROCHLORIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 181 | DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| DOXYLAMINE SUCCINATE | U.S.P. | 10 MG | |||
| PYRIDOXINE HYDROCHLORIDE | I.P. | 10 MG | |||
| FOLIC ACID | I.P. | 2.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 182 | DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| DROTAVERINE HYDROCHLORIDE | B.P. | 40 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 183 | DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DROTAVERINE HYDROCHLORIDE | I.P. | 40 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 184 | DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| DROTAVERINE HYDROCHLORIDE | B.P. | 80 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 185 | DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DROTAVERINE HYDROCHLORIDE | I.P. | 80 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 186 | DROTAVERINE HYDROCHLORIDE, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAIN: | DOMESTIC | ||
| DROTAVERINE HYDROCHLORIDE | I.P. | 80 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 187 | DROTAVERINE HYDROCHLORIDE, MEFENAMIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DROTAVERINE HYDROCHLORIDE | I.P. | ||||
| EQ. TO DROTAVERINE | 80 MG | ||||
| MEFENAMIC ACID | I.P. | 250 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 188 | DULOXETINE GASTRO-RESISTANT TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| DULOXETINE HYDROCHLORIDE | I.P. | ||||
| EQ TO DULOXETINE | 20 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 189 | DULOXETINE GASTRO-RESISTANT TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| DULOXETINE HYDROCHLORIDE | I.P. | ||||
| EQ TO DULOXETINE | 30 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 190 | DULOXETINE GASTRO-RESISTANT TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| DULOXETINE HYDROCHLORIDE | I.P. | ||||
| EQ TO DULOXETINE | 40 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 191 | DULOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DULOXETINE HYDROCHLORIDE | U.S.P. | ||||
| EQ TO DULOXETINE | 20 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 192 | DULOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| DULOXETINE HYDROCHLORIDE | U.S.P. | ||||
| EQ TO DULOXETINE | 30 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 193 | ERYTHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ERYTHROMYCIN ESTOLATE | U.S.P. | ||||
| EQ.TO ERYTHROMYCIN | 250 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 194 | ERYTHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ERYTHROMYCIN ESTOLATE | U.S.P. | ||||
| EQ.TO ERYTHROMYCIN | 500 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 195 | ESCITALOPRAM OXALATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ESCITALOPRAM OXALATE | I.P. | ||||
| EQ.TO ESCITALOPRAM | 5 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 196 | ESCITALOPRAM OXALATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ESCITALOPRAM OXALATE | I.P. | ||||
| EQ.TO ESCITALOPRAM | 10 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 197 | ESCITALOPRAM OXALATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ESCITALOPRAM OXALATE | I.P. | ||||
| EQ.TO ESCITALOPRAM | 20 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 198 | ESCITALOPRAM OXALATE, CLONAZEPAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ESCITALOPRAM OXALATE | I.P. | ||||
| EQ.TO ESCITALOPRAM | 5 MG | ||||
| CLONAZEPAM | I.P. | 0.50 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 199 | ESCITALOPRAM OXALATE, CLONAZEPAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ESCITALOPRAM OXALATE | I.P. | ||||
| EQ.TO ESCITALOPRAM | 10 MG | ||||
| CLONAZEPAM | I.P. | 0.50 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 200 | ESCITALOPRAM OXALATE, CLONAZEPAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ESCITALOPRAM OXALATE | I.P. | ||||
| EQ.TO ESCITALOPRAM | 20 MG | ||||
| CLONAZEPAM | I.P. | 0.50 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 201 | ESOMEPRAZOLE GASTRO RESISTANCE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| ESOMEPRAZOLE MAGNESIUM TRIHYDRATE | B.P. | ||||
| EQ TO ESOMEPRAZOLE | 20 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 202 | ESOMEPRAZOLE GASTRO RESISTANCE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| ESOMEPRAZOLE MAGNESIUM TRIHYDRATE | B.P. | ||||
| EQ TO ESOMEPRAZOLE | 40 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 203 | ESOMEPRAZOLE MAGNESIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| ESOMEPRAZOLE MAGNESIUM TRIHYDRATE | I.P. | ||||
| EQ TO ESOMEPRAZOLE | 40 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 204 | ETAMSYLATE, MEFENAMIC ACID, TRANEXAMIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| ETAMSYLATE | B.P. | 250 MG | |||
| MEFENAMIC ACID | B.P. | 250 MG | |||
| TRANEXAMIC ACID | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 205 | ETHAMSYLATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ETHAMSYLATE | B.P. | 250 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 206 | ETIZOLAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ETIZOLAM | I.P. | 0.25 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 207 | ETIZOLAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ETIZOLAM | I.P. | 0.5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 208 | ETIZOLAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ETIZOLAM | I.P. | 1 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 209 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ETORICOXIB | I.P. | 60 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 210 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ETORICOXIB | I.P. | 90 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 211 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ETORICOXIB | I.P. | 120 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 212 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ETORICOXIB | B.P. | 90 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 213 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ETORICOXIB | B.P. | 120 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 214 | ETORICOXIB, THIOCOLCHICOSIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ETORICOXIB | I.P. | 60 MG | |||
| THIOCOLCHICOSIDE | I.P. | 4 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 215 | FAMOTIDINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| FAMOTIDINE | B.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 216 | FAMOTIDINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| FAMOTIDINE | B.P. | 20 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 217 | FAMOTIDINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| FAMOTIDINE | B.P. | 40 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 218 | FERROUS ASCORBATE, FOLIC ACID TABLETS | EACH FILM COTAED TABLET CONTAINS: | DOMESTIC | ||
| FERROUS ASCORBATE | I.P. | ||||
| EQ.TO ELEMENTAL IRON | 100 MG | ||||
| FOLIC ACID | I.P. | 1.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 219 | FERROUS ASCORBATE, FOLIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| FERROUS FUMARATE | I.P. | ||||
| EQ TO 50 MG ELEMENTAL IRON | 152 MG | ||||
| FOLIC ACID | I.P. | 1.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 220 | FERROUS ASCORBATE, ZINC, FOLIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| FERROUS ASCORBATE | I.P. | ||||
| EQ TO ELEMENTAL IRON | 100 MG | ||||
| FOLIC ACID | I.P. | 1.5 MG | |||
| ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
| EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 221 | FERROUS ASCORBATE, ZINC, FOLIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| FERROUS FUMARATE | I.P. | 150 MG | |||
| EQ TO 50 MG ELEMENTAL IRON | |||||
| FOLIC ACID | I.P. | 750 MCG | |||
| ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
| EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 222 | FERROUS FUMARATE, CYANOCOBALAMIN, ZINC, FOLIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| FERROUS FUMARATE | I.P. | 300 MG | |||
| FOLIC ACID | I.P. | 1.5 MG | |||
| CYANOCOBALAMIN | I.P. | 15 MCG | |||
| ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
| EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 223 | FERROUS FUMARATE, CYANOCOBALAMIN, ZINC, FOLIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| FERROUS FUMARATE | I.P. | 400 MG | |||
| FOLIC ACID | I.P. | 1.5 MG | |||
| CYANOCOBALAMIN | I.P. | 15 MCG | |||
| ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
| (EQ. TO 22.5 MG ELEMENTAL ZINC) | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 224 | FEXOFENADINE HYDROCHLORIDE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | EXPORT | ||
| FXOFENADINE HYDROCHLORIDE | U.S.P. | 60 MG | |||
| EXCIPIENTS | Q.S | ||||
| 225 | FEXOFENADINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| FEXOFENADINE HYDROCHLORIDE | U.S.P. | 60 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 226 | FEXOFENADINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| FEXOFENADINE HYDROCHLORIDE | U.S.P. | 120 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 227 | FEXOFENADINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| FEXOFENADINE HYDROCHLORIDE | U.S.P. | 180 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 228 | FEXOFENADINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| FEXOFENADINE HYDROCHLORIDE | I.P. | 120 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 229 | FEXOFENADINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| FEXOFENADINE HYDROCHLORIDE | I.P. | 180 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 230 | FEXOFENADINE HYDROCHLORIDE, MONTELUKAST TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| FEXOFENADINE HYDROCHLORIDE | I.P. | 120 MG | |||
| MONTELUKAST SODIUM | I.P. | ||||
| EQ TO MONTELUKAST | 10 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 231 | FLUCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| FLUCONAZOLE | U.S.P. | 150 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 232 | FLUCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| FLUCONAZOLE | I.P. | 150 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 233 | FLUCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| FLUCONAZOLE | I.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 234 | FLUCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| FLUCONAZOLE | I.P. | 300 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 235 | FLUCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| FLUCONAZOLE | I.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 236 | FLUNARIZINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| FLUNARIZINE DIHYDROCHLORIDE | I.P. | ||||
| EQ TO FLUNARIZINE | 5 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 237 | FLUNARIZINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| FLUNARIZINE DIHYDROCHLORIDE | I.P. | ||||
| EQ TO FLUNARIZINE | 10 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 238 | FLUOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| FLUOXETINE HYDROCHLORIDE | U.S.P. | ||||
| EQ. TO FLUOXETINE | 20 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 239 | FLUOXETINE HYDROCHLORIDE TABLETS | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| FLUOXETINE HYDROCHLORIDE | I.P. | ||||
| EQ. TO FLUOXETINE | 20 MG | ||||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 240 | FLUOXETINE HYDROCHLORIDE TABLETS | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| FLUOXETINE HYDROCHLORIDE | I.P. | ||||
| EQ. TO FLUOXETINE | 40 MG | ||||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 241 | FLUOXETINE HYDROCHLORIDE TABLETS | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| FLUOXETINE HYDROCHLORIDE | I.P. | ||||
| EQ. TO FLUOXETINE | 60 MG | ||||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 242 | FLUVOXAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| FLUVOXAMINE MALEATE | I.P. | 50 MG | |||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 243 | FLUVOXAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| FLUVOXAMINE MALEATE | I.P. | 100 MG | |||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 244 | FLUVOXAMINE MALEATE SUSTIANED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| FLUVOXAMINE MALEATE | I.P. | 100 MG | |||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 245 | FOLIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| FOLIC ACID | B.P. | 1 MG | |||
| EXCIPIENTS | Q.S | ||||
| 246 | FOLIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| FOLIC ACID | B.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 247 | FOLIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| FOLIC ACID | I.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 248 | GLIBENCLAMIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| GLIBENCLAMIDE | B.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 249 | GLIMEPIRIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| GLIMEPIRIDE | I.P. | 2 MG | |||
| EXCIPIENTS | Q. S | ||||
| 250 | GLIMEPIRIDE TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| GLIMEPIRIDE | U.S.P. | 1 MG | |||
| EXCIPIENTS | Q.S | ||||
| 251 | GLIMEPIRIDE TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| GLIMEPIRIDE | U.S.P. | 2 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 252 | GLIMEPIRIDE TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| GLIMEPIRIDE | U.S.P. | 3 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 253 | GLIMEPIRIDE TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| GLIMEPIRIDE | U.S.P. | 4 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 254 | GLIMEPIRIDE, METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| GLIMEPIRIDE | U.S.P. | 1 MG | |||
| METFORMIN HYDROCHLORIDE | U.S.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 255 | GLIMEPIRIDE, METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| GLIMEPIRIDE | U.S.P. | 2 MG | |||
| METFORMIN HYDROCHLORIDE | U.S.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 256 | GLIMEPIRIDE, METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| GLIMEPIRIDE | I.P. | 1 MG | |||
| METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) | I.P. | 500 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 257 | GLIMEPIRIDE, METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| GLIMEPIRIDE | I.P. | 2 MG | |||
| METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) | I.P. | 500 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 258 | HALOPERIDOL TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| HALOPERIDOL | B.P. | 5 MG | |||
| EXCIPIENTS | |||||
| 259 | HALOPERIDOL TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| HALOPERIDOL | I.P. | 1.5 MG | |||
| EXCIPIENTS | Q. S | ||||
| 260 | HALOPERIDOL TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| HALOPERIDOL | I.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| 261 | HALOPERIDOL TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| HALOPERIDOL | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| 262 | HYDROXYCHLOROQUINE SULPHATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| HYDROXYCHLOROQUINE SULPHATE | I.P. | 200 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 263 | HYDROXYZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| HYDROXYZINE HYDROCHLORIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 264 | HYDROXYZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| HYDROXYZINE HYDROCHLORIDE | I.P. | 25 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 265 | IBUPROFEN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| IBUPROFEN | B.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 266 | IBUPROFEN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| IBUPROFEN | B.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 267 | IBUPROFEN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| IBUPROFEN | I.P. | 600 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 268 | IBUPROFEN, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| IBUPROFEN | B.P. | 400 MG | |||
| PARACETAMOL | B.P. | 325 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 269 | IBUPROFEN, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| IBUPROFEN | B.P. | 400 MG | |||
| PARACETAMOL | B.P. | 325 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 270 | IBUPROFEN, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| IBUPROFEN | I.P. | 400 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | I.P. | Q.S | |||
| APPROVED COLOUR USED | |||||
| 271 | IMIPRAMINE HYDROCHLORIDE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| IMIPRAMINE HYDROCHLORIDE | I.P. | 25 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 272 | IMIPRAMINE HYDROCHLORIDE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| IMIPRAMINE HYDROCHLORIDE | I.P. | 75 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 273 | INDOMETHACIN TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| INDOMETHACIN | U.S.P. | 25 MG | |||
| EXCIPIENTS | Q.S | ||||
| 274 | ISOXSUPRINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ISOXSUPRINE HYDROCHLORIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| 275 | ISOXSUPRINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| ISOXSUPRINE HYDROCHLORIDE | I.P. | 20 MG | |||
| EXCIPIENTS | Q. S | ||||
| 276 | ISOXSUPRINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| ISOXSUPRINE HYDROCHLORIDE | I.P. | 40 MG | |||
| EXCIPIENTS | Q. S | ||||
| 277 | IVERMECTIN TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| IVERMECTIN | I.P. | 6 MG | |||
| AQUEOUS BASE | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 278 | IVERMECTIN TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| IVERMECTIN | I.P. | 12 MG | |||
| AQUEOUS BASE | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 279 | KETOCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| KETOCONAZOLE | I.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| 280 | KETOCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| KETOCONAZOLE | U.S.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| 281 | KETOROLAC TROMETHAMINE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
| KETOROLAC TROMETHAMINE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| 282 | KETOROLAC TROMETHAMINE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | EXPORT | ||
| KETOROLAC TROMETHAMINE | U.S.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| 283 | KETOROLAC TROMETHAMINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| KETOROLAC TROMETHAMINE | U.S.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 284 | KETOTIFEN FUMARATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| KETOTIFEN FUMARATE | B.P. | 1 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 285 | LACTIC ACID BACILLUS TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| LACTIC ACID BACILLUS | I.P. | 100 MLN SPORES | |||
| EXCIPIENTS | Q.S | ||||
| 286 | LACTIC ACID BACILLUS TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| LACTIC ACID BACILLUS | I.P. | 120 MLN SPORES | |||
| EXCIPIENTS | Q.S | ||||
| 287 | LAMOTRIGINE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
| LAMOTRIGINE | I.P. | 25 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 288 | LAMOTRIGINE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
| LAMOTRIGINE | I.P. | 50 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 289 | LEFLUNOMIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEFLUNOMIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 290 | LEVAMISOLE TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| LEVAMISOLE HYDROCHLORIDE | I.P. | ||||
| EQ TO LEVAMISOLE | 50 MG | ||||
| EXCIPIENTS | Q. S | ||||
| 291 | LEVETIRACETAM TABLES | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEVETIRACETAM | I.P. | 250 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 292 | LEVETIRACETAM TABLES | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEVETIRACETAM | I.P. | 500 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 293 | LEVETIRACETAM TABLES | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEVETIRACETAM | I.P. | 1000 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 294 | LEVETIRACETAM TABLES | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEVETIRACETAM | U.S.P. | 750 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 295 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 296 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 297 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| LEVOCETIRIZINE DIHYDROCHLORIDE | U.S.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 298 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 299 | LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM DISPERSIBLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| LEVOCETIRIZINE DIHYDROCHLORIDE | U.S.P. | 5 MG | |||
| MONTELUKAST SODIUM | B.P. | ||||
| EQ. TO MONTELUKAST | 10 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 300 | LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
| LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 2.5 MG | |||
| MONTELUKAST SODIUM | I.P. | ||||
| EQ. TO MONTELUKAST | 4 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 301 | LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST TABLETS I.P. | EACH FILM COATED TABLET CONTAINS : | DOMESTIC | ||
| LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 5 MG | |||
| MONTELUKAST SODIUM | I.P. | ||||
| EQ. TO MONTELUKAST | 10 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 302 | LEVOCETIRIZINE HYDROCHLORIDE, AMBROXOL HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEVOCETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
| AMBROXOL HYDROCHLORIDE | I.P. | 60 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 303 | LEVOCETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEVOCETIRIZINE HYDROCHLORIDE | I.P. | 2.5 MG | |||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 304 | LEVOFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEVOFLOXACIN HEMIHYDRATE | I.P. | ||||
| EQ. TO LEVOFLOXACIN | 250 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 305 | LEVOFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LEVOFLOXACIN HEMIHYDRATE | I.P. | ||||
| EQ. TO LEVOFLOXACIN | 500 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 306 | LEVOFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| LEVOFLOXACIN HEMIHYDRATE | U.S.P. | ||||
| EQ. TO LEVOFLOXACIN | 500 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 307 | LINEZOLID TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
| LINEZOLID | I.P. | 400 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 308 | LINEZOLID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LINEZOLID | I.P. | 600 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 309 | LINEZOLID TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| LINEZOLID | I.P. | 600 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 310 | LISINOPRIL DIHYDRATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| LISINOPRIL DIHYDRATE | B.P. | ||||
| EQ TO ANHYDROUS LISINOPRIL | 5 MG | ||||
| EXCIPIENTS | Q.S | ||||
| 311 | LISINOPRIL DIHYDRATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| LISINOPRIL DIHYDRATE | B.P. | ||||
| EQ TO ANHYDROUS LISINOPRIL | 10 MG | ||||
| EXCIPIENTS | Q.S | ||||
| 312 | LOPERAMIDE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| LOPERAMIDE HYDROCHLORIDE | U.S.P. | 2 MG | |||
| EXCIPIENTS | Q.S | ||||
| 313 | LORATADINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| LORATADINE | U.S.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| 314 | LORAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| LORAZEPAM | I.P. | 1 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 315 | LORAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| LORAZEPAM | I.P. | 2 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 316 | LORAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| LORAZEPAM | I.P. | 3 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 317 | LORAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| LORAZEPAM | I.P. | 4 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 318 | LORAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| LORAZEPAM | I.P. | 1 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 319 | LORAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| LORAZEPAM | I.P. | 2 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 320 | LORAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| LORAZEPAM | I.P. | 3 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 321 | LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LOSARTAN POTTASIUM | I.P. | 25 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 322 | LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LOSARTAN POTTASIUM | I.P. | 50 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 323 | LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LOSARTAN POTTASIUM | I.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 324 | LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| LOSARTAN POTASSIUM | U.S.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 325 | LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| LOSARTAN POTASSIUM | U.S.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 326 | LOSARTAN POTASSIUM, HYDROCHLORTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| LOSARTAN POTASSIUM | I.P. | 25 MG | |||
| HYDROCHLORTHIAZIDE | I.P. | 12.5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 327 | MAGNESIUM LACTATE DIHYDRATE, PYRIDOXINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| MAGNESIUM LACTATE DIHYDRATE | B.P. | ||||
| EQ. TO ELEMENTAL MAGNESIUM | 48 MG | ||||
| PYRIDOXINE HYDROCHLORIDE | B.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 328 | MEBENDAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| MEBENDAZOLE | U.S.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| 329 | MEBHYDROLINE NAPADISYLATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| MEBHYDROLINE NAPADISYLATE | U.S.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 330 | MEFENAMIC ACID, DICYCLOMINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| MEFENAMIC ACID | I.P. | 250 MG | |||
| DICYCLOMINE HYDROCHLORIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 331 | MELOXICAM TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| MELOXICAM | B.P. | 7.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 332 | MELOXICAM TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| MELOXICAM | B.P. | 15 MG | |||
| EXCIPIENTS | Q.S | ||||
| 333 | METAMIZOLE SODIUM TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| METAMIZOLE SODIUM | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| 334 | METAMIZOLE SODIUM, PITOFENONE HYDROCHLORIDE, FENPIVERINIUM BROMIDE TABLETS | EACH UNCOATED TABLET CONATINS: | EXPORT | ||
| METAMIZOLE SODIUM | B.P. | 12 MG | |||
| PITOFENONE HYDROCHLORIDE | B.P. | 5 MG | |||
| FENPIVERINIUM BROMIDE | B.P. | 0.1 MG | |||
| EXCIPIENTS | Q.S | ||||
| 335 | METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| METFORMIN HYDROCHLORIDE | U.S.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 336 | METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| METFORMIN HYDROCHLORIDE | U.S.P. | 850 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 337 | METFORMIN HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| METFORMIN HYDROCHLORIDE | U.S.P. | 1000 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 338 | METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: | EXPORT | ||
| METFORMIN HYDROCHLORIDE | U.S.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 339 | METHYLCOBALAMIN TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| METHYLCOBALAMIN | I.P. | 5000 MCG | |||
| EXCIPIENTS | Q.S | ||||
| 340 | METHYLCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID TABLETS | EACH UNCOATED SUBLINGUAL TABLET CONTAINS: | DOMESTIC | ||
| METHYLCOBALAMIN | I.P. | 1500 MCG | |||
| PYRIDOXINE HYDROCHLORIDE | I.P. | 20 MG | |||
| FOLIC ACID | I.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 341 | METHYLPREDNISOLONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| METHYLPREDNISOLONE | B.P. | 4 MG | |||
| EXCIPIENTS | Q.S | ||||
| 342 | METOCLOPRAMIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| METOCLOPRAMIDE HYDROCHLORIDE | B.P. | ||||
| EQ TO METOCLOPRAMIDE | 10 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 343 | METRONIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| METRONIDAZOLE | B.P. | 250 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 344 | METRONIDAZOLE, FURAZOLIDINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| METRONIDAZOLE | B.P. | 400 MG | |||
| FURAZOLIDINE | B.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| 345 | METOPROLOL TARTRATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| METOPROLOL TARTRATE | U.S.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 346 | MINOCYCLINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| MINOCYCLINE HYDROCHLORIDE U.S.P. | U.S.P. | ||||
| EQ TO MINOCYCLINE | 100 MG | ||||
| EXCIPIENTS | Q. S | ||||
| 347 | MIRTAZAPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| MIRTAZAPINE | I.P. | 7.5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 348 | MIRTAZAPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| MIRTAZAPINE | I.P. | 15 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 349 | MIRTAZAPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| MIRTAZAPINE | I.P. | 15 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 350 | NALIDIXIC ACID TABLETS | EACH FILM COATED TABLET.CONTAINS: | EXPORT | ||
| NALIDIXIC ACID | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 351 | MULTIVITAMIN AND MINERAL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| BIOTIN | 30 MCG | ||||
| NIACINAMIDE | B.P. | 12 MCG | |||
| VITAMIN B 12 | B.P. | 1 MCG | |||
| VITAMIN E ACETATE (50% POWDER FORM) | B.P. | 10 MG | |||
| ZINC SULPHATE MONOHYDRATE | B.P. | ||||
| EQ TO ELEMENTAL ZINC | 10 MG | ||||
| THIAMINE HYDROCHLORIDE | B.P. | 1 MG | |||
| MAGNESIUM SULPHATE ANHYDROUS | B.P. | ||||
| EQ TO ELEMENTEL MAGNESE | 1.8 MG | ||||
| VITAMIN B2 | 1.1 MG | ||||
| COPPER SULPHATE | B.P. | ||||
| EQ TO ELEMENTAL COPPER | 0.5 MG | ||||
| CALCIUM PANTOTHENATE | B.P. | 5 MG | |||
| POTASSIUM IODINE | B.P. | ||||
| EQ TO ELEMENTAL IODINE | 150 MCG | ||||
| PYRIDOXINE HYDROCHLORIDE (VIT.B6) | B.P. | 2 MG | |||
| SODIUM SALENATE | B.P. | ||||
| EQ TO ELEMENTAL SELENIUM | 25 MCG | ||||
| FOLIC ACID | B.P. | 200 MCG | |||
| CHROMIUM PICOLINATE | B.P. | ||||
| EQ TO CHROMIUM | 25 MCG | ||||
| VITAMIN A | B.P. | 200 I.U | |||
| VITAMIN D3 | B.P. | 400 I.U | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 352 | NICLOSAMIDE (ANHYDROUS) TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS: | EXPORT | ||
| ANHYDROUS NICLOSAMIDE | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| 353 | NIMESULIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| NIMESULIDE | B.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED NOT TO BE USED FOR CHILDREN BELOW 12 YEAR OLD | |||||
| 354 | NIMESULIDE TABLETS | EACH UNCOATED TABLETS CONTAINS: | DOMESTIC | ||
| NIMESULIDE | B.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 355 | NIMESULIDE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| NIMESULIDE | B.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 356 | NIMESULIDE, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| NIMESULIDE | B.P. | 100 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| NOT TO BE USED FOR CHILDREN BELOW 12 YEAR OLD | |||||
| 357 | NITRAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| NITRAZEPAM | I.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| 358 | NITRAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| NITRAZEPAM | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| 359 | NITROXOLINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| NITROXOLINE | B.P. | 50 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 360 | NORFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| NORFLOXACIN | I.P. | 400 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 361 | NORFLOXACIN, TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| NORFLOXACIN | I.P. | 400 MG | |||
| TINIDAZOLE | I.P. | 600 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 362 | NORTRIPTYLINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| NORTRIPTYLINE HYDROCHLORIDE | I.P. | ||||
| EQ.TO NORTRIPTYLINE | 10 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 363 | NORTRIPTYLINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| NORTRIPTYLINE HYDROCHLORIDE | I.P. | ||||
| EQ.TO NORTRIPTYLINE | 50 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 364 | NYSTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| NYSTATIN | B.P. | 500000 IU | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 365 | OFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| OFLOXACIN | I.P. | 200 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 366 | OFLOXACIN TABLETS | EACH FILM COATED TABET CONTAINS: | EXPORT | ||
| OFLOXACIN | B.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 367 | OFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| OFLOXACIN | B.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 368 | OFLOXACIN TABLETS | EACH FILM COATED TABET CONTAINS: | EXPORT | ||
| OFLOXACIN | U.S.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 369 | OFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| OFLOXACIN | U.S.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 370 | OFLOXACIN, ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| OFLOXACIN | I.P. | 100 MG | |||
| ORNIDAZOLE | I.P. | 250 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 371 | OFLOXACIN, ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| OFLOXACIN | B.P. | 200 MG | |||
| ORNIDAZOLE | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 372 | OFLOXACIN, ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| OFLOXACIN | I.P. | 200 MG | |||
| ORNIDAZOLE | I.P. | 500 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 373 | OFLOXACIN, TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| OFLOXACIN | I.P. | 200 MG | |||
| TINIDAZOLE | I.P. | 600 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 374 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| OLANZAPINE | I.P. | 2.5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 375 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| OLANZAPINE | I.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 376 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| OLANZAPINE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 377 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| OLANZAPINE | I.P. | 15 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 378 | OMEPRAZOLE MAGNESIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| OMEPRAZOLE MAGNESIUM | U.S.P. | ||||
| EQ TO OMEPRAZOLE | 10 MG | ||||
| DOMPERIDONE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 379 | OMEPRAZOLE MAGNESIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| OMEPRAZOLE MAGNESIUM | I.P. | ||||
| EQ TO OMEPRAZOLE | 10 MG | ||||
| DOMPERIDONE | I.P. | 15 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 380 | OMEPRAZOLE MAGNESIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| OMEPRAZOLE MAGNESIUM | U.S.P. | ||||
| EQ TO OMEPRAZOLE | 10 MG | ||||
| DOMPERIDONE | I.P. | 15 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 381 | ONDANSETRON HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS | EACH UNCOATED ORALLY DISINTEGRATING TABLET CONTAINS: | DOMESTIC | ||
| ONDANSETRON HYDROCHLORIDE | I.P. | ||||
| EQ.TO ONDANSETRON | 4 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 382 | ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ORNIDAZOLE | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 383 | PANTOPRAZOLE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| PANTOPRAZOLE SOD. SESQUIHYDRATE | I.P. | ||||
| EQ TO PANTOPRAZOLE | 40 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 384 | PANTOPRAZOLE GASTRO-RESISTANCE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| PANTOPRAZOLE SOD. SESQUIHYDRATE | B.P. | ||||
| EQ TO PANTOPRAZOLE | 40 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 385 | PANTOPRAZOLE DELAYED RELEASE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| PANTOPRAZOLE SOD. SESQUIHYDRATE | U.S.P. | ||||
| EQ TO PANTOPRAZOLE | 20 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 386 | PANTOPRAZOLE DELAYED RELEASE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| PANTOPRAZOLE SOD. SESQUIHYDRATE | B.P. | ||||
| EQ TO PANTOPRAZOLE | 40 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 387 | PANTOPRAZOLE SODIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET. CONTAINS: | DOMESTIC | ||
| PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | ||||
| EQ.TO PANTOPRAZOLE | 20 MG | ||||
| DOMPERIDONE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 388 | PANTOPRAZOLE SODIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET. CONTAINS: | DOMESTIC | ||
| PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | ||||
| EQ.TO PANTOPRAZOLE | 40 MG | ||||
| DOMPERIDONE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 389 | PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| PARACETAMOL | B.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| 390 | PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| PARACETAMOL | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| 391 | PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PARACETAMOL | I.P. | 500 MG | |||
| EXCIPIENTS | Q. S | ||||
| 392 | PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| PARACETAMOL | B.P. | 650 MG | |||
| EXCIPIENTS | Q.S | ||||
| 393 | PARACETAMOL TABLETS | EACH UNCOATED TABLET. CONTAINS: | DOMESTIC | ||
| PARACETAMOL | I.P. | 650 MG | |||
| EXCIPIENTS | Q.S | ||||
| 394 | PARACETAMOL TABLETS | EACH UNCOATED TABLET. CONTAINS: | DOMESTIC | ||
| PARACETAMOL | I.P. | 1000 MG | |||
| EXCIPIENTS | Q.S | ||||
| 395 | PARACETAMOL DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
| PARACETAMOL | I.P. | 650 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 396 | PARACETAMOL, CAFFEINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PARACETAMOL | I.P. | 325 MG | |||
| CAFFEINE ANHYDROUS | I.P. | 50 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 397 | PARACETAMOL, CAFFEINE, ACETYLSALICYLIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| PARACETAMOL | B.P. | 180 MG | |||
| CAFFEINE (ANHYDROUS) | B.P. | 30 MG | |||
| ACETYLSALICYLI ACID | B.P. | 240 MG | |||
| EXCIPIENTS | Q.S | ||||
| 398 | PARACETAMOL, ETODOLAC TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ETODOLAC | I.P. | 400 MG | |||
| PARACETAMOL | I.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 399 | PARACETAMOL, ETODOLAC TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ETODOLAC | I.P. | 400 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 400 | PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| PARACETAMOL | B.P. | 500 MG | |||
| CAFFEINE (ANHYDROUS) | B.P. | 30 MG | |||
| PHENYLEPHRINE HYDROCHLORIDE | B.P. | 2.5 MG | |||
| CETIRIZINE HYDROCHLORIDE | B.P. | 4 MG | |||
| EXCIPIENTS | Q.S | ||||
| 401 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET. CONTAINS: | DOMESTIC | ||
| PARACETAMOL | I.P. | 325 MG | |||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | |||
| CETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
| EXCPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 402 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PARACETAMOL | I.P. | 325 MG | |||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 10 MG | |||
| CETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
| EXCPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 403 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE DI-HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PARACETAMOL | I.P. | 325 MG | |||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | |||
| CETIRIZINE DI- HYDROCHLORIDE | I.P. | 5 MG | |||
| EXCPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 404 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE LEVOCETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PARACETAMOL | I.P. | 325 MG | |||
| PHENYLE PHRINE HYDROCHLORIDE | I.P. | 5 MG | |||
| LEVOCETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 405 | PARACETAMOL, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| PARACETAMOL | B.P. | 500 MG | |||
| CAFFEINE ANHYDROUS | B.P. | 30 MG | |||
| PHENYEPHRINE HYDROCHLORIDE | B.P. | 12 MG | |||
| CHLORPHENIRAMINE MALEATE | B.P. | 2 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 406 | PARACETAMOL, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PARACETAMOL | I.P. | 325 MG | |||
| CAFFEINE ANHYDROUS | I.P. | 30 MG | |||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | |||
| DIPHENHYDRAMINE HYDROCHLORIDE | I.P. | 25 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 407 | PAROXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| PAROXETINE HYDROCHLORIDE HEMIHYDRATE | U.S.P. | ||||
| EQ TO PAROXETINE | 12.5 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 408 | PAROXETINE HYDROCHLORIDE CONTROLLED RELEASE TABLETS | EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| PAROXETINE HYDROCHLORIDE | I.P. | ||||
| EQ TO PAROXETINE | 12.5 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 409 | PAROXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| PAROXETINE HYDROCHLORIDE HEMIHYDRATE | I.P. | ||||
| EQ TO PAROXETINE | 20 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 410 | PAROXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| PAROXETINE HYDROCHLORIDE HEMIHYDRATE | U.S.P. | ||||
| EQ TO PAROXETINE | 25 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 411 | PAROXETINE HYDROCHLORIDE CONTROLLED RELEASE TABLETS | EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| PAROXETINE HYDROCHLORIDE | I.P. | ||||
| EQ TO PAROXETINE | 25 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 412 | PIRACETAM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| PIRACETAM | B.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 413 | POTASSIUM OROTATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| ORITIC ACID (AS POTASSIUM OROTATE) | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| 414 | PRAMIPEXOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE | U.S.P. | 0.5 MG | |||
| EXCIPIENTS | Q. S | ||||
| 415 | PRAZIQUANTEL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PRAZIQUANTEL | U.S.P. | 600 MG | |||
| EXCIPIENTS | Q. S | ||||
| 416 | PREDNISOLONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| PREDNISOLONE | B.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| 417 | PRIMAQUINE PHOSPHATE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
| PRIMAQUINE PHOSPHATE | I.P. | ||||
| EQ TO PRIMAQUINE | 2.5 MG | ||||
| EXCIPIENTS | Q. S | ||||
| 418 | PRIMAQUINE PHOSPHATE TABLETS | EACH FILM COATED TABLET CONTAINS | DOMESTIC | ||
| PRIMAQUINE PHOSPHATE | I.P. | ||||
| EQ TO PRIMAQUINE | 7.5 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 419 | PRIMAQUINE PHOSPHATE TABLETS | EACH FILM COATED TABLET CONTAINS | DOMESTIC | ||
| PRIMAQUINE PHOSPHATE | I.P. | ||||
| EQ TO PRIMAQUINE | 15 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 420 | PROCHLORPERAZINE MALEATE TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PROCHLORPERAZINE MALEATE | I.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| 421 | PROCHLORPERAZINE MALEATE DISPERSIBLE TABLET | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
| PROCHLORPERAZINE MALEATE | I.P. | 5 MG | |||
| EXCIPIENTS | Q. S | ||||
| 422 | PROMETHAZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| PROMETHAZINE HYDROCHLORIDE | B.P. | 25 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 423 | PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PROPRANOLOL HYDROCHLORIDE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 424 | PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PROPRANOLOL HYDROCHLORIDE | I.P. | 20 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 425 | PROPRANOLOL HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| PROPRANOLOL HYDROCHLORIDE | I.P. | 20 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 426 | PROPRANOLOL HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| PROPRANOLOL HYDROCHLORIDE | I.P. | 40 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 427 | PROPRANOLOL HYDROCHLORIDE (EXTENDED RELEASE), FLUNARIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) | I.P. | 40 MG | |||
| FLUNARIZINE DIHYDROCHLORIDE | I.P. | ||||
| EQ TO FLUNARIZINE | 10 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 427 | PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) | I.P. | 40 MG | |||
| FLUNARIZINE DIHYDROCHLORIDE | B.P. | ||||
| EQ TO FLUNARIZINE | 5 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 428 | PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) | I.P. | 40 MG | |||
| FLUNARIZINE DIHYDROCHLORIDE | B.P. | ||||
| EQ TO FLUNARIZINE | 10 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 428 | PYRIDOXINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| PYRIDOXINE HYDROCHLORIDE | I.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| 429 | QUETIAPINE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| QUETIAPINE FUMARATE | I.P. | ||||
| EQ TO QUETIAPINE | 25 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 430 | QUETIAPINE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| QUETIAPINE FUMARATE | I.P. | ||||
| EQ TO QUETIAPINE | 50 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 431 | QUETIAPINE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| QUETIAPINE FUMARATE | I.P. | ||||
| EQ TO QUETIAPINE | 100 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 432 | QUETIAPINE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| QUETIAPINE FUMARATE | I.P. | ||||
| EQ TO QUETIAPINE | 200 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 433 | RABEPRAZOLE SODIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| RABEPRAZOLE SODIUM | I.P. | 20 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 434 | RABEPRAZOLE SODIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| RABEPRAZOLE SODIUM | I.P. | 20 MG | |||
| DOMPERIDONE | I.P. | 10 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 435 | RISPERIDONE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| RISPERIDONE | B.P. | 1 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 436 | RISPERIDONE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| RISPERIDONE | B.P. | 2 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 437 | RISPERIDONE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
| RISPERIDONE | B.P. | 1 MG | |||
| EXCIPIENTS | Q. S | ||||
| 438 | RISPERIDONE, TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| RISPERIDONE | I.P. | 2 MG | |||
| TRIHEXYPHENIDYL HYDROCHLORIDE | I.P. | 2 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 439 | RISPERIDONE, TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| RISPERIDONE | I.P. | 3 MG | |||
| TRIHEXYPHENIDYL HYDROCHLORIDE | I.P. | 2 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 440 | ROSUVASTATIN CALCIUM TABLETS | EACH FILM COATED TABLET. CONTAINS: | DOMESTIC | ||
| ROSUVASTATIN CALCIUM | I.P. | ||||
| EQ.TO ROSUVASTATIN | 10 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 441 | ROSUVASTATIN CALCIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ROSUVASTATIN CALCIUM | U.S.P. | ||||
| EQ.TO ROSUVASTATIN | 10 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 442 | ROSUVASTATIN CALCIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| ROSUVASTATIN CALCIUM | U.S.P. | ||||
| EQ.TO ROSUVASTATIN | 20 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 443 | ROXITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| ROXITHROMYCIN | I.P. | 150 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 444 | SALBUTAMOL SULPHATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| SALBUTAMOL SULPHATE | B.P. | ||||
| EQ TO SALBUTAMOL | 4 MG | ||||
| EXCIPIENTS | Q.S | ||||
| 445 | SALBUTAMOL, THEOPHYLLINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| SALBUTAMOL SULPHATE | I.P. | ||||
| EQ. TO SALBUTAMOL | 4 MG | ||||
| THEOPHYLLINE (ANHYDROUS) | I.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| 446 | SALBUTAMOL, ETOFYLLINE, BROMHEXINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| SALBUTAMOL SULPHATE | I.P. | ||||
| EQ TO SALBUTAMOL | 4 MG | ||||
| ETOPHYLLINE (ANHYDROUS) | I.P. | 200 MG | |||
| BROMHEXINE HYDROCHLORIDE | I.P. | 16 MG | |||
| EXCIPIENTS | Q. S | ||||
| 447 | SERRATIOPEPTIDASE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
| SERRATIOPEPTIDASE | B.P. | 10 MG | |||
| (EQ TO 20000 ENZYME ACTIVITY) | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 448 | SERRATIOPEPTIDASE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| SERRATIOPEPTIDASE | I.P. | 10 MG | |||
| (EQ TO 20000 UNITS OF ENZYME ACTIVITY) | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 449 | SERTRALINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| SERTRALINE HYDROCHLORIDE | I.P. | ||||
| EQ TO SERTRALINE | 25 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 450 | SERTRALINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| SERTRALINE HYDROCHLORIDE | I.P. | ||||
| EQ TO SERTRALINE | 50 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 451 | SERTRALINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| SERTRALINE HYDROCHLORIDE | I.P. | ||||
| EQ TO SERTRALINE | 100 MG | ||||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 452 | SILDENAFIL CITRATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| SILDENAFIL CITRATE | B.P. | ||||
| EQ.TO SILDENAFIL | 100 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 453 | SILDENAFIL CITRATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| SILDENAFIL CITRATE | I.P. | ||||
| EQ.TO SILDENAFIL | 100 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 454 | SILYMARIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| SILYMARIN (AS SILYBIN) | I.P. | 70 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 455 | SILYMARIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| SILYMARIN (AS SILYBIN) | I.P. | 140 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 455 | SITAGLIPTIN PHOSPHATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| SITAGLIPTIN PHOSPHATE MONOHYDRATE | U.S.P. | ||||
| EQ. TO SITAGLIPTIN | 50 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 456 | SITAGLIPTIN PHOSPHATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| SITAGLIPTIN PHOSPHATE MONOHYDRATE | U.S.P. | ||||
| EQ. TO SITAGLIPTIN | 100 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 456 | SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| 64.25 MG OF SITAGLIPTIN PHOSPHATE MONOHYDRATE | U.S.P. | ||||
| EQ. TO SITAGLIPTIN | 50 MG | ||||
| METFORMIN HYDROCHLORIDE | U.S.P. | 500 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 457 | SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| 64.25 MG OF SITAGLIPTIN PHOSPHATE MONOHYDRATE | U.S.P. | ||||
| EQ. TO SITAGLIPTIN | 50 MG | ||||
| METFORMIN HYDROCHLORIDE | U.S.P. | 1000 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 458 | SODIUM FEREDETATE, FOLIC ACID, VITAMIN B12 TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| SODIUM FEREDETATE | B.P. | ||||
| EQ. TO 33 MG ELEMENTAL IRON | 231 MG | ||||
| FOLIC ACID | I.P. | 1.5 MG | |||
| VITAMIN B12 | I.P. | 15 MCG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 459 | SODIUM VALPROATE GASTRO-RESISTANT TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
| SODIUM VALPROATE | I.P. | 200 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 460 | SODIUM VALPROATE, VALPROIC ACID CONTROLLED RELEASE TABLETS | EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| SODIUM VALPROATE | I.P. | 200 MG | |||
| VALPROIC ACID | I.P. | 87 MG | |||
| (BOTH TOGETHER CORRESPONDS TO SODIUM VALPROATE 300 MG) | |||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 461 | SODIUM VALPROATE, VALPROIC ACID CONTROLLED RELEASE TABLETS | EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| SODIUM VALPROATE | I.P. | 333 MG | |||
| VALPROIC ACID | I.P. | 145 MG | |||
| (BOTH TOGETHER CORRESPONDS TO SODIUM VALPROATE IP 500 MG) | |||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 462 | SPARFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| SPARFLOXACIN | I.P. | 200 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 463 | SULFASALZINE DELAYED RELEASE TABLETS | EACH ENTERIC COATED DELAYED RELEASE TABLET CONTEINS: | EXPORT | ||
| SULFASALAZINE | U.S.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 464 | TADALAFIL TABETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TADALAFIL | I.P. | 20 MG | |||
| EXCIPINTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 465 | TELMISARTAN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| TELMISARTAN | I.P. | 20 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 466 | TELMISARTAN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| TELMISARTAN | I.P. | 40 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 467 | TELMISARTAN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TELMISARTAN | I.P. | 80 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 468 | TELMISARTAN, CHLORTHALIDONE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TELMISARTAN | I.P. | 40 MG | |||
| CHLORTHALIDONE | I.P. | 12.5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 469 | TELMISARTAN, HYDROCHLORTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TELMISARTAN | I.P. | 40 MG | |||
| HYDROCHLORTHIAZIDE | I.P. | 12.5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 470 | TELMISARTAN, HYDROCHLORTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TELMISARTAN | I.P. | 80 MG | |||
| HYDROCHLORTHIAZIDE | I.P. | 12.5 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 471 | TELMISARTAN, HYDROCHLORTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| TELMISARTAN | B.P. | 40 MG | |||
| HYDROCHLORTHIAZIDE | B.P. | 12.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 472 | TELMISARTAN, HYDROCHLORTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| TELMISARTAN | B.P. | 80 MG | |||
| HYDROCHLORTHIAZIDE | B.P. | 12.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 473 | TERBINAFINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| TERBINAFINE HYDROCHLORIDE | I.P. | ||||
| EQ.TO TERBINAFINE (IN BETACYCLODEXTRIN) | 250 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 474 | TERBINAFINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| TERBINAFINE HYDROCHLORIDE | U.S.P. | ||||
| EQ.TO TERBINAFINE (IN BETACYCLODEXTRIN) | 250 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 475 | THIAMINE MONONITRATE, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| THIAMINE MONONITRATE | B.P. | 10 MG | |||
| PYRIDOXINE HCL | B.P. | 3 MG | |||
| CYANOCOBALAMIN | B.P. | 15 MCG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 476 | THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, CYNOCOBALAMIN TABLETS | EACH FILM COATED TABLET. CONTAINS: | EXPORT | ||
| THIAMINE HYDROCHLORIDE | B.P. | 100 MG | |||
| PYRIDOXINE HCL | B.P. | 200 MG | |||
| CYNOCOBALAMIN | B.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 477 | TINIDAZOLE TABLETS | EACH FILMCOATED TABLET CONTAINS: | EXPORT | ||
| TINIDAZOLE | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 478 | TOPIRAMATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TOPIRAMATE | I.P. | 25 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 479 | TOPIRAMATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TOPIRAMATE | I.P. | 50 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 480 | TRAMADOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| TRAMADOL HYDROCHLORIDE | I.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 481 | TRAMADOL HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH FILM COATED SUSTAINED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| TRAMADOL HYDROCHLORIDE | I.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 482 | TRAMADOL HYDROCHLORIDE, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TRAMADOL HYDROCHLORIDE | I.P. | 37.5 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q.S | ||||
| 483 | TRAMADOL HYDROCHLORIDE, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TRAMADOL HYDROCHLORIDE | I.P. | 50 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 484 | TRAMADOL HYDROCHLORIDE, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| TRAMADOL HYDROCHLORIDE | I.P. | 50 MG | |||
| PARACETAMOL | I.P. | 325 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 485 | TRANEXAMIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| TRANEXAMIC ACID | B.P. | 500 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 486 | TRANEXAMIC ACID, ETAMSYLATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| TRANEXAMIC ACID | B.P. | 250 MG | |||
| ETAMSYLATE | B.P. | 250 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 487 | TRANEXAMIC ACID, ETAMSYLATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TRANEXAMIC ACID | I.P. | 250 MG | |||
| ETAMSYLATE | I.P. | 250 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 488 | TRANEXAMIC ACID, MEFENAMIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TRANEXAMIC ACID | I.P. | 500 MG | |||
| MEFENAMIC ACID | I.P. | 250 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 489 | TRAZODONE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| TRAZODONE HYDROCHLORIDE | U.S.P. | 25 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 490 | TRAZODONE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| TRAZODONE HYDROCHLORIDE | U.S.P. | 50 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 491 | TRAZODONE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| TRAZODONE HYDROCHLORIDE | U.S.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 492 | TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| TRIHEXYPHENIDYL HYDROCHLORIDE | U.S.P. | 2 MG | |||
| EXCIPIENTS | Q.S | ||||
| 493 | TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
| TRIHEXYPHENIDYL HYDROCHLORIDE | I.P. | 2 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 494 | TRIHEXYPHENIDYL HYDROCHLORIDE, TRIFLUOPERAZINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TRIHEXYPHENIDYL HYDROCHLORIDE | I.P. | 2 MG | |||
| TRIFLUOPERAZINE HYDROCHLORIDE | I.P. | ||||
| EQ. TO TRIFLUOPERAZINE | 5 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 495 | TRIMETHOPRIM, SULFAMETHOXAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| TRIMETHOPRIM | B.P. | 80 MG | |||
| SULFAMETHOXAZOLE | B.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 496 | TRIMETHOPRIM, SULFAMETHOXAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| TRIMETHOPRIM | B.P. | 160 MG | |||
| SULFAMETHOXAZOLE | B.P. | 800 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 497 | TRIOXSALEN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
| TRIOXSALEN | U.S.P. | 25 MG | |||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED | |||||
| 498 | URSODIOL TABLETS (URSODESOXYCHOLIC ACID) TABLETS | EACH UNCOATED TABLET CONATINS: | DOMESTIC | ||
| URSODEOXYCHOLIC ACID | I.P. | 150 MG | |||
| EXCIPIENTS | Q. S | ||||
| 499 | URSODIOL TABLETS (URSODESOXYCHOLIC ACID) TABLETS | EACH UNCOATED TABLET CONATINS: | DOMESTIC | ||
| URSODEOXYCHOLIC ACID | I.P. | 300 MG | |||
| EXCIPIENTS | Q. S | ||||
| 500 | URSODIOL TABLETS (URSODESOXYCHOLIC ACID) TABLETS | EACH UNCOATED TABLET CONATINS: | EXPORT | ||
| URSODEOXYCHOLIC ACID | U.S.P. | 300 MG | |||
| EXCIPIENTS | Q.S | ||||
| 501 | VALACYCLOVIR TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
| VALACYCLOVIR HCL | U.S.P. | ||||
| EQ.TO VALACYCLOVIR | 500 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 502 | VALACYCLOVIR TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
| VALACYCLOVIR HYDROCHLORIDE | U.S.P. | ||||
| EQ.TO VALACYCLOVIR | 500 MG | ||||
| EXCIPIENTS | Q.S | ||||
| 503 | VENLAFAXINE HYDROCHLORIDE EXTEND RELEASE TABLETS | EACH UNCOATED EXTENDE RELEASE TABLET CONTAINS: | DOMESTIC | ||
| VENLAFAXINE HYDROCHLORIDE | B.P. | ||||
| EQ TO VENLAFAXINE | 75 MG | ||||
| EXCIPIENTS | Q. S | ||||
| 504 | VENLAFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS | EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS: | DOMESTIC | ||
| VENLAFAXINE HYDROCHLORIDE | I.P. | ||||
| EQ TO VENLAFAXINE | 75 MG | ||||
| EXCIPIENTS | Q. S | ||||
| 505 | ZINC SULPHATE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
| ZINC SULPHATE MONOHYDRATE | I.P. | 55 MG | |||
| EQ. TO 20 MG ELEMENTAL ZINC | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED | |||||
| 506 | ZOPICLONE TABLETS | EACH FILMCOATED TABLET CONTAINS: | EXPORT | ||
| ZOPICLONE | B.P. | 7.5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOURED USED | |||||
| NO | NAME OF PRODUCT | COMPOSITION | GRADE | STRENGTH | MARKET |
| 1 | AZITHROMYCIN CAPSULE | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| AZITHROMYCIN DIHYDRATE | U.S.P. | ||||
| EQ. TO ANHYDROUS AZITHROMYCIN | 250 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN HARD GELATIN CAPSULE SHELLS | |||||
| 2 | AZITHROMYCIN CAPSULE | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| AZITHROMYCIN DIHYDRATE | U.S.P. | ||||
| EQ. TO ANHYDROUS AZITHROMYCIN | 500 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
| 3 | AZITHROMYCIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| AZITHROMYCIN DIHYDRATE | I.P. | ||||
| EQ TO ANHYDROUS AZITHROMYCIN | 500 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY CAPSULES SHELL | |||||
| 4 | BUDESONIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| BUDESONIDE (AS CONTROLLED RELEASE PELLETS) | B.P. | 3 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELL & PELLETS | |||||
| 5 | BUDESONIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| BUDESONIDE (AS CONTROLLED RELEASE PELLETS) | I.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS & PELLETS | |||||
| 6 | CLINDAMYCIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| CLINDAMYCIN HYDROCHLORIDE | |||||
| EQ TO CLINDAMYCIN | 300 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 7 | DICYCLOMINE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| TRAMADOL HYDROCHLORIDE | I.P. | 50 MG | |||
| DICYCLOMINE HYDROCHLORIDE | I.P. | 10 MG | |||
| ACETAMINOPHEN | I.P. | 325 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 8 | DOXYCYCLINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULES CONTAINS: | EXPORT | ||
| DOXYCYCLINE HYDROCHLORIDE | U.S.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS | |||||
| 9 | DOXYCYCLINE HYDROCHLORIDE, LACTIC ACID BACILLUS CAPSULES | EACH HARD GELATIN CAPSULES CONTAINS: | EXPORT | ||
| DOXYCYCLINE HYDROCHLORIDE | B.P. | ||||
| EQ.TO DOXYCYCLINE (PELLETS) | 100 MG | ||||
| LACTIC ACID BACILLUS 5 BILLION SPORES (AS ENTRIC COATED PELLETS) | 5 MLN SPORES | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS | |||||
| 10 | DRIED FERROUS SULFATE, VITAMIN C, THIAMINE MONONITRATE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN NICOTINAMIDE, CALCIUM PANTOTHENATE, FOLIC ACID, ZINC SULFATE MONOHYDRATE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| DRIED FERROUS SULFATE | B.P. | 150 MG | |||
| EQ. TO 46 MG ELEMENTARY IRON | |||||
| VITAMIN C(AS COATED | B.P. | 50 MG | |||
| THIAMINE MONONITRATE | U.S.P. | 2 MG | |||
| PYRIDOXINE HYDROCHLORIDE | B.P. | 1 MG | |||
| RIBOFLAVIN | B.P. | 2 MG | |||
| NICOTINAMIDE | B.P. | 15 MG | |||
| CALCIUM PANTOTHENATE | B.P. | 2.5 MG | |||
| FOLIC ACID | B.P. | 0.5 MG | |||
| ZINC SULFATE MONOHYDRATE | B.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
| 11 | ESOMEPRAZOLE (ENTERIC COATED), DOMPERIDONE SUSTAINED RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| ESOMEPRAZOLE MAGNESIUM TRIHYDRATE | I.P. | ||||
| EQ. TO ESOMEPRAZOLE | 40 MG | ||||
| (AS ENTERIC COATED PELLETS) | |||||
| DOMPERIDONE | I.P. | 30 MG | |||
| (AS SUSTAINED RELEASE PELLETS) | |||||
| EXCIPIENTS: | Q. S | ||||
| APPROVED COLOUR USED IN HARD GELATIN CAPSULE SHELL & PELLETS. | |||||
| 12 | FERROUS FUMARATE, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, ZINC CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| FERROUS FUMARATE | B.P. | 304 MG | |||
| EQ. TO 100 MG ELEMENTAL IRON | |||||
| FOLIC ACID | B.P. | 0.75 MG | |||
| CYANOCOBALAMIN | B.P. | 5 MCG | |||
| ASCORBIC ACID | B.P. | 75 MG | |||
| ZINC SULPHATE MONO HYDRATE | B.P. | 5 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROPRIATE OVERAGE OF VITAMINS ADDED | |||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 13 | FERROUS FUMARATE, CYANOCOBALAMIN, FOLIC ACID, ZINC CAPSULES | EACH HARD GELATIN CAPSULES CONTAINS: | DOMESTIC | ||
| FERROUS FUMARATE | I.P. | 200 MG | |||
| EQ. TO ELEMENTAL IRON | 65 MG | ||||
| CYANOCOBALAMIN | I.P. | 10 MCG | |||
| FOLIC ACID | I.P. | 1 MG | |||
| ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
| EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN HARD GELATIN CAPSULE SHELL | |||||
| 14 | FERROUS FUMARATE, CYANOCOBALAMIN, FOLIC ACID, ZINC CAPSULES | EACH HARD GELATIN CAPSULES CONTAINS: | DOMESTIC | ||
| FERROUS FUMARATE | I.P. | 300 MG | |||
| EQ. TO 98.6 MG OF ELEMENTAL IRON | |||||
| CYANOCOBALAMIN | I.P. | 15 MCG | |||
| FOLIC ACID | I.P. | 1.5 MG | |||
| ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
| EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN HARD GELATIN CAPSULE SHELL | |||||
| 15 | FERROUS FUMARATE, CYANOCOBALAMIN, FOLIC ACID, ZINC CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| FERROUS FUMARATE | I.P. | 400 MG | |||
| FOLIC ACID | I.P. | 1.5 MG | |||
| CYANOCOBALAMIN | I.P. | 15 MCG | |||
| ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
| EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN HARD GELATIN CAPSULE SHELL | |||||
| 16 | FLUCONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| FLUCONAZOLE | U.S.P. | 50 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
| 17 | FLUCONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| FLUCONAZOLE | B.P. | 150 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
| 18 | FLUCONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| FLUCONAZOLE | I.P. | 150 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 19 | FLUOXETINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| FLUOXETINE HYDROCHLORIDE | B.P. | ||||
| EQ. TO FLUOXETINE | 20 MG | ||||
| EXCIPIENT | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATINS CAPSULE SHELLS | |||||
| 20 | FLUOXETINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| FLUOXETINE HYDROCHLORIDE | I.P. | ||||
| EQ. TO FLUOXETINE | 20 MG | ||||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 21 | FLUOXETINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| FLUOXETINE HYDROCHLORIDE | I.P. | ||||
| EQ. TO FLUOXETINE | 40 MG | ||||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 22 | FLUOXETINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| FLUOXETINE HYDROCHLORIDE | I.P. | ||||
| EQ. TO FLUOXETINE | 60 MG | ||||
| EXCIPIENT | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 23 | ILAPRAZOLE, DOMPERIDONE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| ILAPRAZOLE (AS ENTERIC COATED PELLETS) | I.P. | 10 MG | |||
| DOMPERIDONE (AS SUSTAINED RELEASE PELLETS) | I.P. | 30 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES | |||||
| 24 | ISOTRETINOIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| ISOTRETINOIN | I.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS | |||||
| 25 | ISOTRETINOIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| ISOTRETINOIN | I.P. | 20 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GLATIN CAPSULES SHELL | |||||
| 26 | ISOXSUPRINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| ISOXSUPRINE HYDROCHLORIDE | I.P. | 20 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN HARD GELATIN CAPSULES SHELL | |||||
| 27 | ITRACONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| ITRACONAZOLE PELLETS | B.P. | ||||
| EQ.TO ITRACONAZOLE | 50 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY CAPSULE SHELLS & PELLETS | |||||
| 28 | ITRACONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| ITRACONAZOLE PELLETS | B.P. | ||||
| EQ.TO ITRACONAZOLE | 100 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 29 | ITRACONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| ITRACONAZOLE PELLETS | B.P. | ||||
| EQ.TO ITRACONAZOLE | 200 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 30 | ITRACONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| ITRACONAZOLE PELLETS | I.P. | ||||
| EQ.TO ITRACONAZOLE | 100 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 31 | ITRACONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| ITRACONAZOLE PELLETS | I.P. | ||||
| EQ.TO ITRACONAZOLE | 200 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 32 | LOPERAMIDE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| LOPERAMIDE HYDROCHLORIDE | U.S.P. | 2 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 33 | LOPERAMIDE HYDOCHLORIDE, DICYCLOVERINE HYDROCHLORIDE, LACTIC ACID BACILLUS CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| LOPERAMIDE HYDROCHLORIDE | B.P. | 2 MG | |||
| DICYCLOVERINE HYDROCHLORIDE | B.P. | 10 MG | |||
| LACTIC ACID BACILLUS (BACILLUS COAGULANS (LB SPOROGENES)) | 60 MLN SPORES | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 34 | OMEPRAZOLE GASTRO-RESISTANT CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| OMEPRAZOLE (AS ENTERIC COATED PELLETS) | B.P. | 20 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 35 | OMEPRAZOLE, DOMPERIDONE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| OMEPRAZOLE (AS ENTERIC COATED PELLETS) | B.P. | 20 MG | |||
| DOMPERIDONE (AS IMMIDIATE RELEASE PELLETS) | B.P. | 10 MG | |||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 36 | OMEPRAZOLE, DOMPERIDONE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| OMEPRAZOLE (AS ENTERIC COATED PELLETES) | B.P. | 20 MG | |||
| DOMPERIDONE (AS SUSTAINED RELEASE PELLETS) | B.P. | 30 MG | |||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 37 | OMEPRAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| OMEPRAZOLE | I.P. | 20 MG | |||
| (AS ENTERIC COATED) | |||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
| 38 | PANTOPRAZOLE SODIUM DELAYED-RELEASE CAPSULES | EACH HARD GELATIN CAPULE CONTAINS: | EXPORT | ||
| PANTOPRAZOLE SODIUM SESQUIHYDRATE | B.P. | ||||
| EQ TO PANTOPRAZOLE (AS ENTERIC COATED PELLETS) | 40 MG | ||||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 39 | PANTOPRAZOLE (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) CAPSULES | EACH HARD GELATIN CAPULE CONTAINS: | EXPORT | ||
| PANTOPRAZOLE SODIUM SESQUIHYDRATE | B.P. | ||||
| EQ TO PANTOPRAZOLE (AS ENTERIC COATED PELLETS) | 40 MG | ||||
| DOMPERIDONE (AS SUSTAINED RELEASE PELLETS) | B.P. | 30 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 40 | PANTOPRAZOLE (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) CAPSULES | EACH HARD GELATIN CAPULE CONTAINS: | EXPORT | ||
| PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | ||||
| EQ TO PANTOPRAZOLE (AS ENTERIC COATED PELLETS) | 40 MG | ||||
| DOMPERIDONE (AS SUSTAINED RELEASE PELLETS) | I.P. | 10 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 41 | PANTOPRAZOLE (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | ||||
| EQ. TO PANTOPRAZOLE (AS ENTRIC COATED PELLETS) | 40 MG | ||||
| DOMPERIDONE (AS IR PELLETS) | I.P. | 30 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN HARD GELATIN EMPTY CAPSULE SHELL & PELLETS | |||||
| 42 | PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENAMINE MALEATE, PARACETAMOL, ASCORBIC ACID, CAFFEINE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| PHENYLEPHRINE HYDROCHLORIDE | B.P. | 5 MG | |||
| CHLORPHENAMINE MALEATE | B.P. | 2 MG | |||
| PARACETAMOL | B.P. | 300 MG | |||
| ASCORBIC ACID | B.P. | 75 MG | |||
| CAFFEINE (ANHYDROUS) | B.P. | 30 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS & PELLETS | |||||
| 43 | PANTOPRAZOLE SODIUM, LEVOSULPIRIDE SUSTAINED RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | ||||
| EQ.TO PANTOPRAZOLE (AS ENTERIC COATED PELLETS) | 40 MG | ||||
| LEVOSULPIRIDE (AS SUSTAINED RELEASE PELLETS) | I.P. | 75 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS & PELLETS | |||||
| 44 | PIRACETAM CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| PIRACETAM | B.P. | 400 MG | |||
| EXCIPIENTS | Q.S | ||||
| EXCIPIENTS | |||||
| 45 | PREGABALIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| PREGABALIN | U.S.P. | 75 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 46 | PREGABALIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| PREGABALIN | U.S.P. | 300 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
| 47 | PREGABALIN, METHYLCOBALAMIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| PREGABALIN | I.P. | 75 MG | |||
| METHYLCOBALAMIN | I.P. | 1500 MCG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
| 48 | PREGABALIN, METHYLCOBALAMIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| PREGABALIN | U.S.P. | 75 MG | |||
| METHYLCOBALAMIN | U.S.P. | 750 MCG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
| 49 | PREGABALIN, METHYLCOBALAMIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| PREGABALIN | U.S.P. | 150 MG | |||
| METHYLCOBALAMIN | U.S.P. | 750 MCG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
| 50 | PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) | I.P. | 40 MG | |||
| FLUNARIZINE DIHYDROCHLORIDE | B.P. | ||||
| EQ TO FLUNARIZINE | 5 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS | |||||
| 51 | PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) | I.P. | 40 MG | |||
| FLUNARIZINE DIHYDROCHLORIDE | B.P. | ||||
| EQ TO FLUNARIZINE | 10 MG | ||||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATN CAPSULE SHELL | |||||
| 52 | RABEPRAZOLE SODIUM (ENTERIC COATED) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| RABEPRAZOLE SODIUM (AS ENTERIC COATED PELLETS) | B.P. | 20 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 53 | RABEPRAZOLE SODIUM (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| RABEPRAZOLE SODIUM (AS ENTERIC COATED PELLETS) | I.P. | 20 MG | |||
| DOMPERIDONE (AS SUSTAINED RELEASE PELLETS) | I.P. | 30 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 54 | RABEPRAZOLE (ENTERIC COATED), DICLOFENAC SODIUM (SUSTAINED RELEASE) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| RABEPRAZOLE SODIUM (AS ENTERIC COATED PELLETS) | I.P. | 20 MG | |||
| DICLOFENAC SODIUM (AS SUSTAINED RELEASE PELLETS) | I.P. | 100 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS & PELLETS | |||||
| 55 | RABEPRAZOLE (ENTERIC COATED), LEVOSULPIRIDE SUSTAINED RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| RABEPRAZOLE SODIUM (AS ENTERIC COATED PELLETS) | I.P. | 20 MG | |||
| LEVOSULPIRIDE (AS SUSTAINED RELEASE PELLETS) | I.P. | 75 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS & PELLETS | |||||
| 56 | TAMSULOSIN HYDROCHLORIDE PROLONGED RELEASE AND DUTASTERIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| DUTASTERIDE | 0.5 MG | ||||
| TAMSULOSIN HYDROCHLORIDE | B.P. | 0.4 MG | |||
| (AS PROLONGED RELEASE) | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
| 57 | TRAMADOL HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
| TRAMADOL HYDROCHLORIDE | I.P. | 50 MG | |||
| EXCIPIENTS | Q. S | ||||
| APPROVED COLOUR USED IN EMPTY CAPSULE SHELL | |||||
| 58 | UMIFENOVIR HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| UMIFENOVIR HYDROCHLORIDE | B.P. | 100 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELL & PELLETS | |||||
| 59 | UMIFENOVIR HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
| UMIFENOVIR HYDROCHLORIDE | B.P. | 200 MG | |||
| EXCIPIENTS | Q.S | ||||
| APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
| NO | NAME OF PRODUCT | COMPOSITION | GRADE | STRENGTH | FORM | MARKET |
| 1 | ACYCLOVIR OINTMENT | EACH GM CONTAINS: | OINTMENT | EXPORT | ||
| ACYCLOVIR | U.S.P. | 50 MG | ||||
| WATER MISCIBLE OINTMENT BASE | Q.S | |||||
| 2 | AMOROLFINE HYDROCHLORIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| AMOROLFINE HYDROCHLORIDE | I.P. | |||||
| EQ. TO AMOROLFINE | 0.25%W/W | |||||
| CREAM BASE | Q.S | |||||
| 3 | BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
| BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/V | ||||
| CLOTRIMAZOLE | I.P. | 1.000%W/V | ||||
| NON AQUEOUS BASE | Q.S | |||||
| 4 | BECLOMETHASONE DIPROPIONATE, FUSIDIC ACID CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/W | ||||
| FUSIDIC ACID | I.P. | 2.0% W/W | ||||
| IN CREAM BASE | Q.S | |||||
| 5 | BECLOMETHASONE DIPROPIONATE, NEOMYCIN, CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/W | ||||
| NEOMYCIN SULPHATE | I.P. | |||||
| EQ.TO NEOMYCIN BASE | 0.5%W/W | |||||
| CLOTRIMAZOLE | I.P. | 1.0%W/W | ||||
| CHLOROCRESOL (AS PRESERVATIVE) | I.P. | 0.1%W/W | ||||
| CREAM BASE | Q.S | |||||
| 6 | BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE, NEOMYCIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| BECLOMETHASONE DIPROPIONATE | I.P. | 0.05 % W/W | ||||
| CLOTRIMAZOLE | I.P. | 1.00 % W/W | ||||
| NEOMYCIN SULPHATE | I.P. | |||||
| EQ. TO NEOMYCIN BASE | 0.50 % W/W | |||||
| CREAM BASE | Q.S | |||||
| 7 | BENZOYL PEROXIDE GEL | COMPOSITION: | GEL | EXPORT | ||
| HYDROUS BENZOYL PEROXIDE | B.P. | |||||
| EQ. TO ANHYDROUS BENZOYL PEROXIDE | 5.0%W/W | |||||
| AQUEOUS GEL BASE | Q.S | |||||
| 8 | BENZOYL PEROXIDE GEL | COMPOSITION: | GEL | EXPORT | ||
| HYDROUS BENZOYL PEROXIDE | B.P. | |||||
| EQ. TO HYDROUS BENZOYL PEROXIDE | 5.0%W/W | |||||
| AQUEOUS GEL BASE | Q.S | |||||
| 9 | BETAMETHASONE DIPROPIONATE, GENTAMYCIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
| BETAMETHASONE DIPROPIONATE | B.P. | 0.1% W/W | ||||
| GENTAMYCIN SULFATE | B.P. | 0.1% W/W | ||||
| CREAM BASE | Q.S | |||||
| 10 | BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE, GENTAMICIN OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| BETAMETHASONE DIPROPIONATE | B.P. | |||||
| EQ. TO BETAMETHASONE | 0.05%W/W | |||||
| GENTAMICIN SULFATE | B.P. | |||||
| EQ. TO GENTAMICIN | 0.1%W/W | |||||
| CLOTRIMAZOLE | B.P. | 1.0%W/W | ||||
| OINTMENT BASE | Q.S | |||||
| 11 | BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE, GENTAMICIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
| BETAMETHASONE DIPROPIONATE | B.P. | |||||
| EQ. TO BETAMETHASONE | 0.1%W/W | |||||
| GENTAMICIN SULFATE | B.P. | 0.1%W/W | ||||
| CLOTRIMAZOLE | B.P. | 0.5%W/W | ||||
| CREAM BASE | Q.S | |||||
| 12 | BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE, GENTAMICIN OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| BETAMETHASONE DIPROPIONATE | B.P. | |||||
| EQ. TO BETAMETHASONE | 1 MG | |||||
| GENTAMICIN SULFATE | B.P. | |||||
| EQ. TO GENTAMICIN | 1 MG | |||||
| CLOTRIMAZOLE | B.P. | 10 MG | ||||
| OINTMENT BASE | Q.S | |||||
| 13 | BETAMETHASONE DIPROPIONATE, GENTAMICIN SULPHATE ,TOLNAFTATE, IODOCHLORHYDROXYQUINOLINE CREAM CREAM | EACH GM CONATINS: | CREAM | EXPORT | ||
| BETAMETHASONE DIPROPIONATE | U.S.P. | 0.50 MG | ||||
| GENTAMICIN SULPHATE | B.P. | |||||
| EQ. TO GENTAMICIN BASE | 1 MG | |||||
| TOLNAFTATE | U.S.P. | 10 MG | ||||
| IODOCHLORHYDROXYQUINOLINE | U.S.P. | 10 MG | ||||
| CHLOROCRESOL (AS PRESERVATIVE) | B.P. | 1 MG | ||||
| CREAM BASE | Q.S | |||||
| 14 | BETAMETHASONE VALERATE, GENTAMICIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
| BETAMETHASONE VALERATE | B.P. | 0.1% W/W | ||||
| GENTAMYCIN SULFATE | B.P. | 0.1% W/W | ||||
| CREAM BASE | Q.S | |||||
| 15 | BETAMETHASONE VALERATE, NEOMYCIN SULPHATE, TOLNAFTATE, IODOCHLORHYDROXQUINOLINE CREAM | EACH GM CONATINS: | CREAM | DOMESTIC | ||
| BETAMETHASOMNE VALERATE | I.P. | 0.50 MG | ||||
| NEOMYCIN SULPHAE | I.P. | 5 MG | ||||
| TOLNAFTATE | I.P. | 10 MG | ||||
| IODOCHLORHYDROXYQUINOLINE | I.P. | 10 MG | ||||
| CREAM BASE | Q.S | |||||
| 16 | BORIC ACID, METHENAMINE, TALC, SODIUM TETRABORATE, SALICYLIC ACID, LEAD ACETATE, FORMALDEHYDE, ZINC OXIDE PASTE | COMPOSITIONS: | PASTE | EXPORT | ||
| BORIC ACID | B.P. | 70 MG | ||||
| METHENAMINE | B.P. | 35 MG | ||||
| TALC | B.P. | 250 MG | ||||
| SODIUM TETRABORATE | 70 MG | |||||
| SALICYLIC ACID | B.P. | 15 MG | ||||
| LEAD ACETATE | 3 MG | |||||
| FORMALDEHYDE | B.P. | 35 MG | ||||
| ZINC OXIDE | B.P. | 250 MG | ||||
| CREAM BASE | Q.S | |||||
| 17 | CALAMINE, ZINC OXIDE SKIN SOLUTION | COMPOSITION: | SOLUTION | DOMESTIC | ||
| CALAMINE | I.P. | 15% W/V | ||||
| ZINC OXIDE | I.P. | 5% W/V | ||||
| AQUEOUS BASE | Q.S | |||||
| 18 | CALAMINE, ZINC OXIDE SKIN LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
| CALAMINE | I.P. | 15 % W/V | ||||
| ZINC OXIDE | I.P. | 5 % W/V | ||||
| AQUEOUS BASE | ||||||
| 19 | CHLORHEXIDINE GLUCONATE, METRONIDAZOLE GEL | COMPOSITION: | GEL | EXPORT | ||
| CHLORHEXIDINE GLUCONATE SOLUTION | B.P. | 0.25%W/W | ||||
| METRONIDAZOLE BENZOATE | B.P. | |||||
| EQ TO METRONIDAZOLE | 1.00%W/W | |||||
| WATER SOLUBLE GEL BASE | Q.S | |||||
| 20 | CHLORPHENESIN, ZINC OXIDE, STARCH, MENTHOL DUSTING POWDER | COMPOSITION: | POWDER | DOMESTIC | ||
| CHLORPHENESIN | I.P. | 1.0%W/W | ||||
| ZINC OXIDE | I.P. | 16.0%W/W | ||||
| STARCH | I.P. | 51.0%W/W | ||||
| MENTHOL POWDER | I.P. | 0.3%W/W | ||||
| PURIFIED TALC | Q.S | |||||
| 21 | CHOLINE SALICYLATE, LIGNOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE GEL | COMPOSITION: | GEL | EXPORT | ||
| CHOLINE SALICYLATE SOLUTION | B.P. | |||||
| EQ TO CHOLINE SALICYLATE | 8.7%W/W | |||||
| LIGNOCAINE HYDROCHLORIDE | B.P. | 2.0 %W/W | ||||
| BENZALKONIUM CHLORIDE SOLUTION | B.P. | 0.01%W/W | ||||
| FLAVOURED GEL BASE | Q.S | |||||
| 22 | CIPROFLOXACIN HYDROCHLORIDE, FLUOCINOLONE ACETONIDE, CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | EXPORT | ||
| CIPROFLOXACIN HYDROCHLORIDE | B.P. | |||||
| EQ. TO CIPROFLOXACIN | 0.500%W/W | |||||
| FLUOCINOLONE ACETONIDE | B.P. | 0.025%W/W | ||||
| CLOTRIMAZOLE | B.P. | 1.00%W/W | ||||
| CREAM BASE | Q.S | |||||
| 23 | CLARITHROMYCIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| CLARITHROMYCIN | I.P. | 1.00%W/W | ||||
| CREAM BASE | Q.S | |||||
| 24 | CLINDAMYCIN PHOSPHATE GEL | COMPOSITION: | GEL | DOMESTIC | ||
| CLINDAMYCIN PHOSPHATE | I.P. | |||||
| EQ. TO CLINDAMYCIN | 1%W/W | |||||
| GEL BASE | Q.S | |||||
| 25 | CLINDAMYCIN PHOSPHATE GEL | COMPOSITION: | GEL | DOMESTIC | ||
| CLINDAMYCIN PHOSPHATE | I.P. | |||||
| EQ. TO CLINDAMYCIN | 1.0% W/W | |||||
| PRESERVATIVE: | ||||||
| SODIUM METHYL PARABEN | I.P. | 0.114% W/W | ||||
| SODIUM PROPYL PARABEN | I.P. | 0.056% W/W | ||||
| GEL BASE | Q.S | |||||
| 26 | CLINDAMYCIN PHOSPHATE, NICOTINAMIDE GEL | COMPOSITION: | GEL | DOMESTIC | ||
| CLINDAMYCIN PHOSPHATE | I.P. | |||||
| EQ. TO CLINDAMYCIN | 1.0%W/W | |||||
| NICOTINAMIDE | I.P. | 4.0%W/W | ||||
| GEL BASE | Q.S | |||||
| 27 | CLINDAMYCIN PHOSPHATE, NICOTINAMIDE GEL | COMPOSITION: | GEL | DOMESTIC | ||
| CLINDAMYCIN PHOSPHATE | I.P. | |||||
| EQ. TO CLINDAMYCIN | 1.0% W/W | |||||
| NICOTINAMIDE | I.P. | 4.0% W/W | ||||
| IN ALOE, ALLANTION BASE WITH ETHYL LACTATE | ||||||
| GEL BASE | Q.S | |||||
| 28 | CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
| CLOBETASOL PROPIONATE | U.S.P. | 0.05% W/W | ||||
| IN CREAM BASE | Q.S | |||||
| 29 | CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| CLOBETASOL PROPIONATE | I.P. | 2.0 % W/W | ||||
| PRESERVATIVES | ||||||
| METHYL PARABEN | I.P. | 0.1% W/W | ||||
| PROPYL PARABEN | I.P. | 0.06% W/W | ||||
| CREAM BASE | Q.S | |||||
| 30 | CLOBETASOL PROPIONATE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| CLOBETASOL PROPIONATE | U.S.P. | 0.05% W/W | ||||
| OINTMENT BASE | Q.S | |||||
| 31 | CLOBETASOL PROPIONATE AND FUSIDIC ACID CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| CLOBETASOLE PROPIONATE | I.P. | 0.05% W/W | ||||
| FUSIDIC ACID | I.P. | 2.0% W/W | ||||
| CREAM BASE | Q.S | |||||
| 32 | CLOBETASOL PROPIONATE, SALICYLIC ACID OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
| SALICYLIC ACID | I.P. | 3.00%W/W | ||||
| IN AN OINTMENT BASE | Q.S | |||||
| 33 | CLOBETASOL PROPIONATE, GENTAMICIN, TOLNAFTATE, IODOCHLORHYDROXYQUINOLINE, CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
| GENTAMICIN SULPHATE | I.P. | |||||
| EQ TO GENTAMICIN | 0.1%W/W | |||||
| TOLNAFTATE | I.P. | 1.0%W/W | ||||
| IODOCHLORHYDROXYQUINOLINE | I.P. | 1.0%W/W | ||||
| CLOTRIMAZOLE | I.P. | 1.0%W/W | ||||
| CHLOROCRESOL (PRESERVATIVE) | I.P. | 0.1%W/W | ||||
| CREAM BASE | Q.S | |||||
| 34 | CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
| NEOMYCIN SULPHATE | I.P. | |||||
| EQ TO NEOMYCIN BASE | 0.50%W/W | |||||
| CHLOROCRESOL (AS PRESERVATIVE) | I.P. | 0.10%W/W | ||||
| CREAM BASE | Q.S | |||||
| 35 | CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE, CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
| CLOTRIMAZOLE | I.P. | 1.00%W/W | ||||
| NEOMYCIN SULPHATE | I.P. | |||||
| EQ TO NEOMYCIN BASE | 0.50%W/W | |||||
| CHLOROCRESOL | I.P. | 0.10%W/W | ||||
| (AS PRESERVATIVE) | ||||||
| CREAM BASE | Q.S | |||||
| 36 | CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE, MICONAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
| NEOMYCIN SULPHATE | I.P. | |||||
| EQ TO NEOMYCIN BASE | 0.50%W/W | |||||
| MICONAZOLE NITRATE | I.P. | 2.0%W/W | ||||
| CHLOROCRESOL | I.P. | 0.10%W/W | ||||
| CREAM BASE | Q.S | |||||
| 37 | CLOBETASONE 17-BUTYRATE, GENTAMICIN SULPHATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| CLOBETASONE 17-BUTYRATE | I.P. | 0.050%W/W | ||||
| GENTAMICIN SULPHATE | I.P. | |||||
| EQ. TO GENTAMICIN BASE | 0.100%W/W | |||||
| CREAM BASE | Q.S | |||||
| 38 | CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | EXPORT | ||
| CLOTRIMAZOLE | B.P. | 1.0%W/W | ||||
| CREAM BASE | Q.S | |||||
| 39 | CLOTRIMAZOLE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
| CLOTRIMAZOLE | I.P. | 1.0%W/W | ||||
| NON AQUEOUS BASE | Q.S | |||||
| 40 | CLOTRIMAZOLE VAGINAL GEL | COMPOSITION: | GEL | DOMESTIC | ||
| CLOTRIMAZOLE | I.P. | 2.0%W/W | ||||
| BENZYL ALCOHOL | I.P. | 2.0%W/W | ||||
| CHLOROCRESOL | I.P. | 0.10 %W/W | ||||
| GEL BASE | Q.S | |||||
| 41 | CLOTRIMAZOLE, BECLOMETHASONE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| CLOTRIMAZOLE | I.P. | 1.0% W/W | ||||
| BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/W | ||||
| CREAM BASE | Q.S | |||||
| 42 | CLOTRIMAZOLE, BECLOMETHASONE DIPROPIONATE, GENTAMYCIN SULPHATE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| CLOTRIMAZOLE | B.P. | 1.00%W/W | ||||
| BECLOMETHASONE DIPROPIONATE | B.P. | 0.050%W/W | ||||
| GENTAMYCIN SULPHATE | B.P. | |||||
| EQ. TO GENTAMYCIN | 0.100%W/W | |||||
| OINTMENT BASE | Q.S | |||||
| 43 | DEXAMETHASONE SODIUM PHOSPHATE, NEOMYCIN SULPHATE CREAM | EACH GM CONTAINS: | CREAM | EXPORT | ||
| DEXAMETHASONE SODIUM PHOSPHATE | U.S.P. | |||||
| EQ. TO DEXAMETHASONE PHOSPHATE | 1 MG | |||||
| NEOMYCIN SULPHATE | U.S.P. | |||||
| EQ TO NEOMYCIN | 3500 I.U | |||||
| CREAM BASE | Q.S | |||||
| 44 | DEXAMETHASONE SODIUM PHOSPHATE, NEOMYCIN SULPHATE OINTMENT | EACH GM CONTAINS: | OINTMENT | EXPORT | ||
| DEXAMETHASONE SODIUM PHOSPHATE | U.S.P. | |||||
| EQ. TO DEXAMETHASONE PHOSPHATE | 1 MG | |||||
| NEOMYCIN SULPHATE | U.S.P. | |||||
| EQ. TO NEOMYCIN | 3500 I.U | |||||
| OINTMENT BASE | Q.S | |||||
| 45 | DEXAMETHASONE, NEOMYCIN SULPHATE OINTMENT | EACH GM CONTAINS: | OINTMENT | EXPORT | ||
| DEXAMETHASONE | B.P. | 1 MG | ||||
| NEOMYCIN SULPHATE | B.P. | 3.5 MG | ||||
| OINTMENT BASE | Q.S | |||||
| 46 | DEXPANTHENOL OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| DEXPANTHENOL | B.P. | 5%W/W | ||||
| OINTMENT BASE | Q.S | |||||
| 47 | DICLOFENAC GEL | COMPOSITION: | GEL | EXPORT | ||
| DICLOFENAC DIETHYLAMINE | B.P. | 1.16% W/W | ||||
| EQ TO DICLOFENAC SODIUM | 1.000%W/W | |||||
| GEL BASE | Q.S | |||||
| 48 | DICLOFENAC GEL | COMPOSITION: | GEL | DOMESTIC | ||
| DICLOFENAC DIETHYLAMINE | I.P. | 1.16% W/W | ||||
| EQ. TO DICLOFENAC SODIUM | 1.00% W/W | |||||
| BENZYL ALCOHOL | I.P. | 1.00% W/W | ||||
| (AS PRESERVATIVE) | ||||||
| GEL BASE | Q. S | |||||
| 49 | DICLOFENAC DIETHYLAMINE, BENZYL ALCOHOL GEL | COMPOSITION: | GEL | EXPORT | ||
| DICLOFENAC DIETHYLAMINE | B.P. | 1.16%W/W | ||||
| EQ TO DICLOFENAC SODIUM | 1.00%W/W | |||||
| BENZYL ALCOHOL (AS PRESERVATIVE) | B.P. | 1.0%W/W | ||||
| GEL BASE | Q.S | |||||
| 50 | DICLOFENAC DIETHYLAMINE, OLIUM LINI, MENTHOL, METHYL SALICYLATE, BENZYL ALCOHOL GEL | COMPOSITION: | GEL | EXPORT | ||
| DICLOFENAC DIETHYLAMINE | B.P. | 1.16%W/W | ||||
| EQ TO DICLOFENAC SODIUM | 1.0%W/W | |||||
| OLEUM LINI (CONT. PREDOMINANTLY a-LINOLENIC ACID) | B.P. | 3.00%W/W | ||||
| METHYL SALICYLATE | B.P. | 10.0 %W/W | ||||
| MENTHOL | B.P. | 5.0% W/W | ||||
| BENZYL ALCOHOL (AS PERSERVATIVE) | B.P. | 1.0%W/W | ||||
| GEL BASE | Q.S | |||||
| 51 | DICLOFENAC DIETHYLAMINE, OLIUM LINI,MENTHOL , METHYL SALICYLATE, BENZYL ALCOHOL GEL | EACH GRAM CONTAINS: | GEL | EXPORT | ||
| DICLOFENAC DIETHYLAMINE | B.P. | |||||
| EQ TO DICLOFENAC SODIUM | 3.0%W/W | |||||
| OLEUM LINI (CONT. PREDOMINANTLY a-LINOLENIC ACID) | B.P. | 3.00%W/W | ||||
| METHYL SALICYLATE | B.P. | 10.0 %W/W | ||||
| MENTHOL | B.P. | 5.0% W/W | ||||
| BENZYL ALCOHOL (AS PERSERVATIVE) | B.P. | 1.0%W/W | ||||
| GEL BASE | Q.S | |||||
| 52 | DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE GEL | COMPOSITION: | GEL | DOMESTIC | ||
| DICLOFENAC DIETHYLAMINE | I.P. | 1.16% W/W | ||||
| EQ. TO DICLOFENAC SODIUM | 1.00% W/W | |||||
| LINSEED OIL | B.P. | 3.000 % W/W | ||||
| MENTHOL | I.P. | 0.50%W/W | ||||
| METHYL SALICYLATE | I.P. | 10.000%W/W | ||||
| GEL BASE | Q. S | |||||
| 53 | DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE GEL | COMPOSITION: | GEL | EXPORT | ||
| DICLOFENAC DIETHYLAMINE | B.P. | |||||
| EQ. TO DICLOFENAC SODIUM | 3.00% W/W | |||||
| LINSEED OIL | B.P. | 3.000 % W/W | ||||
| (CONT. PREDOMINANTLY a-LINOLENIC ACID) | ||||||
| METHYL SALICYLATE | B.P. | 10.000%W/W | ||||
| MENTHOL | B.P. | 5.000%W/W | ||||
| BENZYL ALCOHOL (AS PRESERVATIVE) | B.P. | 1.000%W/W | ||||
| GEL BASE | Q. S | |||||
| 54 | DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE, BENZYL ALCOHOL GEL | COMPOSITION: | GEL | DOMESTIC | ||
| DICLOFENAC DIETHYLAMINE | I.P. | 2.30%W/W | ||||
| EQ. TO DICLOFENAC SODIUM | 2.00%W/W | |||||
| LINSEED OIL | B.P. | 3.00%W/W | ||||
| MENTHOL | I.P. | 5.00%W/W | ||||
| METHYL SALICYLATE | I.P. | 10.000%W/W | ||||
| BENZYL ALCOHOL | I.P. | 1.0% W/W | ||||
| GEL BASE | Q. S | |||||
| 55 | DICLOFENAC DIETHYLAMINE, LINSEED OIL,MENTHOL , METHYL SALICYLATE, BENZYL ALCOHOL GEL | COMPOSITION: | GEL | DOMESTIC | ||
| DICLOFENAC DIETHYLAMINE | I.P. | 1.16% W/W | ||||
| EQ. TO DICLOFENAC SODIUM | 1.00% W/W | |||||
| LINSEED OIL | B.P. | 3.00%W/W | ||||
| MENTHOL | I.P. | 5.00%W/W | ||||
| METHYL SALICYLATE | I.P. | 10.000%W/W | ||||
| BENZYL ALCOHOL | I.P. | 1.0% W/W | ||||
| GEL BASE | Q. S | |||||
| 56 | DICLOFENAC DIETHYLAMINE, LINSEED OIL,MENTHOL , METHYL SALICYLATE, CAPSAICIN GEL | COMPOSITION: | GEL | DOMESTIC | ||
| DICLOFENAC DIETHYLAMINE | I.P. | 1.16% W/W | ||||
| EQ. TO DICLOFENAC SODIUM | 1.00% W/W | |||||
| LINSEED OIL | B.P. | 3.00%W/W | ||||
| MENTHOL | I.P. | 5.00%W/W | ||||
| METHYL SALICYLATE | I.P. | 10.000%W/W | ||||
| CAPSAICIN | USP | 0.025%W/W | ||||
| GEL BASE | Q. S | |||||
| 57 | DICLOFENAC DIETHYLAMINE, MENTHOL, METHYL SALICYLATE GEL | COMPOSITION: | GEL | DOMESTIC | ||
| DICLOFENAC DIETHYLAMINE | I.P. | 1.16% W/W | ||||
| EQ. TO DICLOFENAC SODIUM | 1.00% W/W | |||||
| MENTHOL | I.P. | 5.00%W/W | ||||
| METHYL SALICYLATE | I.P. | 10.000%W/W | ||||
| GEL BASE | Q. S | |||||
| 58 | EBERCONAZOLE NITRATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| EBERCONAZOLE NITRATE | I.P. | |||||
| EQ.TO EBERCONAZOLE | 1.00%W/W | |||||
| CREAM BASE | Q.S | |||||
| 59 | FLUCONAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| FLUCONAZOLE | I.P. | 2.0% W/W | ||||
| CREAM BASE | Q.S | |||||
| 60 | FLUOCINOLONE ACETONIDE OINTMENTS | COMPOSITION: | OINTMENT | EXPORT | ||
| FLUOCINOLONE ACETONIDE | B.P. | 0.025% W/W | ||||
| OINTMENT BASE | Q.S | |||||
| 61 | FLUOCINOLONE ACETONIDE, MICONAZOLE NITRATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| FLUOCINOLONE ACETONIDE | I.P. | 0.01% W/W | ||||
| MICONAZOLE NITRATE | I.P. | 2.0%W/W | ||||
| CREAM BASE | Q. S | |||||
| 62 | FLUTICASONE PROPIONATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
| FLUTICASONE PROPIONATE | U.S.P. | 0.05% W/W | ||||
| CREAM BASE | Q.S | |||||
| 63 | FUSIDIC ACID OINTMENT | EACH GM CONTAINS: | OINTMENT | DOMESTIC | ||
| FUSIDIC ACID | I.P. | 20 MG | ||||
| IN OINTMENT BASE | Q.S | |||||
| 64 | FUSIDIC ACID CREAM | EACH GM CONTAINS: | CREAM | DOMESTIC | ||
| FUSIDIC ACID | I.P. | 20 MG | ||||
| CREAM BASE | Q.S | |||||
| 65 | GAMMABENZENE HEXACHLORIDE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
| GAMMABENZENE HEXACHLORIDE | I.P. | 1.0 % W/V | ||||
| IN AQUEOUS BASE | Q. S | |||||
| 66 | GAMMABENZENE HEXACHLORIDE, CETRIMIDE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
| GAMMABENZENE HEXACHLORIDE | I.P. | 1.0 % W/V | ||||
| CETRIMIDE | I.P. | 0.06%W/V | ||||
| IN EMULSION BASE | Q. S | |||||
| 67 | GAMMABENZENE HEXACHLORIDE, CETRIMIDE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
| GAMMABENZENE HEXACHLORIDE | I.P. | 1.0% W/V | ||||
| CETRIMIDE | I.P. | 0.1% W/V | ||||
| IN EMULSION BASE | Q. S | |||||
| 68 | HALOBETASOLE PROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| HALOBETASOL PROPIONATE | B.P. | 0.05% W/W | ||||
| CREAM BASE | Q.S | |||||
| 69 | HALOBETASOLE PROPIONATE, SALICYLIC ACID OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| HALOBETASOL PROPIONATE | U.S.P. | 0.050%W/W | ||||
| SALICYLIC ACID | I.P. | 2.0%W/W | ||||
| IN OINTMENT BASE | Q.S | |||||
| 70 | HALOBETASOLE PROPIONATE, SALICYLIC ACID OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| HALOBETASOL PROPIONATE | U.S.P. | 0.050%W/W | ||||
| SALICYLIC ACID | I.P. | 6.0%W/W | ||||
| IN OINTMENT BASE | Q.S | |||||
| 71 | HALOBETASOLE PROPIONATE, CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| HALOBETASOL PROPIONATE | U.S.P. | 0.050%W/W | ||||
| CLOTRIMAZOLE | I.P. | 1.0%W/W | ||||
| CREAM BASE | Q.S | |||||
| 72 | HYDROCORTISONE 1 % W/W CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| HYDROCORTISONE | I.P. | 1.0% W/W | ||||
| CREAM BASE | Q.S | |||||
| 73 | HYDROQUINONE ,TRETINOIN, MOMETASONE FUROATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| HYDROQUINONE | I.P. | 2.000% W/W | ||||
| TRETINOIN | I.P. | 0.025% W/W | ||||
| MOMETASONE FUROATE | I.P. | 0.100% W/W | ||||
| CREAM BASE | Q.S | |||||
| 74 | HYDROQUINONE ,TRETINOIN, MOMETASONE FUROATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
| HYDROQUINONE | U.S.P. | 2.000% W/W | ||||
| TRETINOIN | U.S.P. | 0.025%W/W | ||||
| MOMETASONE FUROATE | U.S.P. | 0.100% W/W | ||||
| CREAM BASE | Q.S | |||||
| 75 | IBUPROFEN, MENTHOL, METHYL SALICYLATE, MEPHENESIN GEL | COMPOSITION: | GEL | EXPORT | ||
| IBUPROFEN | B.P. | 5.0%W/W | ||||
| MENTHOL | U.S.P. | 0.5%W/W | ||||
| METHYL SALICYLATE | B.P. | 0.5%W/W | ||||
| MEPHENESIN | B.P. | 5.0% W/W | ||||
| IN GEL BASE | Q.S | |||||
| 76 | ITRACONAZOLE GEL 1% W/W | COMPOSITION: | GEL | DOMESTIC | ||
| ITRACONAZOLE | B.P. | 1.00% W/W | ||||
| METHYL PARABEN | I.P. | 0.10% W/W | ||||
| PROPYL PARABEN | I.P. | 0.05% W/W | ||||
| IN A GEL BASE | Q. S | |||||
| 77 | ITRACONAZOLE, OFLOXACIN, ORNIDAZOLE, CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| ITRACONAZOLE | B.P. | 1.00 % W/W | ||||
| OFLOXACIN | I.P. | 0.75 % W/W | ||||
| ORNIDAZOLE | I.P. | 2.00 % W/W | ||||
| CLOBETASOL PROPIONATE | I.P. | 0.05 % W/W | ||||
| METHYL PARABEN (AS PRESERVATIVE) | I.P. | 0.20 % W/W | ||||
| PROPYL PARABEN (AS PRESERVATIVE) | I.P. | 0.02 % W/W | ||||
| IN A CREAM BASE | Q.S | |||||
| 78 | IVERMECTIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| IVERMECTIN | I.P. | 1.00%W/W | ||||
| CREAM BASE | Q. S | |||||
| 79 | IVERMECTIN SHAMPOO | COMPOSITION: | SHAMPOO | DOMESTIC | ||
| IVERMECTIN | I.P. | 0.50%W/V | ||||
| AQUEOUS BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 80 | KETOCONAZOLE SHAMPOO | COMPOSITION: | SHAMPOO | DOMESTIC | ||
| KETOCONAZOLE | I.P. | 2.00%W/V | ||||
| SHAMPOO BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 81 | KETOCONAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| KETOCONAZOLE | I.P. | 2.00%W/W | ||||
| CREAM BASE | Q.S | |||||
| 82 | KETOCONAZOLE, CLOBETASOLE PROPIONATE, NEOMYCIN CREAM | EACH GM CONTAINS: | CREAM | EXPORT | ||
| KETOCONAZOLE | B.P. | 10 MG | ||||
| CLOBETASOL PROPIONATE | B.P. | 0.25 MG | ||||
| NEOMYCIN SULPHATE | B.P. | |||||
| EQ TO NEOMYCIN BASE | 5000 IU | |||||
| CREAM BASE | Q.S | |||||
| 83 | KETOCONAZOLE, IODOCHLORHYDROXYQUINOLINE, TOLNAFTATE, NEOMYCIN SULPHATE, CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| KETOCONAZOLE | I.P. | 2.00%W/W | ||||
| IODOCHLORHYDROXYQUINOLINE | I.P. | 1.00%W/W | ||||
| TOLNAFTATE | I.P. | 1.00%W/W | ||||
| NEOMYCIN SULPHATE | I.P. | |||||
| EQ. TO NEOMYCIN | 0.10%W/W | |||||
| CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
| CREAM BASE | Q.S | |||||
| 84 | KETOCONAZOLE, ZINC PYRITHIONE SHAMPOO | COMPOSITION: | SHAMPOO | DOMESTIC | ||
| KETOCONAZOLE | I.P. | 2.0%W/V | ||||
| ZINC PYRITHIONE (ZPTO) | I.P. | 1.0%W/V | ||||
| AQUEOUS BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 85 | KETOCONAZOLE, BECLOMETHASONE DIPROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| KETOCONAZOLE | I.P. | 2.0%W/W | ||||
| BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/W | ||||
| IN CREAM BASE | Q.S | |||||
| 86 | KETOPROFEN GEL | COMPOSITION: | GEL | EXPORT | ||
| KETOPROFEN | B.P. | 2.5%W/W | ||||
| GEL BASE | Q.S | |||||
| 87 | LIGNOCAINE HYDROCHLORIDE GEL | COMPOSITION: | GEL | DOMESTIC | ||
| LIGNOCAINE HYDROCHLORIDE | I.P. | 2.00%W/W | ||||
| METHYL PARABEN | I.P. | 0.061%W/W | ||||
| PROPYL PARABEN | I.P. | 0.027%W/W | ||||
| IN A WATER SOLUBLE GEL BASE | Q.S | |||||
| 88 | LULICONAZOLE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
| LULICONAZOLE | I.P. | 1.0%W/W | ||||
| NON AQUEOUS BASE | Q.S | |||||
| 89 | LULICONAZOLE CREAM 1%W/W | COMPOSITION: | CREAM | DOMESTIC | ||
| LULICONAZOLE | I.P. | 1.0%W/W | ||||
| BENZYL ALCOHOL (AS PRESERVATIVE) | I.P. | 1.0% W/W | ||||
| CREAM BASE | Q.S | |||||
| 90 | LULICONAZOLE, CLOBETASOLE PROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| LULICONAZOLE | I.P. | 1.0%W/W | ||||
| CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
| CREAM BASE | Q.S | |||||
| 91 | MOMETASONE FUROATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| MOMETASONE FUROATE | I.P. | 0.10%W/W | ||||
| PRESERVATIVES | ||||||
| METHYL PARABEN | I.P. | 0.20%W/W | ||||
| PROPYL PARABEN | I.P. | 0.02%W/W | ||||
| CREAM BASE | Q.S | |||||
| 92 | MOMETASONE FUROATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| MOMETASONE FUROATE | I.P. | 0.10%W/W | ||||
| CREAM BASE | Q.S | |||||
| 93 | MOMETASONE FUROATE, FUSIDIC ACID CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| MOMETASONE FUROATE | I.P. | 0.1%W/W | ||||
| FUSIDIC ACID | I.P. | 2.0%W/W | ||||
| IN CREAM BASE | Q.S | |||||
| 94 | MOMETASONE FUROATE, SALICYLIC ACID CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| MOMETASONE FUROATE | I.P. | 0.1%W/W | ||||
| SALICYCLIC ACID | I.P. | 5.0%W/W | ||||
| CREAM BASE | Q.S | |||||
| 95 | MOMETASONE FUROATE, TERBINAFINE HYDROCHLORIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| MOMETASONE FUROATE | I.P. | 0.10% W/W | ||||
| TERBINAFINE HYDROCHLORIDE | I.P. | 1.00% W/W | ||||
| IN A CREAM BASE | Q.S | |||||
| 96 | MUPIROCIN OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| MUPIROCIN | I.P. | 2.0% W/W | ||||
| OINTMENT BASE | Q.S | |||||
| 97 | MUPIROCIN OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| MUPIROCIN | U.S.P. | 2.0% W/W | ||||
| OINTMENT BASE | Q.S | |||||
| 98 | NADIFLOXACIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
| NADIFLOXACIN | 1.00%W/W | |||||
| IN A CREAM BASE | Q.S | |||||
| 99 | NEOMYCIN SULPHATE, FLUOCINOLONE ACETONIDE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| NEOMYCIN SULPHATE | B.P. | |||||
| EQ TO NEOMYCIN | 0.50%W/W | |||||
| FLUOCINOLONE ACETONIDE | B.P. | 0.025%W/W | ||||
| OINTMENT BASE | Q.S | |||||
| 100 | NEOMYCIN SULPHATE, CLOBETASOL PROPIONATE, MICONAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| NEOMYCIN SULPHATE | I.P. | 0.50%W/W | ||||
| CLOBETASOL PROPIONATE | I.P. | 0.05% W/W | ||||
| MICONAZOLE NITRATE | I.P. | 2.00% W/W | ||||
| CREAM BASE | Q.S | |||||
| 101 | NIFEDIPINE, LIDOCAINE HYDROCHLORIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| NIFEDIPINE | I.P. | 0.30% W/W | ||||
| LIDOCAINE HYDROCHLORIDE | I.P. | 1.50% W/W | ||||
| IN CREAM BASE | Q. S | |||||
| 102 | OFLOXACIN, ORNIDAZOLE, TERBINAFINE HYDROCHLORIDE, CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
| OFLOXACIN | B.P. | 0.75% W/W | ||||
| ORNIDAZOLE | B.P. | 2.0% W/W | ||||
| TERBINAFINE HYDROCHLORIDE | B.P. | 1.0% W/W | ||||
| CLOBETASOL PROPIONATE | U.S.P. | 1.0% W/W | ||||
| PRESERVATIVES | ||||||
| METHYL PARABEN | B.P. | 0.20%W/W | ||||
| PROPYL PARABEN | B.P. | 0.02%W/W | ||||
| CREAM BASE | Q.S | |||||
| 103 | OFLOXACIN, ORNIDAZOLE, TERBINAFINE HYDROCHLORIDE, CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
| OFLOXACIN | B.P. | 0.75% W/W | ||||
| ORNIDAZOLE | B.P. | 2.0% W/W | ||||
| TERBINAFINE HYDROCHLORIDE | B.P. | 1.0% W/W | ||||
| CLOBETASOL PROPIONATE | U.S.P. | 0.05% W/W | ||||
| PRESERVATIVES | ||||||
| METHYL PARABEN | B.P. | 0.20%W/W | ||||
| PROPYL PARABEN | B.P. | 0.02%W/W | ||||
| CREAM BASE | Q.S | |||||
| 104 | OFLOXACIN, TERBINAFINE HYDROCHLORIDE, ORNIDAZOLE, BECLOMETHASONE DIPROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| OFLOXACIN | I.P. | 0.75 % W/W | ||||
| ORNIDAZOLE | I.P. | 2.00 %W/W | ||||
| TERBINAFINE HYDROCHLORIDE | I.P. | |||||
| EQ. TO TERBINAFINE | 1.00 % W/W | |||||
| BECLOMETHASONE DIPROPIONATE | I.P. | 0.025 % W/W | ||||
| METHYL PARABEN (AS PRESERVATIVE) | I.P. | 0.20 % W/W | ||||
| PROPYL PARABEN (AS PRESERVATIVE) | I.P. | 0.02 % W/W | ||||
| IN A NON GRESY BASE | Q.S | |||||
| 105 | ORNIDAZOLE, POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| POVIDONE IODINE | I.P. | 5.0 %W/W | ||||
| (0.5%W/W AVAILABLE IODINE) | ||||||
| ORNIDAZOLE | I.P. | 1.0 %W/W | ||||
| WATER SOLUBLE OINTMENT BASE | Q. S | |||||
| 106 | PERMETHRIN CREAM | EACH GM OF CREAM CONTAINS: | CREAM | DOMESTIC | ||
| PERMETHRIN | I.P. | 50 MG | ||||
| CREAM BASE | Q. S | |||||
| 107 | PERMETHRIN LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
| PERMETHRIN | I.P. | 5 % W/V | ||||
| LOTION BASE | Q. S | |||||
| 108 | POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| POVIDONE IODINE | U.S.P. | 5 % W/W | ||||
| AVAILABLE IODINE | 0.5 % W/W | |||||
| WATER SOLUBLE BASE | ||||||
| 109 | POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| POVIDONE IODINE (0.5%W/W AVAILABLE IODINE) | I.P. | 5% W/W | ||||
| OINTMENT BASE | Q. S | |||||
| 110 | POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| POVIDONE IODINE (1.0 %W/W AVAILABLE IODINE) | I.P. | 10.0 % W/W | ||||
| WATER WASHABLE BASE | Q. S | |||||
| 111 | POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| POVIDONE IODINE | U.S.P. | 10 %W/W | ||||
| AVAILABLE IODINE | 1.0%W/W | |||||
| WATER SOLUBLE BASE | ||||||
| 112 | POVIDONE IODINE, SUCRALFATE OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| POVIDONE IODINE | I.P. | 5.00% W/W | ||||
| (AVAILABLE IODINE) | 0.50% W/W | |||||
| SUCRALFATE | I.P. | 7.0% W/W | ||||
| WATER SOLUBLE OINTMENT BASE | Q. S | |||||
| 113 | RACEMIC MENTHOL, PROCAINE HYDROCHLORIDE, BENZOCAINE OINTMENT | EACH GM CONTAINS: | OINTMENT | EXPORT | ||
| RACEMIC MENTHOL | B.P. | 25 MG | ||||
| PROCAINE HYDROCHLORIDE | B.P. | 10 MG | ||||
| BENZOCAINE | B.P. | 10 MG | ||||
| OINTMENT BASE | Q. S | |||||
| 114 | SALICYLIC ACID OINTMENT | COMPOSITION | OINTMENT | DOMESTIC | ||
| SALICYLIC ACID | I.P. | 12.0% W/W | ||||
| OINTMENT BASE | Q.S | |||||
| 115 | SALICYLIC ACID FOAMING FACE WASH | COMPOSITION: | FACE WASH | DOMESTIC | ||
| SALICYLIC ACID | I.P. | 1.0% W/W | ||||
| IN A AQUEOUS BASE | Q. S | |||||
| 116 | SERTACONAZOLE NITRATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| SERTACONAZOLE NITRATE | I.P. | 2.0 % W/W | ||||
| PRESERVATIVE | ||||||
| BENZYL ALCOHOL | I.P. | 1.0% W/W | ||||
| CREAM BASE | Q. S | |||||
| 117 | SILVER SULFADIAZINE, CHLORHEXADINE GLUCONATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
| SILVER SULFADIAZINE | U.S.P. | 1.0 W/W | ||||
| CHLORHEXADINE GLUCONATE SOLUTION | U.S.P. | |||||
| EQ TO CHLORHEXADINE GLUCONATE | 0.20%W/W | |||||
| CREAM BASE | Q.S | |||||
| 118 | SILVER SULFADIAZINE, CHLORHEXADINE GLUCONATE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| SILVER SULFADIAZINE | U.S.P. | 1.0 % W/W | ||||
| CHLORHEXADINE GLUCONATE SOLUTION | U.S.P. | |||||
| EQ. TO CHLORHEXADINE GLUCONATE | 0.20 % W/W | |||||
| OINTMENT BASE | Q.S | |||||
| 119 | SILVER SULFADIAZINE, LIGNOCAINE HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| SILVER SULFADIAZINE | I.P. | 1.00 % W/W | ||||
| LIGNOCAINE HYDROCHLORIDE | I.P. | 2.00 % W/W | ||||
| CHLORHEXIDINE GLUCONATE SOLUTION | I.P. | |||||
| EQ. TO CHLORHEXIDINE GLUCONATE | 0.20 % W/W | |||||
| CREAM BASE | Q. S | |||||
| 120 | SODIUM FUSIDATE OINTMENT | EACH GM CONTAINS: | OINTMENT | DOMESTIC | ||
| SODIUM FUSIDATE | I.P. | 20 MG | ||||
| OINTMENT BASE | Q.S | |||||
| 121 | SUCRALFATE, METRONIDAZOLE, POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| SUCRALFATE | U.S.P. | 7.0%W/W | ||||
| METRONIDAZOLE | I.P. | 1.00%W/W | ||||
| POVIDONE IODINE (AVIALABLE IODINE 0.50%W/W) | I.P. | 5.0%W/W | ||||
| IN OINTMENT BASE | Q. S | |||||
| 122 | SUCRALFATE, METRONIDAZOLE, LIGNOCAINE HYDROCHORIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| SUCRALFATE | I.P. | 7.0%W/W | ||||
| METRONIDAZOLE | I.P. | 1.00%W/W | ||||
| LIGNOCAINE HYDROCHLORIDE | I.P. | 4.0%W/W | ||||
| CREAM BASE | Q. S | |||||
| 123 | TACROLIMUS OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| TACROLIMUS | I.P. | 0.01 % W/W | ||||
| OINTMENT BASE | Q. S | |||||
| 124 | TACROLIMUS OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| TACROLIMUS | I.P. | 0.03 % W/W | ||||
| OINTMENT BASE | Q. S | |||||
| 125 | TERBINAFINE HYDROCHLORIDE CREAM | COMPOSITION: | CREAM | EXPORT | ||
| TERBINAFINE HYDROCHLORIDE | B.P. | 1.00%W/W | ||||
| CREAM BASE | Q.S | |||||
| 126 | TERBINAFINE HYDROCHLORIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| TERBINAFINE HYDROCHLORIDE | I.P. | 1.0%W/W | ||||
| BENZYL ALCOHOL (AS PRESERVATIVE) | I.P. | 1.0%W/W | ||||
| CREAM BASE | Q.S | |||||
| 127 | TERBINAFINE HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE, SALICYLIC ACID LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
| TERBINAFINE HYDROCHLORIDE | I.P. | 1.00%W/V | ||||
| CHLORHEXIDINE GLUCONATE SOLUTION | I.P. | 0.20%W/V | ||||
| SALICYLIC ACID | I.P. | 5.00%W/V | ||||
| IN A NON AQUEOUS BASE | Q.S | |||||
| 128 | THYMOL, MENTHOL, ICHTHAMMOL, LIGNOCAINE HCl OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| THYMOL | I.P. | 0.50%W/W | ||||
| MENTHOL | I.P. | 0.20%W/W | ||||
| ICHTHAMMOL | B.P. | 1.00%W/W | ||||
| LIGNOCAINE HYDROCHLORIDE | I.P. | 1.00%W/W | ||||
| IN OINTMENT BASE | Q. S | |||||
| 129 | THYMOL, MENTHOL, ICHTHAMMOL, LIGNOCAINE HCl OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
| THYMOL | I.P. | 0.50%W/W | ||||
| MENTHOL | I.P. | 1.00%W/W | ||||
| ICHTHAMMOL | B.P. | 0.20%W/W | ||||
| LIGNOCAINE HYDROCHLORIDE | I.P. | 1.00%W/W | ||||
| IN OINTMENT BASE | Q. S | |||||
| 130 | TRETINOIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| TRETINOIN | U.S.P. | 0.025%W/W | ||||
| CREAM BASE | Q.S | |||||
| 131 | TRETINOIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
| TRETINOIN | U.S.P. | 0.025%W/W | ||||
| CREAM BASE | Q.S | |||||
| 132 | TRETINOIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
| TRETINOIN | U.S.P. | 0.050%W/W | ||||
| CREAM BASE | Q.S | |||||
| 133 | TROXERUTIN GEL | COMPOSITION: | GEL | EXPORT | ||
| TROXERUTIN | B.P. | 2%W/W | ||||
| GEL BASE | Q.S | |||||
| 134 | TRIAMCINOLONE ACETONIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| TRIAMCINOLONE ACETONIDE | I.P. | 1.00%W/W | ||||
| CREAM BASE | Q.S | |||||
| 135 | UREA, LACTIC ACID, PROPYLENE GLYCOL, LIQUID PARAFFIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| UREA | I.P. | 10.0%W/W | ||||
| LACTIC ACID | I.P. | 10.0%W/W | ||||
| PROPYLENE GLYCOL | I.P. | 10.0%W/W | ||||
| LIQUID PARFAFFIN | I.P. | 10.0%W/W | ||||
| IN A CREAM BASE | Q. S | |||||
| 136 | WHITE SOFT PARAFFIN, LIGHT LIQUID PARAFFIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
| WHITE SOFT PARAFFIN | I.P. | 13.2% W/W | ||||
| LIGHT LIQUID PARAFFIN | I.P. | 10.2% W/W | ||||
| CREAM BASE | Q. S | |||||
| 137 | WHITE PETROLIUM JELLY, LIGHT LIQUID PARAFFIN OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
| WHITE PETROLIUM JELLY | U.S.P | 50%W/W | ||||
| LIGHT LIQUID PARAFFIN | 50%W/W | |||||
| OINTMENT BASE | Q. S | |||||
| NO | NAME OF PRODUCT | COMPOSITION | GRADE | STRENGTH | FORM | MARKET |
| 1 | ACECLOFENAC, PARACETAMOL SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| ACECLOFENAC | I.P. | 50 MG | ||||
| PARACETAMOL | I.P. | 125 MG | ||||
| IN A FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 2 | ACETAMINOPHEN ORAL SUSPENSION | EACH 5 ML CONTAINS : | SYRUP | DOMESTIC | ||
| PARACETAMOL | I.P | 240 MG | ||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 3 | ACETAMINOPHEN ORAL SUSPENSION | EACH 5 ML CONTAINS : | SUSPENSION | EXPORT | ||
| PARACETAMOL | U.S.P. | 240 MG | ||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 4 | ALBENDAZOLE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| ALBENDAZOLE | I.P. | 200 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 5 | ALBENDAZOLE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| ALBENDAZOLE | U.S.P. | 200 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 6 | ALBENDAZOLE, IVERMECTIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| ALBENDAZOLE | I.P. | 200 MG | ||||
| IVERMECTIN | I.P. | 1.5 MG | ||||
| FLAVOURED SYRUP BASE | ||||||
| APPROVED COLOUR USED | ||||||
| 7 | ALBENDAZOLE, IVERMECTIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| ALBENDAZOLE | I.P. | 200 MG | ||||
| IVERMECTIN | I.P. | 3 MG | ||||
| FLAVOURED SYRUP BASE | ||||||
| APPROVED COLOUR USED | ||||||
| 8 | ALPHA AMYLASE, PEPSIN SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| ALPHA AMYLASE I.P. (1:2000) | I.P. (1:2000) | 18.75 MG | ||||
| (FUNGAL DIASTASE DERIVED FROM ASPERGILLUS ORYZAE DIGESTS NOT LESS THAN 37.50 GM OF COOKED STARCH) | ||||||
| PEPSIN | I.P. (1:3000) | 12.50 MG | ||||
| (DIGESTS NOT LESS THAN 37.50 GM OF COAGULATED EGG ALBUMIN) | ||||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVE COLOUR USED APPROPRIATE OVERAGE ARE ADDED | ||||||
| 9 | ALPHA AMYLASE, PAPAIN, DIL OIL, ANISE OIL, CARAWAY OIL DROPS | EACH ML CONTAINS: | DROPS | DOMESTIC | ||
| ALPHA AMYLASE (1800) | I.P. | 20 MG | ||||
| DIGEST NOT LESS THEN 60 GM OF COOKED STARCH | ||||||
| PAPAIN | I.P. | 10 MG | ||||
| DIL OIL | B.P. | 2 MG | ||||
| ANISE OIL | B.P. | 2 MG | ||||
| CARAWAY OIL | B.P. | 2 MG | ||||
| FL. SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED APPROPRIATE OVERAGE ARE ADDED | ||||||
| 10 | AMBROXOL HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| AMBROXOL HYDROCHLORIDE | B.P. | 15 MG | ||||
| IN FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 11 | AMBROXOL HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | ||||
| IN FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 12 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| AMBROXOL HYDROCHLORIDE | B.P. | 15 MG | ||||
| CETIRIZINE HYDROCHLORIDE | B.P. | 2.5 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| 13 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | ||||
| CETIRIZINE HYDROCHLORIDE | B.P. | 5 MG | ||||
| IN FLAVOURED BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 14 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | ||||
| CETIRIZINE HYDROCHLORIDE | B.P. | 15 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| 15 | AMBROXOL HYDROCHLORIDE, LEVOCETIRIZINE HYDROCHLORIDE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| AMBROXOL HYDROCHLORIDE | B.P. | 60 MG | ||||
| LEVOCETIRIZINE HYDROCHLORIDE | B.P. | 5 MG | ||||
| IN FLAVOURED SUSPENSION BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 16 | AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIFENESIN SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| AMBROXOL HYDROCHLORIDE | I.P. | 15 MG | ||||
| GUAIPHENESIN | I.P. | 50 MG | ||||
| TERBUTALINE SULPHATE | I.P. | 2.5 MG | ||||
| MENTHOL | I.P. | 2.5 MG | ||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 17 | AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIFENESIN SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | ||||
| TERBUTALINE SULFATE | B.P. | 1.5 MG | ||||
| GUAIFENESIN | B.P. | 50 MG | ||||
| EXCIPIENTS | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 18 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| AMBROXOL HYDROCHLORIDE | I.P. | 15 MG | ||||
| GUAIPHENESIN | I.P. | 50 MG | ||||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 2.5 MG | ||||
| IN A FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 19 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE, MENTHOL SYRUP | EACH 10 ML CONTAINS: | SYRUP | DOMESTIC | ||
| AMBROXOL HYDROCHLORIDE | I.P. | 30 MG | ||||
| GUAIPHENESIN | I.P. | 100 MG | ||||
| TERBUTALINE SULPHATE | I.P. | 2.5 MG | ||||
| MENTHOL | I.P. | 5 MG | ||||
| FLAVOURED SYRUPY BASE. | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 20 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE, MENTHOL SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| AMBROXOL HYDROCHLORIDE | I.P. | 15 MG | ||||
| TERBUTALINE SULPHATE | I.P. | 1.25 MG | ||||
| GUAIPHENESIN | I.P. | 50 MG | ||||
| MENTHOL | I.P. | 2.5 MG | ||||
| FLAVOURED BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 21 | ARTEMETHER, LUMEFENTRINE SUSPENSION | EACH 5 ML RECONSTITUTED SUSPENSION CONTAINS | SUSPENSION | DOMESTIC | ||
| ARTEMETHER | I.P. | 20 MG | ||||
| LUMEFANTRINE | I.P. | 120 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 22 | AZITHROMYCIN SUSPENSION | EACH ML CONTAINS: | SUSPENSION | EXPORT | ||
| AZITHROMYCIN DIHYDRATE | U.S.P. | |||||
| EQ TO AZITHROMYCIN ANHYDROUS | 40 MG | |||||
| EXCIPIENTS | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 23 | AZITHROMYCIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| AZITHROMYCIN DIHYDRATE | U.S.P. | |||||
| EQ. TO AZITHROMYCIN ANHYDROUS | 100 MG | |||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 24 | AZITHROMYCIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| AZITHROMYCIN DIHYDRATE | U.S.P. | |||||
| EQ. TO AZITHROMYCIN ANHYDROUS | 200 MG | |||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 25 | AZITHROMYCIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| AZITHROMYCIN AS DIHYDRATE | I.P. | |||||
| EQ TO ANHYDROUS AZITHROMYCIN | 200 MG | |||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 26 | BECLOMETHASONE, CLOTRIMAZOLE, LIGNOCAINE, NEOMYCIN EAR DROPS | COMPOSITION: | DROPS | DOMESTIC | ||
| BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/V | ||||
| CLOTRIMAZOLE | I.P. | 1.0%W/V | ||||
| LIGNOCAINE HYDROCHLORIDE | I.P. | 2.0%W/V | ||||
| NEOMYCIN SULPHATE | I.P. | 0.5%W/V | ||||
| IN AQUES BASE SOLUTION | Q. S | |||||
| 27 | BROMHEXINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| BROMHEXINE HYDROCHLORIDE | B.P. | 4 MG | ||||
| IN A FLA. SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 28 | BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| BROMHEXINE HYDROCHLORIDE | I.P. | 2 MG | ||||
| TERBUTALINE SULPHATE | I.P. | 2.5 MG | ||||
| GUAIPHENESIN | I.P. | 100 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 29 | BROMHEXINE HYDROCHLORIDE, SLABUTAMOL SULPHATE, GUAIPHENESIN, MENTHOL SYRUP | EACH 10 ML CONTAINS: | SYRUP | EXPORT | ||
| BROMHEXINE HYDROCHLORIDE | B.P. | 4 MG | ||||
| SALBUTAMOL SULPHATE | B.P. | |||||
| EQ TO SALBUTAMOL | 2 MG | |||||
| GUAIPHENESIN | B.P. | 100 MG | ||||
| MENTHOL | B.P. | 1 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 30 | BROMHEXINE HYDROCHLORIDE, TERBUTALINE, GUAIPHENESIN, MENTHOL SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| BROMHEXINE HYDROCHLORIDE | I.P. | 2 MG | ||||
| TERBUTALINE SULPHATE | I.P. | 1.25 MG | ||||
| GUAIPHENESIN | I.P. | 50 MG | ||||
| MENTHOL | I.P. | 0.5 MG | ||||
| FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 31 | BROMHEXINE HYDROCHLORIDE, TERBUTALINE, GUAIPHENESIN, MENTHOL SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| BROMHEXINE HYDROCHLORIDE | I.P. | 4 MG | ||||
| TERBUTALINE SULPHATE | I.P. | 2.50 MG | ||||
| GUAIPHENESIN | I.P. | 100 MG | ||||
| MENTHOL | I.P. | 0.5 MG | ||||
| FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 32 | CETIRIZINE ORAL SOLUTION | EACH 5 ML CONTAINS: | SOLUTION | EXPORT | ||
| CETIRIZINE HYDROCHLORIDE | B.P. | 5 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 33 | CETIRIZINE HYDROCHLORIDE ORAL SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| CETIRIZINE HYDROCHLORIDE | U.S.P. | 5 MG | ||||
| FLAVOURED SUSPENSION BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 34 | CHLORBUTOL, BENZOCAINE, PARADICHLOROBENZENE EAR DROPS | COMPOSITION: | DROPS | DOMESTIC | ||
| CHLORBUTOL | I.P. | 5.00% W/W | ||||
| BENZOCAINE | I.P. | 2.50% W/W | ||||
| PARADICHLOROBENZENE | 2.00% W/W | |||||
| NON AQUEOUS BASE | Q.S | |||||
| 35 | CHLORHEXIDINE GLUCONATE, METRONIDAZOLE SOLUTION | COMPOSITION: | SOLUTION | EXPORT | ||
| CHLORHEXIDINE GLUCONATE SOLUTION | B.P. | 0.25%W/W | ||||
| METRONIDAZOLE | B.P. | 1.00%W/W | ||||
| SOLUTION BASE | Q.S | |||||
| 36 | CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
| IN FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR | ||||||
| 37 | CIPROFLOXACIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| CIPROFLOXACIN HYDROCHLORIDE | B.P. | |||||
| EQ.TO CIPROFLOXACIN | 125 MG | |||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 38 | CIPROFLOXACIN, TINIDAZOLE SUSPENSION | EACH 10 ML CONTAINS: | SUSPENSION | EXPORT | ||
| CIPROFLOXACIN HYDROCHLORIDE | B.P. | |||||
| EQ.TO CIPROFLOXACIN | 250 MG | |||||
| TINIDAZOLE | B.P. | 300 MG | ||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 39 | CIPROFLOXACIN, TINIDAZOLE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| CIPROFLOXACIN HYDROCHLORIDE | B.P. | |||||
| EQ.TO CIPROFLOXACIN | 500 MG | |||||
| TINIDAZOLE | B.P. | 600 MG | ||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 40 | CYPROHEPTADINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| CYPROHEPTADINE HCL (ANHYDROUS) | I.P. | 2 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 41 | CITICOLINE SODIUM SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| CITICOLINE SODIUM | B.P. | |||||
| EQ TO. CITICOLINE | 500 MG | |||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 42 | CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE DROPS | EACH 5 ML CONTAINS: | DROPS | DOMESTIC | ||
| CYPROHEPTADINE HCL (ANHYDROUS) | I.P. | 1.5 MG | ||||
| TRICHOLINE CITRATE (65%) | I.P. | 55 MG | ||||
| FLAVOURED NON SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 43 | CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| CYPROHEPTADINE HCL (ANHYDROUS) | I.P. | 2 MG | ||||
| TRICHOLINE CITRATE (65%) | I.P. | 275 MG | ||||
| FLAVOURED NON SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 44 | DEFLAZACORT SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| DEFLAZACORT | I.P. | 6 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 45 | DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| DEXTROMETHORPHAN HYDROBROMIDE | I.P. | 10 MG | ||||
| CHLORPHENIRAMINE MALEATE | I.P. | 4 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 46 | DEXTROMETHORPHAN, CHLORPHENIRAMINE MALEATE, HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| DEXTROMETHORPHAN HYDROBROMIDE | I.P. | 10 MG | ||||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
| CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 47 | DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| DEXTROMETHORPHAN HYDROBROMIDE | I.P. | 15 MG | ||||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
| CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 48 | DICYCLOMINE HYDROCHLORIDE, SIMETHICONE SUSPENSION | EACH ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| DICYCLOMINE HYDROCHLORIDE | I.P. | 10 MG | ||||
| SIMETHICONE | I.P. | 40 MG | ||||
| FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 49 | DIPHENHYDRAMINE HYDROCHLORIDE, AMMONIUM CHLORIDE, SODIUM CITRATE, MENTHOL SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| DIPHENHYDRAMINE HYDROCHLORIDE | I.P. | 14.08 MG | ||||
| AMMONIUM CHLORIDE | I.P. | 138 MG | ||||
| SODIUM CITRATE | I.P. | 100 MG | ||||
| MENTHOL | I.P. | 1.14 MG | ||||
| FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 50 | DI-SODIUM HYDROGEN CITRATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| DI-SODIUM HYDROGEN CITRATE | I.P. | 1.38 MG | ||||
| FLAVOURED SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 51 | DI-SODIUM HYDROGEN CITRATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| DI-SODIUM HYDROGEN CITRATE | I.P. | 1.53 MG | ||||
| FLAVOURED SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 52 | DOMPERIDONE SUSPENSION | EACH ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| DOMPERIDONE | I.P. | 1 MG | ||||
| IN FLAVOURED SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 53 | DOMPERIDONE, SIMETHICONE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| DOMPERIDONE | B.P. | 5 MG | ||||
| SIMETHICONE | U.S.P. | 20 MG | ||||
| IN FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 54 | DRIED ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE, ACTIVATED DIMETHICONE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| DRIED ALUMINIUM HYDROXIDE GEL | U.S.P. | 250 MG | ||||
| MAGNESIUM HYDROXIDE | U.S.P. | 250 MG | ||||
| ACTIVATED DIMETHICONE | U.S.P. | 50 MG | ||||
| IN A FLAVOURED NON CRYSTALLIZING SORBITOL BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 55 | ERYTHROMYCIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| ERYTHROMYCIN ESTOLATE | U.S.P. | |||||
| EQ.TO ERYTHROMYCIN | 250 MG | |||||
| FLAVOURED SUSPENSION BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 56 | FERRIC AMMONIUM CITRATE, VITAMIN B12, FOLIC ACID SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| FERRIC AMMONIUM CITRATE | U.S.P. | 235 MG | ||||
| EQ. TO 41 MG ELEMENTAL IRON | ||||||
| VITAMIN B12 | B.P. | 50 MG | ||||
| FOLIC ACID | B.P. | 1.5 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 57 | FERRIC AMMONIUM CITRATE, FOLIC ACID, CYANOCOBALAMIN SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| FERRIC AMMOUNIUM CITRATE | I.P. | 110 MG | ||||
| CYANOCOBALAMIN | I.P. | 15 MCG | ||||
| FOLIC ACID | I.P. | 1.5 MG | ||||
| SORBITOL SOLUTION (70%) | I.P. | 10% W/V | ||||
| (NONCRYSTALLISING) | ||||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| 58 | FERRIC AMMONIUM CITRATE, IRON WITH VITAMIN B12, B- COMPLEX SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| FERRIC AMMONIUM CITRATE | I.P. | 150 MG | ||||
| EQ. TO ELEMENTAL IRON 30 MG | ||||||
| CYANOCOBALAMIN | I.P. | 5 MCG | ||||
| FOLIC ACID | I.P. | 1 MG | ||||
| ZINC SULPHATE MONOHYDRATE | I.P. | 7.42 MG | ||||
| EQ. TO 2.7 MG ELEMENTAL ZINC | ||||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 59 | FERROUS ASCORBATE, FOLIC ACID SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| FERROUS ASCORBATE | I.P. | |||||
| EQ TO ELEMENTAL IRON | 30 MG | |||||
| FOLIC ACID | I.P. | 550 MCG | ||||
| FLAVORED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 60 | FEXOFENADINE HYDROCHLORIDE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| FEXOFENADINE HYDROCHLORIDE | U.S.P. | 30 MG | ||||
| IN FLAVOURED BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 61 | IRON (III) HYDROXIDE POLYMALTOSE COMPLEX SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| IRON (III) HYDROXIDE POLYMALTOSE COMPLEX | ||||||
| EQ. TO ELEMENTAL IRON | 50 MG | |||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 62 | IBUPROFEN ORAL SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| IBUPROFEN | B.P. | 100 MG | ||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 63 | IBUPROFEN, PARACETAMOL SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| IBUPROFEN | B.P. | 100 MG | ||||
| PARACETAMOL | B.P. | 162.50 MG | ||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 64 | IVY LEAF DRY EXTRACT SOLUTION | EACH 100 ML SOLUTION CONTAINS: | SOLUTION | EXPORT | ||
| IVY LEAF DRY EXTRACT | 0.70 GM | |||||
| FLAVOURE SOLUTION BASE | Q.S | |||||
| 65 | LACTULOSE SOLUTION | EACH 5ML CONTAINS: | SOLUTION | EXPORT | ||
| LACTULOSE CONCENTRATE | U.S.P. | |||||
| EQ. TO LACTULOSE | 3.335 GM | |||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| 66 | LACTULOSE SOLUTION | EACH 5ML CONTAINS: | SOLUTION | DOMESTIC | ||
| LACTULOSE CONCENTRATE | U.S.P. | |||||
| EQ. TO LACTULOSE | 3.335 GM | |||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| 67 | LACTULOSE SOLUTION | EACH 15ML CONTAINS: | SOLUTION | DOMESTIC | ||
| LACTULOSE CONCENTRATE | U.S.P. | |||||
| EQ. TO LACTULOSE | 10 GM | |||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| 68 | LEVOCETIRIZINE DIHYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 2.5 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 69 | LEVOCETIRIZINE DIHYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| LEVOCETIRIZINE DIHYDROCHLORIDE | U.S.P. | 2.5 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 70 | LEVOSALBUTAMOL SULPHATE, GUAIPHENESIN, AMBROXOL HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| LEVOSALBUTAMOL SULPHATE | I.P. | 0.5 MG | ||||
| AMBROXOL HYDROCHLORIDE | I.P. | 15 MG | ||||
| GUAIPHENESIN | I.P. | 50 MG | ||||
| FLAVOURED SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 71 | LEVOSALBUTAMOL SULPHATE, GUAIPHENESIN, AMBROXOL HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| LEVOSALBUTAMOL SULPHATE | I.P. | 1 MG | ||||
| AMBROXOL HYDROCHLORIDE | I.P. | 30 MG | ||||
| GUAIPHENESIN | I.P. | 50 MG | ||||
| FLAVOURED SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 72 | LINEZOLID ORAL SUSPENSION | EACH 5 ML RECONSTITUTED SUSPENSION CONTAINS: | SUSPENSION | DOMESTIC | ||
| LINEZOLID | I.P. | 100 MG | ||||
| FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 73 | LORATADINE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| LORATADINE | U.S.P. | 5 MG | ||||
| IN A FLAVOURED SUSPENSION BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 74 | LORATADINE ORAL SOLUTION | EACH 5 ML CONTAINS: | SOLUTION | EXPORT | ||
| LORATADINE | U.S.P. | 5 MG | ||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| 75 | MEFENAMIC ACID, PARACETAMOL SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| MEFENAMIC ACID | I.P. | 50 MG | ||||
| PARACETAMOL | I.P. | 125 MG | ||||
| IN A FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 76 | METRONIDAZOLE ORAL SUSPENSOIN | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| METRONIDAZOLE BENZOATE | B.P. | |||||
| EQ TO METRONIDAZOLE | 200 MG | |||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 77 | METRONIDAZOL, FURAZOLIDONE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| METRONIDAZOLE BENZOATE | B.P. | |||||
| EQ. TO METRONIDAZOLE | 100 MG | |||||
| FURAZOLIDONE | B.P. | 30 MG | ||||
| IN A SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 78 | MONTELUKAST, LEVOCETIRIZINE DIHYDROCHLORIDE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| MONTELUKAST SODIUM | B.P. | |||||
| EQ. TO MONTELUKAST | 4 MG | |||||
| LEVOCETIRIZINE DIHYDROCHLORIDE | U.S.P. | 2.5 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 79 | MULTIVITAMIN AND MINERAL DROPS | EACH ML CONTAINS: | DROPS | EXPORT | ||
| CHOLICALCIFEROL (VIT. D3) | B.P. | 400 I.U (10 µg) | ||||
| VITAMIN A PLAMITATE | B.P. | 350 µg | ||||
| VITAMIN E | B.P. | 2 MG | ||||
| ASCORBIC ACID (VITAMIN C) | B.P. | 12 MG | ||||
| THIAMIN HYDROCHLORIDE (VIT. B1) | B.P. | 0.2 MG | ||||
| (DL ALFA TOCOPHERYL ACETATE) | ||||||
| RIBOFLAVIN SODIUM PHOSPHATE (VIT. B2) | B.P. | 0.25 MG | ||||
| NICOTINAMIDE (VIT. B3) | B.P. | 3 MG | ||||
| PYRIDOXINE HCL (VIT.B6) | B.P. | 0.25 MG | ||||
| FOLIC ACID | B.P. | 50 µg | ||||
| CYANOCOBALAMIN(VITAMIN B12) | B.P. | 4 µg | ||||
| BIOTIN | B.P. | 8 µg | ||||
| D-PANTHENOL (PANTOTHENIC ACID) | B.P. | 0.9 MG | ||||
| FERRIC AMONIUM CITRATE | B.P. | |||||
| EQ TO IRON | 2.2 MG | |||||
| ZINC SULPHATE | B.P. | |||||
| EQ TO ZINC | 1.5 MG | |||||
| L-LYSINE MONOCHLORIDE | B.P. | 10 MG | ||||
| MALT EXTRACT | 150 MG | |||||
| FLAVOURED SYRUPY ASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 79 | NALIDIXIC ACID ORAL SUSPENSOIN | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| NALIDIXIC ACID | B.P. | 300 MG | ||||
| IN SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 80 | NAPHTHYZIN NASAL DROPS | COMPOSITION: | DROPS | EXPORT | ||
| NAPHTHYZIN | B.P. | 1.00%W/V | ||||
| IN NON AQUEOUS BASE | Q.S | |||||
| 81 | NIMESULIDE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| NIMESULIDE | B.P. | 50 MG | ||||
| IN FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 82 | OFLOXACIN, METRONIDAZOLE BENZOATE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| OFLOXACIN | I.P. | 50 MG | ||||
| METRONIDAZOLE BENZOATE | I.P. | |||||
| EQ. TO METRONIDAZOLE | 100 MG | |||||
| IN A FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 83 | OFLOXACIN, ORNIDAZOLE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| OFLOXACIN | B.P. | 50 MG | ||||
| ORNIDAZOLE | B.P. | 125 MG | ||||
| FLAVOURED SYRUP BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 84 | ONDANSETRON HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| ONDANSETRON HYDROCHLORIDE | I.P. | |||||
| EQ.TO ONDANSETRON | 2 MG | |||||
| IN A FLAVOURED SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 85 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION | COMPOSITION: | SOLUTION | EXPORT | ||
| OXYMETAZOLINE HYDROCHLORIDE | U.S.P. | 0.01%W/V | ||||
| PRESERVATIVE | ||||||
| BENZALKONIUM CHLORIDE SOLUTION | B.P. | 0.01%W/V | ||||
| IN A BUFFERED AQUEOUS SOLUTION | Q.S | |||||
| 86 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION | COMPOSITION: | SOLUTION | EXPORT | ||
| OXYMETAZOLINE HYDROCHLORIDE | U.S.P. | 0.025%W/V | ||||
| PRESERVATIVE | ||||||
| BENZALKONIUM CHLORIDE SOLUTION | B.P. | 0.01%W/V | ||||
| IN A BUFFERED AQUEOUS SOLUTION | ||||||
| 87 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION | COMPOSITION: | SOLUTION | EXPORT | ||
| OXYMETAZOLINE HYDROCHLORIDE | U.S.P. | 0.050%W/V | ||||
| PRESERVATIVE | ||||||
| BENZALKONIUM CHLORIDE SOLUTION | B.P. | 0.01%W/V | ||||
| IN A BUFFERED AQUEOUS SOLUTION | ||||||
| 88 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION | COMPOSITION: | SOLUTION | EXPORT | ||
| OXYMETAZOLINE HYDROCHLORIDE | U.S.P. | 0.10%W/V | ||||
| PRESERVATIVE | ||||||
| BENZALKONIUM CHLORIDE SOLUTION | B.P. | 0.01%W/V | ||||
| IN A BUFFERED AQUEOUS SOLUTION | ||||||
| 89 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION | COMPOSITION: | SOLUTION | DOMESTIC | ||
| OXYMETAZOLINE HYDROCHLORIDE | I.P. | 0.05%W/V | ||||
| PRESERVATIVE | ||||||
| BENZALKONIUM CHLORIDE SOLUTION | I.P. | 0.01%W/V | ||||
| IN A BUFFERED AQUEOUS SOLUTION | Q. S | |||||
| 90 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH ML CONTAINS: | SUSPENSION | EXPORT | ||
| PARACETAMOL | B.P. | 100 MG | ||||
| FLAVOURED SUSPENSION BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 91 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| PARACETAMOL | I.P. | 100 MG | ||||
| FLAVOURED SUSPENSION BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 92 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH 5ML CONTAINS: | SUSPENSION | EXPORT | ||
| PARACETAMOL | B.P. | 125 MG | ||||
| IN FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 93 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH 5ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| PARACETAMOL | I.P. | 125 MG | ||||
| IN FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 94 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH 5 ML CONATAINS: | SUSPENSION | EXPORT | ||
| PARACETAMOL | B.P. | 250 MG | ||||
| FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 95 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH 5 ML CONATAINS: | SUSPENSION | DOMESTIC | ||
| PARACETAMOL | I.P. | 250 MG | ||||
| FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 96 | PARACETAMOL DROPS | EACH ML CONTAINS: | DROPS | DOMESTIC | ||
| PARACETAMOL | I.P. | 150 MG | ||||
| FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 97 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, BROMHEXINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| PARACETAMOL | B.P. | 125 MG | ||||
| PHENYLEPHRINE HYDROCHLORIDE | B.P. | 2.5 MG | ||||
| BROMHEXINE HYDROCHLORIDE | B.P. | 2 MG | ||||
| IN A FLAVOURED SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 98 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, BROMHEXINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| PARACETAMOL | I.P. | 125 MG | ||||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 2.5 MG | ||||
| BROMHEXINE HYDROCHLORIDE | I.P. | 2 MG | ||||
| IN A FLAVOURED SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 99 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENAMINE MALEATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
| PARACETAMOL | B.P. | 125 MG | ||||
| PHENYLEPHRINE HYDROCHLORIDE | B.P. | 5 MG | ||||
| CHLORPHENAMINE MALEATE | B.P. | 1 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| 100 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE DI-HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| PARACETAMOL | I.P. | 325 MG | ||||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 10 MG | ||||
| CETIRIZINE DIHYDROCHLORIDE | I.P. | 2.5 MG | ||||
| FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 101 | PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
| CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
| IN FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR | ||||||
| 102 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 2.5 MG | ||||
| PARACETAMOL | I.P. | 125 MG | ||||
| CHLORPHENIRAMINE MALEATE | I.P. | 1 MG | ||||
| IN A FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 103 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
| PARACETAMOL | I.P. | 125 MG | ||||
| CHLORPHENIRAMINE MALEATE | I.P. | 1 MG | ||||
| IN A FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 104 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE SUSPENTION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
| PARACETAMOL | I.P. | 125 MG | ||||
| CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
| IN A FLAVOURED SYRUPY BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 105 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE DROP | EACH ML CONTAINS: | DROPS | DOMESTIC | ||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 2.5 MG | ||||
| PARACETAMOL | I.P. | 125 MG | ||||
| CHLORPHENIRAMINE MALEATE | I.P. | 1 MG | ||||
| IN A FLAVOURED SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 106 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 2.5 MG | ||||
| PARACETAMOL | I.P. | 250 MG | ||||
| CHLORPHENIRAMINE MALEATE | I.P. | 1 MG | ||||
| IN A FLAOUR SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 107 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
| PARACETAMOL | I.P. | 250 MG | ||||
| CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
| IN A FLAOUR SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 108 | POTASSIUM CITRATE MONOHYDRATE, CITRIC ACID MONOHYDRATE SOLUTION | EACH 5 ML CONTAINS: | SOLUTION | DOMESTIC | ||
| POTASSIUM CITRATE MONOHYDRATE | I.P. | 1100 MG | ||||
| CITRIC ACID MONOHYDRATE | I.P. | 334 MG | ||||
| FLAVOURED BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 109 | POTASSIUM NITRATE, SODIUM MONOFLUOROPHOSPHATE, TRICLOSAN TOOTHPASTE | COMPOSITION: | TOOTHPASTE | EXPORT | ||
| POTASSIUM NITRATE | B.P. | 5.0%W/W | ||||
| SODIUM MONOFLUOROPHOSPHATE | U.S.P. | 0.70%W/W | ||||
| TRICLOSAN | U.S.P. | 0.30%W/W | ||||
| IN A PLEASENTLY BASE | Q.S | |||||
| AVAILABLE FLUORIDE CONTENT 917 PPM WHEN PACKED APPROVED COLOUR USED | ||||||
| 110 | PROMETHAZINE ORAL SOLUTION | EACH 10 ML (SPOONFUL) CONTAINS: | SOLUTION | EXPORT | ||
| PROMETHAZINE HYDROCHLORIDE | B.P. | 10 MG | ||||
| FLAVOURED BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 111 | SALBUTAMOL SULPHATE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| SALBUTAMOL SULPHATE | B.P. | |||||
| EQ. TO SALBUTAMOL | 2 MG | |||||
| FLAVOURED SUSPENSION BASE | Q.S | |||||
| APPROVED COLOUR USED | ||||||
| 112 | SILYMARIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
| SILYMARIN (AS SILYBIN) | I.P. | 35 MG | ||||
| FLAVOURED SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 113 | SIMETHICONE, DIL OIL, FENNEL OIL DROPS | EACH ML CONTAINS: | DROPS | EXPORT | ||
| SIMETHICONE EMULSION | U.S.P. | |||||
| EQ TO SIMETHICONE | 40 MG | |||||
| DIL OIL | B.P. | 0.005 ML | ||||
| FENNEL OIL | U.S.P. | 0.0007 ML | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| 114 | SODIUM CHLORIDE NASAL DROPS | COMPOSITION: | DROPS | DOMESTIC | ||
| SODIUM CHLORIDE | I.P. | 0.65%W/V | ||||
| (IN PURIFIED WATER MADE ISOTONIC AND BUFFERED) | ||||||
| BENZALKONIUM CHLORIDE SOLUTION | I.P. | |||||
| EQ. TO. BENZALKONIUM CHLORIDE | 0.01%W/V | |||||
| (AS PRESERVATIVE) | Q.S | |||||
| 115 | TRICHOLINE CITRATE SYRUP | EACH 10 ML CONTAINS: | SYRUP | DOMESTIC | ||
| TRICHOLINE CITRATE (65%) | I.P. | 550 MG | ||||
| FLAVOURED NON SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 116 | THEOPHYLLINE ORAL SOLUTION | EACH 5 ML CONTAINS: | SOLUTION | EXPORT | ||
| THEOPHYLLINE (ANHYDROUS) | U.S.P. | 26.667 MG | ||||
| PRESERVATIVES: | ||||||
| METHYL PARABEN | U.S.P. | 0.1%W/V | ||||
| PROPYL PARABEN | U.S.P. | 0.015%W/V | ||||
| ALCOHOL | U.S.P. | 0.5%V/V | ||||
| IN A FLAOUR SYRUPY BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 117 | TRICHOLINE CITRATE, SORBITOL SOLUTION | EACH 5 ML CONTAINS: | SOLUTION | DOMESTIC | ||
| TRICHOLINE CITRATE (65%) | I.P. | 275 MG | ||||
| SORBITOL SOLUTION (70%) | I.P. | 3.5 MG | ||||
| FLAVOURED SYRUP BASE | Q. S | |||||
| APPROVED COLOUR USED | ||||||
| 118 | TRIMETHOPRIM, SULFAMETHOXAZOLE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
| TRIMETHOPRIM | B.P. | 40 MG | ||||
| SULFAMETHOXAZOLE | B.P. | 200 MG | ||||
| FLAVOURED SYRUPY BASE | Q.S | |||||
| 119 | URSODESOXYCHOLIC ACID ORAL SUSPENSION | EACH 5 ML CONATINS: | SUSPENSION | DOMESTIC | ||
| URSODIOL (URSODEOXYCHOLIC ACID) | I.P. | 125 MG | ||||
| IN FLAVOURED BASE | Q. S | |||||
| APPROVED COLUR USED | ||||||
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| ALPHA AMYLASE, PAPAIN, DIL OIL, ANISE OIL, CARAWAY OIL | DROPS | DIGESTIVE ENZYMES |
| ALPHA AMYLASE, PEPSIN | SYRUP | DIGESTIVE ENZYMES |
| DOMPERIDONE | SUSPENSION | DOPAMINE ANTAGONISTS |
| DOMPERIDONE, SIMETHICONE | SUSPENSION | DOPAMINE ANTAGONISTS |
| DRIED ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE, ACTIVATED DIMETHICONE | SUSPENSION | ANTACIDS |
| LACTULOSE | SOLUTION | LAXATIVES |
| SIMETHICONE, DIL OIL, FENNEL OIL | DROPS | ANTACIDS, ANTIREFLUX AGENTS & ANTIULCERANTS |
| LOPERAMIDE HYDOCHLORIDE, DICYCLOVERINE HYDROCHLORIDE, LACTIC ACID BACILLUS | CAPSULE | ANTI-DIARRHEAL AGENT |
| LOPERAMIDE HYDROCHLORIDE | CAPSULE | ANTI-DIARRHEAL AGENT |
| DICYCLOMINE HYDROCHLORIDE, SIMETHICONE | SUSPENSION | ANTICHOLINERGICS / ANTISPASMODICS |
| OMEPRAZOLE | CAPSULE | GASTROESOPHAGEAL |
| OMEPRAZOLE, DOMPERIDONE | CAPSULE | GASTROESOPHAGEAL |
| PANTOPRAZOLE (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) | CAPSULE | GASTROESOPHAGEAL |
| PANTOPRAZOLE SODIUM DELAYED-RELEASE | CAPSULE | GASTROESOPHAGEAL |
| PANTOPRAZOLE SODIUM, LEVOSULPIRIDE SUSTAINED RELEASE | CAPSULE | GASTROESOPHAGEAL |
| RABEPRAZOLE SODIUM (ENTERIC COATED) | CAPSULE | GASTROESOPHAGEAL |
| RABEPRAZOLE SODIUM (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) | CAPSULE | GASTROESOPHAGEAL |
| ILAPRAZOLE, DOMPERIDONE | CAPSULE | GASTROESOPHAGEAL |
| RABEPRAZOLE (ENTERIC COATED), LEVOSULPIRIDE SUSTAINED RELEASE | CAPSULE | GASTROESOPHAGEAL |
| ESOMEPRAZOLE (ENTERIC COATED), DOMPERIDONE SUSTAINED RELEASE | CAPSULE | GASTROESOPHAGEAL |
| LOPERAMIDE HYDROCHLORIDE | TABLET | ANTI-DIARRHEAL AGENT |
| DICYCLOMINE HYDROCHLORIDE, PARACETAMOL | TABLET | ANTISPASMODICS |
| DROTAVERINE HYDROCHLORIDE | TABLET | ANTISPASMODICS |
| DROTAVERINE HYDROCHLORIDE, MEFENAMIC ACID | TABLET | ANTISPASMODICS |
| DROTAVERINE HYDROCHLORIDE, PARACETAMOL | TABLET | ANTISPASMODICS |
| FAMOTIDINE | TABLET | H2-BLOCKERS |
| ESOMEPRAZOLE GASTRO RESISTANCE | TABLET | PROTON-PUMP INHIBITORS |
| ESOMEPRAZOLE MAGNESIUM | TABLET | PROTON-PUMP INHIBITORS |
| PANTOPRAZOLE | TABLET | PROTON-PUMP INHIBITORS |
| PANTOPRAZOLE SODIUM, DOMPERIDONE | TABLET | PROTON-PUMP INHIBITORS |
| RABEPRAZOLE SODIUM | TABLET | PROTON-PUMP INHIBITORS |
| RABEPRAZOLE SODIUM, DOMPERIDONE | TABLET | PROTON-PUMP INHIBITORS |
| BISACODYL | TABLET | STIMULANT LAXATIVES |
| BISACODYL DELAY RELEASE | TABLET | STIMULANT LAXATIVES |
| OMEPRAZOLE MAGNESIUM, DOMPERIDONE | TABLET | PROTON-PUMP INHIBITORS TREATMENT OF FUNCTIONAL GASTROINTESTINAL DISORDERS |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| BENZOYL PEROXIDE | GEL | ANTIBIOTICS |
| CLARITHROMYCIN | CREAM | ANTIBIOTICS |
| CLINDAMYCIN PHOSPHATE | GEL | ANTIBIOTICS |
| CLINDAMYCIN PHOSPHATE, NICOTINAMIDE | GEL | ANTIBIOTICS |
| FUSIDIC ACID | CREAM/OINTMENT | ANTIBIOTICS |
| MUPIROCIN | OINTMENT | ANTIBIOTICS |
| NADIFLOXACIN | CREAM | ANTIBIOTICS |
| NEOMYCIN SULPHATE, CLOBETASOL PROPIONATE, MICONAZOLE | CREAM | ANTIBIOTICS |
| NEOMYCIN SULPHATE, FLUOCINOLONE ACETONIDE | OINTMENT | ANTIBIOTICS |
| SILVER SULFADIAZINE, CHLORHEXADINE GLUCONATE | CREAM/OINTMENT | ANTIBIOTICS |
| SILVER SULFADIAZINE, LIGNOCAINE HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE | CREAM | ANTIBIOTICS |
| SODIUM FUSIDATE | OINTMENT | ANTIBIOTICS |
| SUCRALFATE, METRONIDAZOLE, POVIDONE IODINE | OINTMENT | ANTIBIOTICS |
| BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE | LOTION | ANTIBIOTICS AND STEROIDS |
| BECLOMETHASONE DIPROPIONATE, FUSIDIC ACID | CREAM | ANTIBIOTICS AND STEROIDS |
| BETAMETHASONE DIPROPIONATE, GENTAMICIN SULPHATE ,TOLNAFTATE, IODOCHLORHYDROXYQUINOLINE | CREAM | ANTIBIOTICS AND STEROIDS |
| BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE, GENTAMICIN | CREAM/OINTMENT | ANTIBIOTICS AND STEROIDS |
| BETAMETHASONE DIPROPIONATE, GENTAMYCIN | CREAM | ANTIBIOTICS AND STEROIDS |
| BETAMETHASONE VALERATE, GENTAMICIN | CREAM | ANTIBIOTICS AND STEROIDS |
| CLOBETASOL PROPIONATE AND FUSIDIC ACID | CREAM | ANTIBIOTICS AND STEROIDS |
| CLOBETASOL PROPIONATE | CREAM/ OINTMENT | ANTIBIOTICS AND STEROIDS |
| CLOBETASOL PROPIONATE, GENTAMICIN, TOLNAFTATE, IODOCHLORHYDROXYQUINOLINE, CLOTRIMAZOLE | CREAM | ANTIBIOTICS AND STEROIDS |
| CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE | CREAM | ANTIBIOTICS AND STEROIDS |
| CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE, CLOTRIMAZOLE | CREAM | ANTIBIOTICS AND STEROIDS |
| CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE, MICONAZOLE | CREAM | ANTIBIOTICS AND STEROIDS |
| CLOBETASOL PROPIONATE, SALICYLIC ACID | OINTMENT | ANTIBIOTICS AND STEROIDS |
| CLOBETASONE 17-BUTYRATE, GENTAMICIN SULPHATE | CREAM | ANTIBIOTICS AND STEROIDS |
| DEXAMETHASONE SODIUM PHOSPHATE, NEOMYCIN SULPHATE | CREAM/OINTMENT | ANTIBIOTICS AND STEROIDS |
| DEXAMETHASONE, NEOMYCIN SULPHATE | OINTMENT | ANTIBIOTICS AND STEROIDS |
| FLUOCINOLONE ACETONIDE, MICONAZOLE NITRATE | CREAM | ANTIBIOTICS AND STEROIDS |
| FLUTICASONE PROPIONATE | CREAM | ANTIBIOTICS AND STEROIDS |
| HALOBETASOLE PROPIONATE | CREAM | ANTIBIOTICS AND STEROIDS |
| HALOBETASOLE PROPIONATE, CLOTRIMAZOLE | CREAM | ANTIBIOTICS AND STEROIDS |
| HALOBETASOLE PROPIONATE, SALICYLIC ACID | OINTMENT | ANTIBIOTICS AND STEROIDS |
| HYDROCORTISONE | CREAM | ANTIBIOTICS AND STEROIDS |
| HYDROQUINONE, TRETINOIN, MOMETASONE FUROATE | CREAM | ANTIBIOTICS AND STEROIDS |
| MOMETASONE FUROATE | CREAM | ANTIBIOTICS AND STEROIDS |
| MOMETASONE FUROATE, FUSIDIC ACID | CREAM | ANTIBIOTICS AND STEROIDS |
| MOMETASONE FUROATE, SALICYLIC ACID | CREAM | ANTIBIOTICS AND STEROIDS |
| MOMETASONE FUROATE, TERBINAFINE HYDROCHLORIDE | CREAM | ANTIBIOTICS AND STEROIDS |
| OFLOXACIN, ORNIDAZOLE, TERBINAFINE HYDROCHLORIDE, CLOBETASOL PROPIONATE | CREAM | ANTIBIOTICS AND STEROIDS |
| TRIAMCINOLONE ACETONIDE | CREAM | ANTIBIOTICS AND STEROIDS |
| ORNIDAZOLE, POVIDONE IODINE | OINTMENT | ANTISEPTIC |
| POVIDONE IODINE | OINTMENT | ANTISEPTIC |
| POVIDONE IODINE, SUCRALFATE | OINTMENT | ANTISEPTIC |
| BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE, NEOMYCIN | CREAM | ANTIBIOTICS AND STEROIDS |
| BECLOMETHASONE DIPROPIONATE, NEOMYCIN, CLOTRIMAZOLE | CREAM | ANTIBIOTICS AND STEROIDS |
| BETAMETHASONE VALERATE, NEOMYCIN SULPHATE, TOLNAFTATE, IODOCHLORHYDROXQUINOLINE | CREAM | ANTIBIOTICS AND STEROIDS |
| CHLORHEXIDINE GLUCONATE, METRONIDAZOLE | GEL | ANTISEPTIC |
| METRONIDAZOL, FURAZOLIDONE | SUSPENSION | MISCELLANEOUS ANTIBIOTICS |
| METRONIDAZOLE SUSPENSOIN | SUSPENSION | AMEBICIDES, MISCELLANEOUS ANTIBIOTICS |
| OFLOXACIN, METRONIDAZOLE BENZOATE | SUSPENSION | ANTIBIOTICS |
| OFLOXACIN, ORNIDAZOLE | SUSPENSION | ANTIBIOTICS |
| AZITHROMYCIN | SUSPENSION | ANTIBIOTICS |
| BECLOMETHASONE, CLOTRIMAZOLE, LIGNOCAINE, NEOMYCIN | DROPS | ANTIBIOTICS AND STEROIDS |
| CHLORHEXIDINE GLUCONATE, METRONIDAZOLE | SOLUTION | ANTISEPTIC AND GERMICIDES, MOUTH AND THROAT PRODUCTS |
| CIPROFLOXACIN | SUSPENSION | QUINOLONES AND FLUOROQUINOLONES |
| CIPROFLOXACIN, TINIDAZOLE | SUSPENSION | FLUOROQUINOLONES |
| ERYTHROMYCIN | SUSPENSION | ANTIBIOTICS |
| LINEZOLID | SUSPENSION | OXAZOLIDINONE-CLASS |
| NALIDIXIC ACID SUSPENSOIN | SUSPENSION | QUINOLONES AND FLUOROQUINOLONES (URINARY ANTI-INFECTIVES) |
| AZITHROMYCIN | CAPSULE | ANTIBIOTICS |
| CLINDAMYCIN | CAPSULE | ANTIBIOTICS |
| DOXYCYCLINE HYDROCHLORIDE | CAPSULE | ANTIBIOTICS |
| LINEZOLID | TABLET | ANTIBACTERIALS |
| CHLORAMPHENICOL | TABLET | ANTIBIOTICS |
| CIPROFLOXACIN HYDROCHLORIDE | TABLET | ANTIBIOTICS |
| CIPROFLOXACIN HYDROCHLORIDE, ORNIDAZOLE | TABLET | ANTIBIOTICS |
| CIPROFLOXACIN HYDROCHLORIDE, TINIDAZOLE | TABLET | ANTIBIOTICS |
| CLARITHROMYCIN | TABLET | ANTIBIOTICS |
| ORNIDAZOLE | TABLET | ANTIBIOTICS |
| TINIDAZOLE | TABLET | ANTIBACTERIALS |
| OFLOXACIN | TABLET | FLUOROQUINOLONE ANTIBIOTICS |
| OFLOXACIN, ORNIDAZOLE | TABLET | FLUOROQUINOLONE ANTIBIOTICS |
| OFLOXACIN, TINIDAZOLE | TABLET | FLUOROQUINOLONE ANTIBIOTICS |
| LEVOFLOXACIN | TABLET | FLUOROQUINOLONE DRUG BACTERICIDAL ANTIBIOTIC |
| SPARFLOXACIN | TABLET | FLUOROQUINOLONES (TREAT VARIOUS TYPES OF BACTERIAL INFECTIONS) |
| NITROXOLINE | TABLET | HYDROXYQUINOLINE DERIVATIVE URINARY ANTIBACTERIAL AGENT |
| ROXITHROMYCIN | TABLET | MACROLIDE ANTIBIOTICS |
| AZITHROMYCIN | TABLET | MACROLIDE ANTIBIOTICS |
| ERYTHROMYCIN | TABLET | MACROLIDE ANTIBIOTICS |
| METRONIDAZOLE | TABLET | NITROIMIDAZOLE CLASS ANTIBIOTIC |
| METRONIDAZOLE, FURAZOLIDINE | TABLET | NITROIMIDAZOLE CLASS ANTIBIOTIC |
| NALIDIXIC ACID | TABLET | QUINOLONE ANTIBIOTICS |
| NORFLOXACIN | TABLET | QUINOLONE ANTIBIOTICS |
| NORFLOXACIN, TINIDAZOLE | TABLET | QUINOLONE ANTIBIOTICS |
| TRIMETHOPRIM, SULFAMETHOXAZOLE | TABLET | SULFONAMIDE ANTIBIOTICS |
| MINOCYCLINE | TABLET | TETRACYCLINE ANTIBIOTICS |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| AMOROLFINE HYDROCHLORIDE | CREAM | ANTIFUNGALS |
| CIPROFLOXACIN HYDROCHLORIDE, FLUOCINOLONE ACETONIDE, CLOTRIMAZOLE | CREAM | ANTIFUNGALS |
| CLOTRIMAZOLE | CREAM/ LOTION | ANTIFUNGALS |
| CLOTRIMAZOLE VAGINAL | GEL | ANTIFUNGALS |
| CLOTRIMAZOLE, BECLOMETHASONE | CREAM | ANTIFUNGALS |
| CLOTRIMAZOLE, BECLOMETHASONE DIPROPIONATE, GENTAMYCIN SULPHATE | OINTMENT | ANTIFUNGALS |
| EBERCONAZOLE NITRATE | CREAM | ANTIFUNGALS |
| FLUCONAZOLE | CREAM | ANTIFUNGALS |
| FLUOCINOLONE ACETONIDE | OINTMENT | ANTIFUNGALS |
| ITRACONAZOLE | GEL | ANTIFUNGALS |
| ITRACONAZOLE, OFLOXACIN, ORNIDAZOLE, CLOBETASOL PROPIONATE | CREAM | ANTIFUNGALS |
| KETOCONAZOLE | CREAM/SHAMPOO | ANTIFUNGALS |
| KETOCONAZOLE, BECLOMETHASONE DIPROPIONATE | CREAM | ANTIFUNGALS |
| KETOCONAZOLE, CLOBETASOLE PROPIONATE, NEOMYCIN | CREAM | ANTIFUNGALS |
| KETOCONAZOLE, IODOCHLORHYDROXYQUINOLINE, TOLNAFTATE, NEOMYCIN SULPHATE, CLOBETASOL PROPIONATE | CREAM | ANTIFUNGALS |
| KETOCONAZOLE, ZINC PYRITHIONE | SHAMPOO | ANTIFUNGALS |
| LULICONAZOLE | LOTION/CREAM | ANTIFUNGALS |
| LULICONAZOLE, CLOBETASOLE PROPIONATE | CREAM | ANTIFUNGALS |
| OFLOXACIN, TERBINAFINE HYDROCHLORIDE, ORNIDAZOLE, BECLOMETHASONE DIPROPIONATE | CREAM | ANTIFUNGALS |
| TERBINAFINE HYDROCHLORIDE | CREAM | ANTIFUNGALS |
| TERBINAFINE HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE, SALICYLIC ACID | LOTION | ANTIFUNGALS |
| SERTACONAZOLE NITRATE | CREAM | ANTIFUNGALS |
| TRIMETHOPRIM, SULFAMETHOXAZOLE | SUSPENSION | SULFONAMIDES |
| FLUCONAZOLE | CAPSULE | ANTIFUNGALS |
| ITRACONAZOLE | CAPSULE | ANTIFUNGALS |
| CLOTRIMAZOLE VAGINAL | TABLET | ANTIFUNGALS |
| FLUCONAZOLE | TABLET | ANTIFUNGALS |
| KETOCONAZOLE | TABLET | ANTIFUNGALS |
| NYSTATIN | TABLET | ANTIFUNGALS |
| TERBINAFINE HYDROCHLORIDE | TABLET | ANTIFUNGALS |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| ONDANSETRON HYDROCHLORIDE | SYRUP | ANTIEMATIC |
| DOMPERIDONE | TABLET | ANTIEMETIC |
| ONDANSETRON HYDROCHLORIDE ORALLY DISINTEGRATING |
TABLET | ANTIEMETIC |
| DIURETIC | TABLET | DOPAMINE ANTAGONIST (TREAT NAUSEA AND VOMITING) |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| ARTEMETHER, LUMEFENTRINE | SUSPENSION | ANTI-MALARIAL |
| ARTEMETHER, LUMEFENTRINE | TABLET | ANTI-MALARIAL |
| HYDROXYCHLOROQUINE SULPHATE | TABLET | ANTI-MALARIAL |
| PRIMAQUINE PHOSPHATE | TABLET | ANTI-MALARIAL |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| CITICOLINE SODIUM | SYRUP | PSYCHOSTIMULANTS |
| PREGABALIN | CAPSULE | ANTICONVULSANTS |
| PREGABALIN, METHYLCOBALAMIN | CAPSULE | ANTICONVULSANTS |
| FLUOXETINE HYDROCHLORIDE | CAPSULE | ANTIDEPRESSANT |
| PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE | CAPSULE | ANTI-MIGRAINE |
| PIRACETAM | CAPSULE | NOOTROPIC DRUG |
| DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE | TABLET | ANTICONVULSANTS |
| DIPHENOXYLATE HYDROCHLORIDE, ATROPINE SULPHATE | TABLET | ANTICHOLINERGICS |
| CARBAMAZEPINE | TABLET | ANTICONVULSANTS |
| LAMOTRIGINE DISPERSIBLE | TABLET | ANTICONVULSANTS |
| LEVETIRACETAM TABLES | TABLET | ANTICONVULSANTS |
| SODIUM VALPROATE GASTRO-RESISTANT | TABLET | ANTICONVULSANTS |
| SODIUM VALPROATE, VALPROIC ACID CONTROLLED RELEASE | TABLET | ANTICONVULSANTS |
| VENLAFAXINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANT/ ANTIPSYCHOTIC |
| ALPRAZOLAM, FLUOXETINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
| DESVENLAFAXINE EXTENDED RELEASE | TABLET | ANTIDEPRESSANTS |
| DIAZEPAM | TABLET | ANTIDEPRESSANTS |
| DULOXETINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
| ESCITALOPRAM OXALATE | TABLET | ANTIDEPRESSANTS |
| ESCITALOPRAM OXALATE, CLONAZEPAM | TABLET | ANTIDEPRESSANTS |
| FLUOXETINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
| NORTRIPTYLINE | TABLET | ANTIDEPRESSANTS |
| PAROXETINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
| SERTRALINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
| TRAZODONE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
| DIVALPROEX SODIUM EXTENDED RELEASE | TABLET | ANTI-EPILEPTICS |
| TOPIRAMATE | TABLET | ANTI-EPILEPTICS |
| PRAMIPEXOLE | TABLET | ANTI-PARKINSONIAN |
| AMISULPRIDE | TABLET | ANTIPSYCHOTICS |
| ETIZOLAM | TABLET | ANTIPSYCHOTICS |
| HALOPERIDOL | TABLET | ANTIPSYCHOTICS |
| OLANZAPINE MOUTH DISSOLVING | TABLET | ANTIPSYCHOTICS |
| PROCHLORPERAZINE MALEATE | TABLET | ANTIPSYCHOTICS |
| PROMETHAZINE HYDROCHLORIDE | TABLET | ANTIPSYCHOTICS |
| QUETIAPINE | TABLET | ANTIPSYCHOTICS |
| RISPERIDONE | TABLET | ANTIPSYCHOTICS |
| RISPERIDONE, TRIHEXYPHENIDYL HYDROCHLORIDE | TABLET | ANTIPSYCHOTICS |
| NITRAZEPAM | TABLET | BENZODIAZEPINE CLASS (TREATMENT OF ANXIETY) |
| LORAZEPAM | TABLET | BENZODIAZEPINES (TREAT ANXIETY) |
| ACETAZOLAMIDE | TABLET | CARBONIC ANHYDRASE INHIBITORS DIURETIC |
| ALPRAZOLAM | TABLET | CENTRAL NERVOUS SYSTEM (CNS) DEPRESSANTS |
| CINNARIZINE, PIRACETAM | TABLET | NOOTROPICS |
| PIRACETAM | TABLET | NOOTROPICS |
| CHLORDIAZEPOXIDE | TABLET | PSYCHOTROPIC AGENT |
| CHLORDIAZEPOXIDE, TRIFLUOPERAZINE | TABLET | PSYCHOTROPIC AGENT |
| CLOBAZAM | TABLET | PSYCHOTROPIC AGENT |
| CLOMIPHENE CITRATE | TABLET | PSYCHOTROPIC AGENT |
| CLOMIPRAMINE HYDROCHLORIDE | TABLET | PSYCHOTROPIC AGENT |
| CLONAZEPAM | TABLET | PSYCHOTROPIC AGENT |
| CLONAZEPAM, PAROXETINE (CONTROLLED RELEASED) | TABLET | PSYCHOTROPIC AGENT |
| CLONAZEPAM, PROPRANOLOL HYDROCHLORIDE | TABLET | PSYCHOTROPIC AGENT |
| CLONIDINE HYDROCHLORIDE | TABLET | PSYCHOTROPIC AGENT |
| CLOZAPINE | TABLET | PSYCHOTROPIC AGENT |
| IMIPRAMINE HYDROCHLORIDE | TABLET | RICYCLIC ANTIDEPRESSANTS |
| ZOPICLONE | TABLET | SEDATIVES/HYPNOTICS |
| MIRTAZAPINE | TABLET | TETRACYCLIC ANTIDEPRESSANTS |
| AMITRIPTYLINE HYDROCHLORIDE | TABLET | TRICYCLIC ANTIDEPRESSANTS (TCA) |
| AMITRIPTYLINE HYDROCHLORIDE, CHLORDIAZEPOXIDE | TABLET | TRICYCLIC ANTIDEPRESSANTS (TCA) |
| AMITRIPTYLINE HYDROCHLORIDE, CLONAZEPAM | TABLET | TRICYCLIC ANTIDEPRESSANTS (TCA) |
| DOXEPIN HYDROCHLORIDE | TABLET | TRICYCLIC ANTIDEPRESSANTS (TCA) |
| DULOXETINE GASTRO-RESISTANT | TABLET | ANTIDEPRESSANTS/ANTISPASMODICS |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| DI-SODIUM HYDROGEN CITRATE | SYRUP | KIDENY STONE |
| POTASSIUM CITRATE MONOHYDRATE, CITRIC ACID MONOHYDRATE | SOLUTION | URINARY ALKALINIZERS |
| POTASSIUM NITRATE, SODIUM MONOFLUOROPHOSPHATE, TRICLOSAN | TOOTHPASTE | DENTAL PRODUCTS |
| SILYMARIN | SUSPENSION | HEPATOPROTECTIVE MEDICINES |
| SODIUM CHLORIDE NASAL | DROPS | DECONGESTANT INTRANASAL |
| TRICHOLINE CITRATE | SYRUP | BILE ACID BINDING AGENT |
| TRICHOLINE CITRATE, SORBITOL | SOLUTION | CHOLESTEROL-LOWERING AGENTS |
| URSODESOXYCHOLIC ACID | SUSPENSION | GASTROINTESTINAL DRUG |
| TAMSULOSIN HYDROCHLORIDE PROLONGED RELEASE AND DUTASTERIDE | CAPSULE | PROSTATIC HYPERPLASIA |
| TRIHEXYPHENIDYL HYDROCHLORIDE | TABLET | ANTICHOLINERGIC |
| TRIHEXYPHENIDYL HYDROCHLORIDE, TRIFLUOPERAZINE | TABLET | ANTICHOLINERGIC |
| LEFLUNOMIDE | TABLET | ANTIRHEUMATIC DRUGS |
| ACETAZOLAMIDE | TABLET | CARBONIC ANHYDRASE INHIBITORS DIURETIC |
| BETAMETHASONE | TABLET | CORTICOSTEROIDS |
| DEFLAZACORT | TABLET | CORTICOSTEROIDS |
| DEXAMETHASONE | TABLET | CORTICOSTEROIDS |
| PREDNISOLONE | TABLET | CORTICOSTEROIDS |
| POTASSIUM OROTATE | TABLET | DIURETIC |
| URSODIOL (URSODESOXYCHOLIC ACID) | TABLET | GALLSTONE DISSOLUTION AGENTS |
| TADALAFIL TABETS | TABLET | ERECTILE DYSFUNCTION |
| SILDENAFIL CITRATE | TABLET | ERECTILE DYSFUNCTION |
| LACTIC ACID BACILLUS | TABLET | PROBIOTICS ANTIDIARRHOEA |
| TRIOXSALEN | TABLET | PSORIASIS |
| FLUVOXAMINE MALEATE | TABLET | SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) |
| CARISOPRODOL | TABLET | SKELETAL MUSCLE RELAXANTS |
| SILYMARIN | TABLET | TREAT CHRONIC (LONG-STANDING) LIVER DISEASES |
| METHYLPREDNISOLONE | TABLET | SYSTEMIC CORTICOSTEROIDS |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| FERRIC AMMONIUM CITRATE, FOLIC ACID, CYANOCOBALAMIN | SYRUP | NUTRITIONAL SUPPLEMENTS |
| FERRIC AMMONIUM CITRATE, IRON WITH VITAMIN B12, B- COMPLEX | SYRUP | NUTRITIONAL SUPPLEMENTS |
| FERRIC AMMONIUM CITRATE, VITAMIN B12, FOLIC ACID | SYRUP | NUTRITIONAL SUPPLEMENTS |
| FERROUS ASCORBATE, FOLIC ACID | SUSPENSION | IRON PRODUCTS, VITAMIN AND MINERALS COMBINATIONS |
| IRON (III) HYDROXIDE POLYMALTOSE COMPLEX | SYRUP | MINERAL SUPLIMENTS |
| IVY LEAF DRY EXTRACT | SOLUTION | HERBAL MEDICATIONS |
| MULTIVITAMIN AND MINERAL | DROPS | VITAMINS (FOOD SUPIMENTS) |
| DRIED FERROUS SULFATE, VITAMIN C, THIAMINE MONONITRATE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN NICOTINAMIDE, CALCIUM PANTOTHENATE, FOLIC ACID, ZINC SULFATE MONOHYDRATE | CAPSULE | ANEMIA |
| FERROUS FUMARATE, CYANOCOBALAMIN, FOLIC ACID, ZINC | CAPSULE | ANEMIA |
| FERROUS FUMARATE, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, ZINC | CAPSULE | ANEMIA |
| FOLIC ACID | TABLET | VITAMINS (FOOD SUPIMENTS) |
| ZINC SULPHATE DISPERSIBLE | TABLET | MINERAL SUPLIMENTS |
| FERROUS ASCORBATE, FOLIC ACID | TABLET | HAEMATINICS |
| FERROUS ASCORBATE, ZINC, FOLIC ACID | TABLET | HAEMATINICS |
| FERROUS FUMARATE, CYANOCOBALAMIN, ZINC, FOLIC ACID | TABLET | HAEMATINICS |
| CALCIUM GLUCONATE | TABLET | HYPOCALCEMIA |
| MAGNESIUM LACTATE DIHYDRATE, PYRIDOXINE HYDROCHLORIDE | TABLET | MINERAL SUPPLEMENT |
| CALCIUM, CHOLECALCIFEROL | TABLET | MULTI-MINERALS |
| CALCIUM, MAGNESIUM, ZINC, VITAMIN D3 | TABLET | MULTI-MINERALS |
| CALCIUM, VITAMIN D3 | TABLET | MULTI-MINERALS |
| DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID |
TABLET | VITAMINS |
| DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE |
TABLET | VITAMINS |
| METHYLCOBALAMIN | TABLET | VITAMINS |
| METHYLCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID | TABLET | VITAMINS |
| MULTIVITAMIN, MINERALS | TABLET | VITAMINS |
| SODIUM FEREDETATE, FOLIC ACID, VITAMIN B12 | TABLET | VITAMINS |
| PYRIDOXINE HYDROCHLORIDE | TABLET | VITAMINS |
| THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, CYNOCOBALAMIN | TABLET | VITAMINS |
| THIAMINE MONONITRATE, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN | TABLET | VITAMINS |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| CETIRIZINE HYDROCHLORIDE | SUSPENSION/SOLUTION | ANTIHISTAMINES (BCS CLASS III) |
| CYPROHEPTADINE HYDROCHLORIDE | SYRUP | ANTIHISTAMINES |
| CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE | DROPS/SYRUP | ANTIHISTAMINES |
| FEXOFENADINE HYDROCHLORIDE | SUSPENSION | ANTIHISTAMINES |
| LEVOCETIRIZINE DIHYDROCHLORIDE | SYRUP | ANTIHISTAMINES |
| LORATADINE | SUSPENSION/SOLUTION | ANTIHISTAMINES |
| MONTELUKAST, LEVOCETIRIZINE DIHYDROCHLORIDE | SUSPENSION | ANTIALLERGIC (SKIN) |
| OXYMETAZOLINE HYDROCHLORIDE NASAL | SOLUTION | NASAL DECONGESTANTS |
| PROMETHAZINE | SOLUTION | PHENOTHIAZINES |
| BUDESONIDE | CAPSULE | CORTICOSTEROID |
| CINNARIZINE, DOMPERIDONE | TABLET | ANTI-HISTAMINE/ANTI-EMETIC |
| CETIRIZINE DI-HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
| CETIRIZINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
| CHLORPHENIRAMINE MALEATE | TABLET | ANTIHISTAMINES |
| CHLORPROMAZINE HDROCHLORIDE | TABLET | ANTIHISTAMINES |
| CINNARIZINE | TABLET | ANTIHISTAMINES |
| CYPROHEPTADINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
| DESLORATADINE | TABLET | ANTIHISTAMINES |
| DIPHENHYDRAMINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
| FEXOFENADINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
| FEXOFENADINE HYDROCHLORIDE DISPERSIBLE | TABLET | ANTIHISTAMINES |
| FEXOFENADINE HYDROCHLORIDE, MONTELUKAST | TABLET | ANTIHISTAMINES |
| HYDROXYZINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
| KETOTIFEN FUMARATE | TABLET | ANTIHISTAMINES |
| LEVOCETIRIZINE DIHYDROCHLORIDE | TABLET | ANTIHISTAMINES |
| LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST | TABLET | ANTIHISTAMINES |
| LEVOCETIRIZINE HYDROCHLORIDE, AMBROXOL HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
| LEVOCETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
| LORATADINE | TABLET | ANTIHISTAMINES |
| MEBHYDROLINE NAPADISYLATE | TABLET | ANTIHISTAMINES |
| FLUNARIZINE | TABLET | ANTIHISTAMINES |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| IVERMECTIN | CREAM/SHAMPOO | ANTHELMINTIC |
| ALBENDAZOLE | SUSPENSION | ANTHELMINTIC (ANTI-WORM MEDICATION) |
| ALBENDAZOLE, IVERMECTIN | SUSPENSION | ANTI PARASITE MEDICATION |
| IVERMECTIN | TABLET | ANTHELMINTICS |
| LEVAMISOLE | TABLET | ANTHELMINTICS |
| MEBENDAZOLE | TABLET | ANTHELMINTICS |
| PRAZIQUANTEL | TABLET | ANTHELMINTICS |
| ALBENDAZOLE | TABLET | ANTHELMINTICS |
| ALBENDAZOLE, IVERMECTIN | TABLET | ANTHELMINTICS |
| BENDAZOLE | TABLET | ANTHELMINTICS |
| NICLOSAMIDE (ANHYDROUS) | TABLET | ANTHELMINTICS |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| GAMMABENZENE HEXACHLORIDE | LOTION | ANTISCABIES |
| GAMMABENZENE HEXACHLORIDE, CETRIMIDE | LOTION | ANTISCABIES |
| PERMETHRIN | CREAM/LOTION | PEDICULICIDE |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| DEXPANTHENOL | OINTMENT | DERMALS |
| SALICYLIC ACID | FACE WASH/OINTMENT | CLEANING AGENT |
| TACROLIMUS | OINTMENT | MISCELLENIOUS TOPICAL AGENT (TREAT MODERATE TO SEVERE ECZEMA) |
| TRETINOIN | CREAM | RETINOIDS |
| ISOTRETINOIN | CAPSULE | DERMALS |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE, MENTHOL | SYRUP | EXPECTORANTS |
| AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, PHENYLEPHRINE HYDROCHLORIDE | SYRUP | EXPECTORANTS |
| AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE, MENTHOL | SYRUP | EXPECTORANTS |
| DIPHENHYDRAMINE HYDROCHLORIDE, AMMONIUM CHLORIDE, SODIUM CITRATE, MENTHOL | SYRUP | EXPECTORANTS |
| PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, BROMHEXINE HYDROCHLORIDE | SYRUP | EXPECTORANTS |
| PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE DI-HYDROCHLORIDE | SYRUP | EXPECTORANTS |
| PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENAMINE MALEATE | SYRUP | EXPECTORANTS |
| AMBROXOL HYDROCHLORIDE | SYRUP | MUCOLYTIC AGENTS |
| AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE | SYRUP | MUCOLYTIC AGENTS |
| AMBROXOL HYDROCHLORIDE, LEVOCETIRIZINE HYDROCHLORIDE | SUSPENSION | MUCOLYTIC AGENTS |
| AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIFENESIN | SYRUP | MUCOLYTIC AGENTS (COUGH AND MUCUS) |
| BROMHEXINE HYDROCHLORIDE | SYRUP | MUCOLYTIC AGENTS |
| BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE | SYRUP | MUCOLYTIC AGENTS (COUGH AND MUCUS) |
| BROMHEXINE HYDROCHLORIDE, TERBUTALINE, GUAIPHENESIN, MENTHOL | SYRUP | MUCOLYTIC AGENTS |
| LEVOSALBUTAMOL SULPHATE, GUAIPHENESIN, AMBROXOL HYDROCHLORIDE | SYRUP | MUCOLYTIC AGENTS (COUGH AND MUCUS) |
| CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE | SYRUP | UPPER RESPIRATORY COMBINATION |
| DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE | SYRUP | UPPER RESPIRATORY COMBINATION |
| DEXTROMETHORPHAN, CHLORPHENIRAMINE MALEATE, HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | SYRUP | UPPER RESPIRATORY COMBINATION |
| PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE | SYRUP | UPPER RESPIRATORY COMBINATION |
| BROMHEXINE HYDROCHLORIDE, SLABUTAMOL SULPHATE, GUAIPHENESIN, MENTHOL | SYRUP | EXPECTORANTS |
| DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE | SYRUP | COUGH AND NASAL CONGESTION |
| PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE | SUSPENSION/DROPS/SYRUP | COUGH AND COLD |
| SALBUTAMOL SULPHATE | SUSPENSION | BRONCHODILATOR |
| THEOPHYLLINE | SOLUTION | ANTIASMTTMATIC |
| PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENAMINE MALEATE, PARACETAMOL, ASCORBIC ACID, CAFFEINE | CAPSULE | ANTICOLD |
| DEXTROMETHORPHAN | TABLET | ANTITUSSIVES |
| SALBUTAMOL SULPHATE | TABLET | BRONCHODILATOR |
| SALBUTAMOL, ETOFYLLINE, BROMHEXINE HYDROCHLORIDE | TABLET | BRONCHODILATOR |
| SALBUTAMOL, THEOPHYLLINE | TABLET | BRONCHODILATOR |
| PARACETAMOL, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE | TABLET | COUGH AND COLD MEDICATIONS |
| PARACETAMOL, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE | TABLET | COUGH AND COLD MEDICATIONS |
| PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE LEVOCETIRIZINE HYDROCHLORIDE | TABLET | COUGH AND COLD MEDICATIONS |
| PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE DI-HYDROCHLORIDE | TABLET | COUGH AND COLD MEDICATIONS |
| PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE | TABLET | COUGH AND COLD MEDICATIONS |
| BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN | TABLET | EXPECTORANT |
| AMBROXOL HYDROCHLORIDE | TABLET | MUCOLYTIC |
| PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE, CETIRIZINE HYDROCHLORIDE | TABLET | COUGH AND COLD MEDICATIONS |
| AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE | TABLET | NON-SEDATIVE ANTIHISTAMINES |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| GLIMEPIRIDE, METFORMIN HYDROCHLORIDE | TABLET | ANTI-DIABETIC DRUGS |
| METFORMIN HYDROCHLORIDE | TABLET | ANTI-DIABETIC DRUGS |
| METFORMIN HYDROCHLORIDE SUSTAINED RELEASE | TABLET | ANTI-DIABETIC DRUGS |
| SITAGLIPTIN PHOSPHATE | TABLET | ANTI-DIABETIC DRUGS |
| SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE | TABLET | ANTI-DIABETIC DRUGS |
| GLIBENCLAMIDE | TABLET | ANTI-DIABETIC DRUGS |
| GLIMEPIRIDE | TABLET | ANTI-DIABETIC DRUGS |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| DICLOFENAC DIETHYLAMINE, BENZYL ALCOHOL | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE, BENZYL ALCOHOL | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC DIETHYLAMINE, LINSEED OIL,MENTHOL , METHYL SALICYLATE, CAPSAICIN | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC DIETHYLAMINE, MENTHOL, METHYL SALICYLATE | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC DIETHYLAMINE, OLIUM LINI,MENTHOL , METHYL SALICYLATE, BENZYL ALCOHOL | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| KETOPROFEN | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| LIGNOCAINE HYDROCHLORIDE | GEL | ANESTHETICS |
| RACEMIC MENTHOL, PROCAINE HYDROCHLORIDE, BENZOCAINE | OINTMENT | ANESTHETICS |
| IBUPROFEN, MENTHOL, METHYL SALICYLATE, MEPHENESIN | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| NIFEDIPINE, LIDOCAINE HYDROCHLORIDE | CREAM | ANTIHEMORROIDAL |
| SUCRALFATE, METRONIDAZOLE, LIGNOCAINE HYDROCHORIDE | CREAM | ANORECTAL PREPARATIONS (BEDSORE, PILES AND ANAL FISSURES) |
| THYMOL, MENTHOL, ICHTHAMMOL, LIGNOCAINE HCl | OINTMENT | ANORECTAL PREPARATIONS |
| TROXERUTIN | GEL | ANTIHEMORROIDAL |
| UREA, LACTIC ACID, PROPYLENE GLYCOL, LIQUID PARAFFIN | CREAM | FOOT CREAM (TO TREAT DRY SKIN) |
| WHITE PETROLIUM JELLY, LIGHT LIQUID PARAFFIN | OINTMENT/CREAM | TOPICAL AGENT (TREAT ECZEMA AND RELATED DRY SKIN CONDITIONS) |
| IBUPROFEN | SUSPENSION | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| IBUPROFEN, PARACETAMOL | SUSPENSION | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| MEFENAMIC ACID, PARACETAMOL | SUSPENSION | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| LIGNOCAINE HYDROCHLORIDE | GEL | ANESTHETICS |
| RACEMIC MENTHOL, PROCAINE HYDROCHLORIDE, BENZOCAINE | OINTMENT | ANESTHETICS |
| CHOLINE SALICYLATE, LIGNOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE | GEL | ANALGESICS |
| ACECLOFENAC, PARACETAMOL | SUSPENSION | ANALGESIC /ANTIPYRETIC DRUG |
| ACETAMINOPHEN | SYRUP/SUSPENSION | MISCELLANEOUS ANALGESICS |
| CHLORBUTOL, BENZOCAINE, PARADICHLOROBENZENE | DROPS | OTIC AGENTS |
| DEFLAZACORT | SUSPENSION | GLUCOCORTICOIDS |
| NIMESULIDE | SUSPENSION | ANTI INFLAMATORY DRUG |
| PARACETAMOL | DROPS | ANTIPYRETICS |
| PARACETAMOL PAEDIATRIC | SUSPENSION | ANALGESIC /ANTIPYRETIC DRUG |
| DICYCLOMINE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN | CAPSULE | ANALGESICS / ANALGESIC /ANTIPYRETIC DRUG |
| RABEPRAZOLE (ENTERIC COATED), DICLOFENAC SODIUM (SUSTAINED RELEASE) | CAPSULE | ANTI INFLAMATORY DRUG |
| TRAMADOL HYDROCHLORIDE | CAPSULE | OPIOID ANALGESICS |
| ACECLOFENAC | TABLET | ANALGESIC |
| ACECLOFENAC, DROTAVERINE HYDROCHLORIDE | TABLET | ANALGESIC AND ANTIPYRETIC |
| ACECLOFENAC, PARACETAMOL | TABLET | ANALGESIC AND ANTIPYRETIC |
| PARACETAMOL | TABLET | ANALGESIC AND ANTIPYRETIC |
| PARACETAMOL DISPERSIBLE | TABLET | ANALGESIC AND ANTIPYRETIC |
| PARACETAMOL, CAFFEINE | TABLET | ANALGESIC AND ANTIPYRETIC |
| PARACETAMOL, CAFFEINE, ACETYLSALICYLIC ACID | TABLET | ANALGESIC AND ANTIPYRETIC |
| PARACETAMOL, ETODOLAC | TABLET | ANALGESIC AND ANTIPYRETIC |
| SULFASALZINE DELAYED RELEASE | TABLET | ANTI-RHEUMATIC DRUG |
| ARIPIPRAZOLE | TABLET | ATYPICAL ANTIPSYCHOTICS |
| ACECLOFENAC, PARACETAMOL, CHLORZOXAZONE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| ACECLOFENAC, PARACETAMOL, SERRATIOPEPTIDASE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| ACECLOFENAC, THIOCOLCHICOSIDE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| ACETYLSALICYLIC ACID | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC POTASSIUM | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC POTASSIUM, PARACETAMOL | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC POTASSIUM, PARACETAMOL, SERRATIOPEPTIDASE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC SODIUM | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC SODIUM, PARACETAMOL | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC SODIUM, PARACETAMOL, CHLORPHENAMINE MALEATE, MAGNESIUM TRISILICATE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| DICLOFENAC SODIUM, PARACETAMOL, CHLORZOXAZONE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| ETORICOXIB | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| ETORICOXIB, THIOCOLCHICOSIDE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| IBUPROFEN | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| IBUPROFEN, PARACETAMOL | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| IBUPROFEN, PARACETAMOL | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| INDOMETHACIN | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| KETOROLAC TROMETHAMINE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| MEFENAMIC ACID, DICYCLOMINE HYDROCHLORIDE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| MELOXICAM | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| METAMIZOLE SODIUM | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| METAMIZOLE SODIUM, PITOFENONE HYDROCHLORIDE, FENPIVERINIUM BROMIDE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| NIMESULIDE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| NIMESULIDE, PARACETAMOL | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| SERRATIOPEPTIDASE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
| TRAMADOL HYDROCHLORIDE | TABLET | OPIOID ANALGESICS |
| TRAMADOL HYDROCHLORIDE SUSTAINED RELEASE | TABLET | OPIOID ANALGESICS |
| TRAMADOL HYDROCHLORIDE, PARACETAMOL | TABLET | OPIOID ANALGESICS |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| ACYCLOVIR | OINTMENT | ANTIVIRAL |
| UMIFENOVIR HYDROCHLORIDE | CAPSULE | ANTIVIRAL |
| VALACYCLOVIR | TABLET | ANTIVIRAL |
| ACICLOVIR | TABLET | ANTIVIRAL |
| ACICLOVIR DISPERSIBLE | TABLET | ANTIVIRAL |
| COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
| ISOXSUPRINE HYDROCHLORIDE | CAPSULES | VASODILATORS |
| LISINOPRIL DIHYDRATE | TABLET | ACE INHIBITORS |
| LOSARTAN POTASSIUM | TABLET | ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (TREAT HIGH BLOOD PRESSURE) |
| LOSARTAN POTASSIUM, HYDROCHLORTHIAZIDE | TABLET | ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (TREAT HIGH BLOOD PRESSURE) |
| TELMISARTAN | TABLET | ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (TREAT HIGH BLOOD PRESSURE) |
| TELMISARTAN, CHLORTHALIDONE | TABLET | ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (TREAT HIGH BLOOD PRESSURE) |
| TELMISARTAN, HYDROCHLORTHIAZIDE | TABLET | ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (TREAT HIGH BLOOD PRESSURE) |
| TRANEXAMIC ACID | TABLET | ANTIFIBRINOLYTICS (TREAT HEAVY BLEEDING) |
| TRANEXAMIC ACID, ETAMSYLATE | TABLET | ANTIFIBRINOLYTICS (TREAT HEAVY BLEEDING) |
| TRANEXAMIC ACID, MEFENAMIC ACID | TABLET | ANTIFIBRINOLYTICS (TREAT HEAVY BLEEDING) |
| ETAMSYLATE, MEFENAMIC ACID, TRANEXAMIC ACID |
TABLET | ANTIHEMORRHAGIC |
| AMLODIPINE, LISINOPRIL | TABLET | ANTI-HYPERTENSIVE DRUGS |
| AMLODIPINE, LOSARTAN POTASSIUM | TABLET | ANTI-HYPERTENSIVE DRUGS |
| ATENOLOL | TABLET | BETA BLOCKERS |
| BISOPROLOL FUMARATE | TABLET | BETA BLOCKERS |
| METOPROLOL TARTRATE | TABLET | BETA BLOCKERS |
| PROPRANOLOL HYDROCHLORIDE | TABLET | BETA BLOCKERS |
| PROPRANOLOL HYDROCHLORIDE, FLUNARIZINE DIHYDROCHLORIDE | TABLET | BETA BLOCKERS |
| AMLODIPINE | TABLET | CALCIUM CHANNEL BLOCKERS |
| AMLODIPINE, ATENOLOL | TABLET | CALCIUM CHANNEL BLOCKERS |
| AMLODIPINE, TELMISARTAN | TABLET | CALCIUM CHANNEL BLOCKERS |
| DILUTED ISOSORBIDE MONONITRATE | TABLET | CORONARY HEART DISEASE |
| ETHAMSYLATE | TABLET | HEMOSTATIC AGENT |
| ATORVASTATIN | TABLET | HMG-COA REDUCTASE INHIBITORS |
| ROSUVASTATIN CALCIUM | TABLET | HMG-COA REDUCTASE INHIBITORS |
| DIPYRIDAMOLE | TABLET | PLATELET INHIBITOR PREVENT BLOOD CLOTS |
| ISOXSUPRINE HYDROCHLORIDE | TABLET | VASODILATORS |
| DIGOXIN | TABLET | CARDIAC GLYCOSIDE |
| CAPTOPRIL | TABLET | ACE INHIBITORS (HYPERTENSION) |